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1 Abstract 
Adenylyl cyclase catalyses the conversion of adenosine triphosphate 
into 3',5'-cyclic adenosine monophosphate and pyrophosphate. Adenylyl 
cyclases are grouped into six distinct Classes based on amino acid sequence 
similarity. Mammalian adenylyl cyclases and numerous prokaryotic adenylyl 
cyclases are grouped into Class III. Class III is further sub-divided into four 
sub-Classes, Ilia, lllb, lllc, and Mid, based upon amino acid polymorphisms 
within the active site. Class Ilia adenylyl cyclases include the mammalian G-
protein regulated transmembrane adenylyl cyclases and numerous prokaryotic 
adenylyl cyclases such as Rv1625c from Mycobacterium tuberculosis. Class 
lllb adenylyl cyclases include the mammalian soluble adenylyl cyclase and 
numerous prokaryotic adenylyl cyclase such as CyaB1 from Anabaena P C C 
7120. Class lllb adenylyl cyclases are stimulated by inorganic carbon. New 
findings dispute whether the inorganic carbon stimulation of Class lllb adenylyl 
cyclases is by HCO3" or C O 2 . Class Ilia adenylyl cyclases have previously 
been demonstrated to be non-responsive to HCO3" but have not been 
investigated with C O 2 . 
Experiments were performed using the prokaryotic Class Ilia adenylyl 
cyclase Rv1625c204^3- The specific activity of Rv1625c204^3 was obtained by 
measuring the conversion of [a-^^P]ATP into pP]cAMP. Rv1625c204^43 was 
assayed for pH dependence, cation dependence, dose dependence, enzyme 
kinetics, and inorganic carbon-activating species in the presence or absence of 
inorganic carbon. The results showed that in vitro Rv1625c204^3 is stimulated 
by C O 2 and not HC03' below pH 7.5 with an apparent E.C.50 value of 13.2 ± 
0.6 mM. Experiments were performed to investigate in vivo C O 2 stimulation of 
Rvl 625C204-443 transformed into Escherichia coli cells. The results showed that 
in vivo Rvl 625C204-443 is stimulated by 10 % (v/v) C O 2 in air. 
C O 2 stimulation of Rv1625c204^3 was further investigated by identifying 
the conditions required for C O 2 to bind to Rv1625c204-443. Numerous 
spectroscopic and biochemical techniques were used to identify conditions 
required for C O 2 binding such as circular dichroism spectroscopy, fourier 
transform infrared spectroscopy, HC03' dependent luminescence probe 
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spectroscopy, C O 2 stimulation a s s a y s on Rv1625c204^3 mutant proteins, and 
^'^C02 binding a s s a y s . The results showed that metal is not required for C O 2 
binding. C O 2 binds solely to the apoprotein. 
As C O 2 does not require any cofactors or substrate to bind to 
Rv1625c204^3, the elucidation of the C O 2 binding site on Rv1625c204-443 was 
attempted. Numerous binding sites were investigated, such as amino acids in 
the active site with a primary or secondary amine side group (forming a 
potential carbamate with C O 2 ) . Double and triple amino acid C O 2 binding sites 
were also investigated by identifying the amino acids that con-espond to the 
HCO3' binding site from mammalian soluble adenylyl cyclase. C O 2 binding was 
also investigated by growing Rv1625c crystals, exposing the crystals to C O 2 
and X-ray diffraction studies on the crystals to obtain a diffraction data set. 
Unfortunately none of these techniques was able to identify the C O 2 binding 
site of Rv1625c. 
This surprising and novel finding that C O 2 binds and stimulates 
Rv1625c204^3 suggests that other C l a s s Ilia adenylyl cyclases, including the 
heterotrimeric G-protein stimulated mammalian adenylyl cyclases are also 
stimulated by C O 2 and further work needs to be done in this area. 
Phillip Holliday 
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1.4 Abbreviations 
2-HE 2-hydroxyestradiol 
2-ME 2-mercaptoethanol 
AC adenylyl cyclase 
ADP adenosine diphosphate 
AMPCPP a,p-methyleneadenosine 5'-triphosphate 
Arg arginine 
Asn asparagine 
Asp aspartate 
ATP adenosine triphosphate 
BSA bovine serum albumin 
CA carbonic anhydrase 
CaM calmodulin 
cAMP 3',5'-cyclic adenosine monophosphate 
CB carotid body 
CBF cilia beat frequency 
CD circular dichroism 
C E catechol oestrogen 
CFTR cystic fibrosis transmembrane conductance regulator 
cGMP 3',5'-cyclic guanosine monophosphate 
CHAPS 3[(3-Cholamidopropyl)dimethylammonio]-propanesulfonic acid 
CHES 2-(cyclohexyamino)ethanesulfonic acid 
Ci inorganic carbon 
CIAP calf intestine alkaline phosphatase 
C R E B cAMP-response element binding protein 
CRP cAMP receptor protein 
CT cholera toxin 
DNA deoxyribonucleic acid 
EDTA ethylenediaminetetraacetic acid 
EEA1 early endosomal antigen 1 
E F edema factor 
EPAC exchange proteins activated by cAMP 
E S electrospray 
FTIR fourier transform infrared 
GAF cGMP-phosphodiesterase, adenylyl cyclases and formate 
hydrogen lyase transcriptional factor 
GALT gut-associated lymphoid tissue 
G C guanylyl cyclase 
GDP guanosine diphosphate 
Gin glutamine 
GPCR G protein-coupled receptor 
GTP guanosine triphosphate 
HAMP histidine kinase, adenyl cyclase, methyl accepting chemotaxis 
proteins and phosphatases 
HEK human embryonic kidney cells 
HEPES N-(2-hydroxyethyl)pipera2ine-N'-(2-ethanesulfonic acid) 
His histidine 
HPLC high performance liquid chromatography 
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HTH helix-turn-helix 
IPTG isopropyl-p-D-thiogalactopyranoside 
LAMP1 lysosomal membrane protein 1 
LB luria broth 
LF lethal factor 
Lys lysine 
MANT N-methylanthraniloyI 
MES 2-morpholinoethanesufonic acid 
mRNA messenger ribonucleic acid 
MS mass spectroscopy 
MTSCE 2-carboxyethyl methanethiosulfonate 
Ni-NTA nickel-nitrilotriacetic acid 
NGF nerve growth factor 
ONP ortho-nitrophenol 
ONPG ortho-nitrophenol-p-D-galactopyranoside 
PA protective antigen 
PAGE polyacrylamide gel electrophoresis 
PAS period clock protein, aryl hydrocarbon receptor and single-
minded protein 
P C O 2 partial pressure of carbon dioxide 
PCR polymerase chain reaction 
PDE phosphodiesterase 
P E G polyethylene glycol 
PKA cAMP-dependent protein kinase A 
PKC cAMP-dependent protein kinase C 
PMSF phenylmethylsulfonyl fiuoride 
poly-P polyphosphates 
PPi pyrophosphates 
PTS phosphotransferase transport system 
Rubisco ribulose-1,5-bisphosphate carboxylase/oxygenase 
sAC soluble adenylyl cyclase 
SDS sodium dodecyl sulphate 
Ser serine 
S O C super optimal catabolite repression 
TAE tris-acetate-EDTA 
TCP toxin-co-regulated pilus 
Thr threonine 
tmAC transmembrane adenylyl cyclase 
TOF time of flight 
Tris tris(hydroxymethyl)aminomethane 
TTSS type III secretion system 
Val valine 
V-ATPase vacuolar H+ ATPase 
10 
Introduction Phillip Holliday 
2 Introduction 
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2.1 cAMP as an intracellular messenger 
cAMP (3',5'-cyclic adenosine monophosphate) was first discovered 
when dog liver homogenates were incubated with ATP (adenosine 
triphosphate) in the presence of adrenaline and glucagon (Rail and 
Sutherland, 1958). Mg *^ ions were also found to be required for the formation 
of cAMP (Sutherland and Rail, 1958). Other particulate preparations from 
heart, skeletal muscle, and brain also formed cAMP under the same conditions 
(Sutherland and Rail, 1958). The enzyme responsible for the conversion of 
ATP into cAMP was termed adenyl cyclase (now known as adenylyl cyclase 
(AC) or adenylate cyclase) and was found in all animal tissues sampled 
(Sutherland et a/., 1962). Increased concentrations of cAMP in the cell diffuse 
through the cytosol and bind to cAMP-dependent protein kinase A (PKA) 
(Walsh etal., 1968), Exchange Proteins Activated by cAMP (EPACs) (de Rooij 
et a/., 1998; Kawasaki ef a/., 1998), cyclic nucleotide gated ion channels 
(Kaupp a/., 1989; Goulding et a/., 1992), and the GAF (cGMP-
phosphodiesterase, adenylyl cyclases and formate hydrogen lyase 
transcriptional factor) domains of phosphodiesterase (PDE) 10 (Gross-
Langenhoff et a/., 2006). Activation of PKA is important for the regulation of 
metabolism and gene expression. PKA activates phosphorylase kinase which 
in turn activates phosphorylase thus increasing the breakdown of glycogen into 
glucose. PKA also controls gene expression by activating transcription factors 
such as C R E (cAMP-response element)-binding protein (CREB), which binds 
to consensus C R E sequences in DNA (deoxyribonucleic acid) and initiates 
gene transcription. This effect is hormone and tissue specific, for example 
adrenaline induces hydrolysis of triglycerides in adipose tissues but increases 
the conversion of glycogen to glucose in the liver (Sutherland, 1972). 
In prokaryotic organisms, cAMP was first discovered in Escherichia coli 
where limitation of carbon and energy sources led to an increase in cAMP 
levels (Makman and Sutherland, 1965). E. coli cells grown on glucose 
produced low levels of cAMP, however when the glucose was exhausted 
cAMP levels increased and then dropped again on addition of more glucose. 
This together with the finding that glucose repressed the synthesis of p-
12 
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galactosidase, suggested that glucose may repress synthesis via a cAMP-
dependent pathway. This hypothesis was shown to be correct by adding cAMP 
to E. coli cultures. cAMP overcame the inhibitory effects of glucose and 
produced p-galactosidase (Perlman and Pastan, 1968). The physiological role 
of cAMP was confirmed by analysis of AC deficient (cya) E. coli (Ide, 1969; 
Tao and Lipmann, 1969) that were unable to utilise lactose or galactose as a 
substrate or numerous other sugars that were also subject to glucose 
repression (Pastan and Perlman, 1969). The addition of cAMP restored the 
ability of the E. coli cya mutants to utilise these sugars and synthesise p-
galactosidase. A cAMP receptor protein (CRP), also known as catabolite 
activator protein (Zubay et a/., 1970) and catabolite gene activator (Riggs et 
a/., 1971) was identified by the addition of cAMP to cya E. coli mutants that 
were not able to synthesise p-galactosidase. On addition of the purified CRP to 
the cAMP-unresponsive cya E. coli mutants, p-galactosidase synthesis was 
recovered demonstrating that CRP is required for cAMP activity (Emmer et a/., 
1970). 
2.2 Classification of ACs 
ACs have an important role in amplifying primary signals. When a 
primary signal, such as a hormone e.g. epinephrine, binds to its receptor on 
the cell surface, the signal is passed to intracellular targets, such as protein 
kinases, ion channels or transcription factors, via ACs. Thus a cellular 
response is produced from the initial primary signal. ACs encompass a large 
group of proteins that may be the product of convergent evolution and have 
been categorised into six distinct classes based on their amino acid sequence 
similarity (Barzu and Danchin, 1994; Cotta et a/., 1998; Sismeiro et a/., 1998; 
Tellez-Sosa etal., 2002). 
Examples of some ACs from the six classes will be discussed below in 
the context of the organism that the ACs are found in and their function within 
the organism. 
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2.2.1 C lass I ACS 
Class I AGs are found in enterobacterial, gram-negative bacteria such 
as Salmonella typhimurium (Carter and Collins, 1974), Vibrio cholerae 
(Mekalanos et a/., 1983), Vibrio vulnificus (Jacket ef a/., 1984), Yersinia 
enterocolitica (Cornelis et a/., 1998), and E. coli (Linder, 2008). They are 
involved in either catabolite repression or the development of virulence through 
the regulation of virulence protein production. 
2.2.1.1 S. typhimurium 
S. typhimurium, is the causative agent of food-borne infectious 
gastroenteritis in humans and infects the gut-associated lymphoid tissue 
(GALT) (Carter and Collins, 1974). The Salmonella pathogenicity island 1 
(SPI1) encodes a TTSS that transports bacterial effecter proteins into the host 
cell eventually leading to internalisation of the bacterium into the cell (Hueck et 
a/., 1995). Construction of cya and crp mutants produced strains that still 
attached and invaded GALT but were otherwise avirulent, thus identifying 
cAMP as a regulator of pathogenesis (Curtiss and Kelly, 1987). 
2.2.1.2 V. cholerae 
The human pathogen that causes severe diarrhoea, V. cholerae, 
secretes a multimeric cholera toxin (CT) protein composed of one A subunit 
and 5 B subunits (Mekalanos et a/., 1983). Toxin-co-regulated pilus (TCP), 
which aids intestinal colonisation, is co-ordinately expressed with CT (Taylor et 
a/., 1987) and the transmembrane DNA-binding protein (ToxR) positively 
regulates expression of CT, TCP, and accessory colonisation factors 
(Peterson and Mekalanos, 1988). Insertion mutation of the cya and crp genes 
increased the expression of the CT promoter and thus negatively regulated the 
expression of ToxR-regulated virulence genes and pathogenesis (Skorupski 
and Taylor, 1997). 
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2.2.1.3 V. vulnificus 
The pathogenic marine bacterium V. vulnificus is the causative agent of 
gastroenteritis and septicaemia in immune compromised patients (Jacket et 
a/., 1984). The organism's virulence factor haemolysin is encoded by a gene, 
wh that has a cAMP-CRP binding promoter sequence. The addition of cAMP 
increased haemolysin production and the presence of glucose inhibited 
production. Mutants deleted for the cya AC gene of V. vulnificus displayed a 
significantly lower virulence in mice and a decrease in haemolysin and 
protease production (Kim et a/., 2005). 
2.2.1.4 Y. enterocolitica 
The gram-negative pathogen Y. enterocolitica causes gastrointestinal 
illnesses in mammals through a cAMP-dependent virulence pathway. 
Production of cya and crp mutants, which encode Cya and the CRP 
respectively, affected the production of virulence proteins that are transported 
by all three hypothesised pathogenic pathways; the Yse (Cornells et a/., 1998), 
Ysa (Haller et a/., 2000), and flagellar type III secretion system (TTSS) (Young 
et a/., 1999). Complementation of the mutants with wild type genes restored 
protein production of each pathogenic pathway (Petersen and Young, 2002) 
suggesting that Cya is required for formation and transport of all virulence 
proteins. 
2.2.1.5 E. co/i 
Growth of £. coli in lactose instead of glucose leads to the induction of 
the phosphoenolpyruvate-sugar phosphotransferase transport system (PTS) 
proteins which in turn activate Cya, a Class I AC, to produce cAMP (Linder, 
2008). cAMP binds to the CRP which subsequently binds to and activates a 
catabolic promoter at a specific recognition sequence of a gene for 
degradation of lactose. The catalytic domain of the E. coli Class I AC was over 
expressed and purified and it displayed a Vmax of 665 nmol mg'"" min"^  and a Km 
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of 2 7 0 |JM (Linder, 2 0 0 8 ) . Twelve amino acids were identified by mutagenesis 
as essential for catalysis, with five residues clustered in a region of the gene 
that is conserved in all proteins of the DNA polymerase p-like 
nucleotidyltransferase superfamily. From these five residues, D 1 1 4 and D116 
were proposed to be involved in metal co-factor binding and S 1 0 3 was 
proposed to be involved in substrate binding. 
2.2.2 Class II A C s 
Class II ACs are produced by pathogenic organisms including Bacillus 
anthracis (Baillie and Read, 2 0 0 1 ) , Bordetella pertussis (Ladant and Ullmann, 
1 9 9 9 ) , and Pseudomonas aeruginosa (Yahr ef a/., 1998 ) . All cause infections 
in immune compromised patients such as cancer patients, HIV* patients, and 
cystic fibrosis sufferers (Garau and Gomez, 2 0 0 3 ) . These phylogenetically 
unrelated bacteria all secrete toxins into the host cell using AC as part of the 
mechanism. 
2.2.2.1 B. anthracis 
The anthrax toxin of 8. anthracis is composed of three proteins, 
protective antigen (PA), lethal factor (LF) and edema factor (EF), which form 
protein pairs that infect host cells to cause death (PA and LF) or edema (PA 
and EF) in the skin (Leppla, 1 9 8 2 ) . E F is a calmodulin (CaM) dependent AC 
(Quo ef a/., 2 0 0 4 ) that is produced in an inactive form,however it is activated 
by contact with the host cell. E F is composed of two functional domains, an N-
terminal 3 0 kDa domain that enables entry into cells by binding the anthrax 
protective antigen (Elliott et a/., 2 0 0 0 ) and a C-terminal 5 8 kDa AC that shares 
sequence homology to CyaA from B. pertussis and ExoY from P. aeruginosa 
(Shen et a/., 2 0 0 2 ) . E F has a for ATP of 0.2-1 mM and a catalytic efficiency 
{kcaxIKm) of approximately 10^ M'^s"\ around 100-fold higher than in 
mammalian ACs (Quo et a!., 2 0 0 4 ) . 
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2.2.2.2 B. pertussis 
In the case of S. pertussis, CyaA, a 188 kDa AC toxin translocates 
across the plasma membrane into the host cell by a two step internalisation 
process, where CyaA initially binds to the cell surface and then internalises in 
a temperature and Ca^* dependent manner (Mock and Ullmann, 1993). Once 
CyaA enters the host cell's cytoplasm, it binds to CaM and produces high 
concentrations of cAMP, which causes cell apoptosis (Khelef et a/., 1993) 
CyaA from 6. pertussis is a CaM activated AC that is able to translocate 
across the plasma membrane of the infected cell through a process called 
intemalisation. CyaA is constructed of an N-terminal AC domain and a C-
terminal domain involved in haemolytic activity and delivery of the AC domain 
into the targeted cell (Bertini et a/., 2004). The AC domain has a high affinity 
for CaM (0.2 nM) which stimulates activity (/Ccat = 2000 s" )^ by over 1000-fold 
(Ladant and Ullmann, 1999). 
2.2.2.3 P. aeruginosa 
P. aeruginosa infects through the TTSS which regulates numerous 
effecter proteins from the exoenzyme S regulon, such as ExoS, ExoT, ExoU, 
and ExoY, in response to host environmental factors (Yahr et a/., 1998). ExoS 
and ExoT are ADP (adenosine diphosphate)-ribosyltransferases, ExoU is an 
acute cytotoxin, and ExoY is a Class II AC (Wolfgang et a/., 2003). On contact 
with a host epithelial cell, the TTSS is activated by stimulation of a membrane-
localised Class III AC, CyaB (Smith et a/., 2004). cAMP subsequently binds to 
a transcriptional regulator, Vfr, which positively regulates the expression of 
ExoY and the other TTSS component proteins for a secretory apparatus and 
the production of toxins that alter host signal transduction pathways, leading to 
cell death. The T T S S also activates the expression of genes for the production 
of pili and flagella (Wolfgang et a/., 2003), which are important for motility and 
attachment to host cells. 
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2.2.3 Class III ACS 
Class III is the predominant class of AC found in eukaryotes and many 
prokaryotes, which gives rise to the class being called the Universal Class. 
The catalytic domains of Class III ACs form dimers, which have six canonical 
amino acids that are essential for catalysis. Two aspartate (Asp) residues bind 
the two metal cofactors; a lysine (Lys) and Asp pair selectively bind ATP; and 
an arginine (Arg) and asparagine (Asn) pair stabilise the transition state 
(reviewed by Linder and Schultz, 2003). Further details of the Class III AC 
catalytic domain will be discussed in Section 2.3. Most Class III ACs are multi-
domain proteins that demonstrate a large variety in protein composition and 
therefore display a large variety of regulatory signals (Linder, 2006). Class III 
ACs can be subdivided into four subclasses based on the divergence of amino 
acid sequence of the catalytic domain, particularly among the six canonical 
residues. These subclasses have been designated Class Ilia, lllb, lllc and llld 
and their distinguishing features are listed in Table 2.1. 
2.2.4 Class IV, V and VI A C s 
The remaining three classes of ACs have only one AC member 
characterised in each class and little information is known about these Classes 
at present. The Class IV AC was identified in the anaerobic, gram-negative 
bacterium, Aeromonas hydrophila. A. hydrophila is an opportunistic pathogen 
that can cause gastroenteritis, wound infections, septicaemia, and meningitis 
in humans (Janda, 1991). A. hydrophila contains 2 AC genes, cya-A encoding a 
Class I AC and cyafi encoding AC2, which is the Class IV AC that has no 
sequence similarity to any of the other class of ACs (Sismeiro et a/., 1998). 
AC2 has an optimum activity at a high temperature (65 °C) and at an alkaline 
pH (9.5); and a significant sequence similarity to proteins of Methanobacterium 
thermoautotrophicum, Archaeglobus fulgidus and Methanococcus jannaschii, 
all of which are hyperthermophilic archaebacteria. 
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Table 2.1: Distinguishing features of the subclasses of Class III ACs 
(Linder and Schultz, 2003). 
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Class Ilia AC Signature motifs of (FA')XX(FA')D participating in formation of 
dimer interface and EKIK containing substrate-defining K. 
Arm region (essential feature for dimerisation (Tesmer et a/., 
1997)) is 14 residues long. 
Class nib AC Distinguished by replacement of substrate-defining Asp with 
Thr/Ser and frequently the replacement of a phosphate-binding 
Arg with Gly/Ser. 
Arm region extended to 15 residues. 
Class 1 lie AC Arm region only 7 to 11 residues long. 
Class Mid AC Signature motif of YEVKT around substrate-defining K. 
Arm region is 14 residues long. 
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The only Class V A C found so far is from the ruminal anaerobic 
bacterium Prevotella ruminicola (Cotta et a/., 1998) and encodes a 67 kDa 
protein that has no sequence similarity with any other protein in the GenBank 
database. 
The Class VI AC was identified in Rhizobium etii by phenotypic 
complementation of an E. coli cya mutant strain with a genomic library by 
restoring cAMP accumulation in the E. coli mutant (Tellez-Sosa et a/., 2002). 
The protein product of the cyaC gene does not have any sequence similarity 
with any other known protein. 
2.3 Mammalian C l a s s III A C s 
All mammalian ACs are from Class III and are represented by 10 AC 
isoforms encoded by distinct genes. Nine AC isoforms are from Class Ilia and 
are membrane-associated owing to the presence of two sets of six 
transmembrane domains and are termed tmACs. These ACs are hormone 
regulated via heterotrimeric G proteins and other activators which will be 
discussed later (Section 2.3.2). The other mammalian AC isoform is a soluble 
AC (sAC) from Class 11 lb and it is more closely related to bacterial ACs than 
mammalian tmACs (Buck et a/. 1999). tmACs and sAC differ structurally, 
molecularly, and biochemically and therefore define two separate cAMP 
pathways in mammalian cells (Kamenetsky et a/., 2006). 
2.3.1 Structure of the Class Ilia A C s 
Before the molecular identification of the 10 isoforms of mammalian 
ACs, only 3 types of ACs were biochemically characterised, a brain specific 
AC that is activated by Gsa and Ca^*-CaM, a ubiquitous Gga activated AC, and 
sAC (Sunahara et a/., 1996). Purification of the brain specific AC (that is 
activated by Gsa and Ca^*-CaM) using forskolin affinity chromatography 
enabled the generation of probes to isolate cDNA for the AC which was termed 
type 1 (Krupinski et a/., 1989). Molecular cloning techniques identified 8 other 
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AC cDNAs (types 2-9). Type 2 AC cDNA was cloned from rat brain (Feinstein 
et a/., 1991), type 3 AC cDNA was cloned from rat olfactory tissue (Bakalyar 
and Reed, 1990), type 4 AC cDNA was cloned from rat testes (Gao and 
Gilman, 1991), type 5 AC cDNA was cloned from dog heart (Ishikawa et a/., 
1992) and rat liver and kidney (Premont ef a/., 1992), type 6 AC cDNA was 
cloned from dog heart (Katsushika ef a/., 1992), rat heart, liver and kidney 
(Premont ef a/., 1992), mouse S49 lymphoma cells (Premont ef a/., 1992) and 
mouse/hamster hybrid NCB-20 cells (Yoshimura and Cooper, 1992), type 7 
AC cDNA from mouse and S49 lymphoma cells (Watson ef a/., 1994), type 8 
AC cDNA from rat brain tissue (Call ef a/., 1994) and type 9 AC cDNA from 
mouse brain tissue (Premont ef a/., 1996). The final isoform to be identified 
was sAC cDNA from rat testis (Buck ef a/., 1999). 
The tissue specificity of ACs has been elucidated by mRNA (messenger 
ribonucleic acid) studies, which have shown a large diversity of expression for 
the different isoforms, from being widely expressed, to only being found in 
specific tissue. Mammalian ACs are generally found in excitable tissue such as 
neurons and muscle, although they are not limited to those tissues. AC1 is 
found in distinct regions of the brain such as the hippocampus and cerebral 
cortex (Xia ef a/., 1991) and the adrenal medulla with its possible function 
linked to learning and memory (Shen ef a/., 1997). AC2 is found in the brain, 
heart, lungs and skeletal muscle (Suzuki ef a/., 1998). The highest expression 
of AC3 is in the olfactory neuroepithelium (Bakalyar and Reed, 1990) of the 
brain. AC4 and ACS are both expressed in the brain, heart, kidneys, the 
glomerulus of the liver (Chabardes ef a/., 1996), lungs, uterus and brown 
adipose tissue (Edelhoff ef a/., 1995), while the adrenal gland and testes 
express AC5 solely. AC6 and AC7 are both ubiquitous (Haber ef a/., 1994) and 
are therefore found in most tissues, with AC7 being highly expressed in 
numerous parts of the brain where it could be involved in drug dependency 
(Hellevuo ef a/., 1995). In the heart, AC6 is expressed in non-myocyte cells 
whereas AC5 is expressed in myocyte cells (Yu ef a/., 1995). 
AC8 is found in the hypothalamus (Matsuoka ef a/., 1992) with possible 
functions in learning and memory and it is also expressed in the heart, lungs, 
uterus and testes (Stengel ef a/., 1992). AC9 is found in the brain and skeletal 
muscle (Hacker ef a/., 1998). 
22 
Introduction Phillip Holliday 
Mammalian Class Ilia ACs contain 12 transmembrane spanning 
segments that can be divided into two sets of six transmembrane domains, 
Tml and Tm2. Adjacent to each transmembrane domain is a cytoplasmic 
domain. The two cytoplasmic domains are similar but not identical and are 
termed C I and C2 and dimerise to form a pseudosymmetric heterodimer 
(Figure 2.1). Both cytoplasmic domains can be further characterised into two 
segments, C1a/C2a and C1b/C2b. C I a and C2a are highly conserved 
sequences that are homologous to each other and contain the catalytic 
residues, whereas C l b and C2b are less conserved and probably contain 
regulatory sites. 
The cytoplasmic domains have six specific residues that are conserved 
in most Class III ACs. These residues are important for binding a metal 
cofactor or nucleotide substrate and also for the stabilisation of the catalytic 
transition state. This information was elucidated from sequence and mutational 
analyses and crystal structure analyses. The CI a domain contains two Asp 
residues that coordinate the first metal cofactor A, which in vivo is usually a 
Mg^ "^  ion. The catalytic mechanism is similar to that of DNA polymerase 
(Zimmermann et a!., 1998), where the hydrated metal ion A lowers the pKa 
value of the hydrogen of the ribose ring 3'-0H group so that deprotonation 
occurs more easily. The resulting 3'-0" nucleophilically attacks the a -
phosphoryl group of ATP, eliminating PPi (pyrophosphate) (Tesmer et a/., 
1999). 
The elimination of PPi is aided by the other hydrated metal cofactor B, 
which lowers the pKa values of the p- and the y-phosphoryl groups of ATP, 
making them a good leaving group. The C2a domain contains a Lys and Asp 
residue pair that gives the AC its substrate selectivity towards ATP and not to 
other nucleotides. The C2a domain also has an Arg and Asn pair that stabilise 
the transition state of the reaction (Tesmer ef a/., 1999). 
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Figure 2.1: Schematic topology of the pseudoheterodimeric Class Ilia 
mammalian AC. The AC is subdivided into the first six transmembrane domain 
Tml (blue cylinders), the first cytoplasmic domain consisting of CI a (red) and 
C l b (black), the second six transmembrane domain Tm2 (blue cylinders), the 
second cytoplasmic domain consisting of C2a (green) and C2b (black). 
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Tml Tm2 
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2.3.2 Activators of mammalian Class Ilia ACs 
Mammalian tmACs are found adjacent to G protein-coupled receptors 
(GPCR), which are seven transmembrane receptors that mediate signal 
transduction through the dissociation of heterotrimeric G proteins. The binding 
of an extracellular signal such as a hormone or neurotransmitter to the 
receptor of a GPCR causes a conformational change that activates an 
adjacent heterotrimeric G protein through the exchanging of guanosine 
diphosphate (GDP) for guanosine triphosphate (GTP) on the a-subunit. This 
activation causes the heterotrimeric G protein to breakdown into a G a subunit 
and a Gpy subunit pair. The G a subunit activates the adjacent tmAC in either a 
stimulatory (Gas) or inhibitory {Ga,) fashion. The Gas subunit binds between 
the C I and C2 domains of AC, at the perimeter of the catalytic centre and aids 
the closing of the catalytic centre around the substrate (Sunahara eta!., 1997). 
Other G protein subunits, such as GPy or Ga, selectively regulate some 
of the mammalian AC isoforms by either stimulating or inhibiting their activity 
(Sprang, 1997). Gpy subunits inhibit AC1 and AC8 but stimulate AC2, AC4 and 
AC7 when Gas is present. It has been suggested that GPy could be increasing 
the ability of Gas to activate AC in AC2, AC4 and AC7 (Dessauer et a/., 1998). 
Gai subunits inhibit ACS and AC6 but not through competition with Gas 
subunits as they bind to a pseudosymmetrical site to the Gas binding site on 
the C I domain in ACS (Dessauer et a/., 1998). This binding of the Gai subunit 
maintains the open form of the catalytic centre even in the presence of ATP. 
Forskolin, a diterpene from the roots of Coleus forskohlii (Bhat et a/., 
1977) was initially discovered to stimulate mammalian ACs in rat brain 
(Seamon ef a/., 1981). It stimulates all mammalian AC isoforms except sAC, 
although AC9 is only weakly stimulated (Premont et a!., 1996). Forskolin binds 
to the non-catalytic pocket of the catalytic centre of the pseudoheterodimeric 
AC (Zhang et al., 1997). 
Ca^" can also regulate AC activity. It has also been shown that CaM 
affects AC activity (Cali et al., 1994). Ca^" ions activate isoforms AC1, AC3 
and AC8, with activation via CaM in AC1 and AC3 (Fagan et al., 1996). The 
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E.C.50 value of free Ca^* concentrations for stimulation of AC1 is 0.05 pM, well 
within physiological ranges (Choi ef a/., 1992). Ca^" ions can also inhibit the 
activity of all ACs when the concentration is in the millimolar range, however 
even at physiological concentrations, isoforms AC5 and AC6 are inhibited 
(Guillou ef a/., 1999). These isoforms are localised in the brain and in excitable 
cell types, which may explain their sensitivity to Ca^" concentrations. 
cAMP signalling in mammals can also be regulated through 
desensitisation of G protein-coupled receptor activation and also through 
desensitisation of the AC. AC6 is desensitised through direct phosphorylation 
of S674 on the C l b region by PKA or PKC (cAMP-dependent protein kinase 
C) which results in a 50 % decrease in AC activity (Chen ef a/., 1997). C O 2 has 
also been demonstrated to stimulate mammalian G-protein regulated ACs in 
vitro. Inorganic carbon (Ci) assays on 7C1.2C2 identified that C O 2 and HCO3" 
was stimulating 7C1.2C2, with a maximum 2-3-fold stimulation at 7 mM C O 2 
(Townsend ef a/., 2009). 7C1.2C2 was also demonstrated to be C O 2 
responsive in vivo in HEK 293T cells, where exposing the cells to 5 % (v/v) 
C O 2 whilst stimulating the recombinant AC with isoproterenol, a p-adrenergic 
receptor agonist, increased the accumulation of cAMP (Townsend ef a/., 
2009). 
2.3.3 Inhibitors of mammalian Class Ilia A C s 
The identification of a specific AC inhibitor has numerous advantages, 
such as identifying the processes that are involved with cAMP at the cellular 
level and creating inhibitors for toxic ACs such as E F produced by S. anthracis 
and CyaA by B. pertussis. Inhibitor specificity for AC is a problem that is 
gradually being overcome with the development of new AC inhibitors, which 
are discussed below. 
Substrate analogues and the majority of nucleotide inhibitors of Class 
Ilia ACs are derived from adenosine (Johnson and Shoshani, 1990). Substrate 
analogues, such as a,p-methylene-ATP and Rp-ATPaS that inhibit tmACs, 
competitively bind to the unliganded enzyme (Dessauer ef a/., 1999). All 
mammalian isoforms including sAC are inhibited by P-site inhibitors, which 
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non-competitively inhibit by binding to the enzyme when it is in a conformation 
that resembles the product-bound state (Dessauer and Gilman, 1997). P-site 
inhibitors are compounds that contain an intact purine ring, bind to the active 
site of an AC and inhibit the enzyme in either a non-competitive manner, 
usually in the presence of Mn *^ ions (Johnson ef a/., 1979) or an un-
competitive manner, usually in the presence of Mg^ "^  ions (Welton and Simko, 
1980). The concentration of P-site inhibitor has no effect on substrate binding. 
The binding of a P-site inhibitor is thought to form a dead-end complex (Florio 
and Ross, 1983) where the inhibitor binds to the AC with PPi still bound to the 
AC. Thus the inhibitor binds to the enzyme-substrate complex or the enzyme-
product complex and not to the free enzyme which explains why the apparent 
potency of the P-site inhibitor seems to increase when the AC is activated. P-
site inhibitors bind to a small hydrophobic region at the C1a-C2a border near 
the 2 canonical Asp residues where it causes a conformational change of the 
active site of the AC from an open to a closed state by rotating residues on the 
CI region towards the P-site binding residues on the C2 region (Dessauer ef 
a/., 1999). 
Another inhibitor of mammalian tmACs is Zn^* which inhibits hormone 
and forskolin stimulation of tmACs in a time, dose and temperature dependent 
manner (Klein ef a/., 2002). Zn^ "" inhibits by decreasing the Vmax of the AC and 
has an I.C.50 of 1-2 pM. Zn^ "" inhibition was shown not to compete with Mg *^ 
binding to the active site, thus there is a distinct Zn^* binding site (Klein ef a/., 
2002). 
2.3.4 Mammalian soluble Class lllb AC 
sAC was initially identified in cytosolic extracts of rat testes and was 
proposed to be involved in spermatogenesis. Unlike mammalian tmACs, sAC 
preferentially utilises Mn *^ over Mg *^ for biochemical activity (Braun and Dods, 
1975) and is insensitive to the tmAC activators G protein (Braun ef a/., 1977) 
and forskolin (Forte, 1983). Therefore in mammalian cells, sAC is an 
independent system to tmACs giving two biochemically distinct cAMP 
pathways. A functional cDNA form of sAC was isolated (Buck ef a/., 1999) and 
28 
Introduction Phillip Holliday 
gave a predicted full length protein of 187 kDa, which contained two putative 
catalytic domains, C I and C2, a consensus P-loop, and a leucine zipper 
sequence. The CI and C2 catalytic domains of sAC dimerise to form a 
pseudoheterodimer. The full length sAC mRNA can be alternatively spliced to 
either include or exclude exon 11 (Jaiswal and Conti, 2001). mRNA including 
exon 11 encoded the 187 kDa full length sAC and mRNA excluding exon 11 
encoded a 48 kDa truncated sAC molecule. The 48 kDa truncated protein has 
more similarity to the catalytic domains of prokaryotic Class lllb ACs than to 
the catalytic domains of other isoforms of mammalian ACs. This truncated 
version of sAC has an activity 20 times greater than the full length protein, as 
there is an autoinhibitory site on the full length protein that lowers Vmax of the 
enzyme without affecting Km (Chaloupka et a/., 2006). 
sAC is activated by numerous factors. During experiments investigating 
the effects of Ca^* on sperm capacitation and the acrosome reaction, Hyne 
and Garbers showed that Ca^* increased concentrations of cAMP in guinea 
pig spermatozoa (Hyne and Garbers, 1979). This Ca^*-induced increase in 
cAMP concentrations was further shown to be dependent on the presence of 
HCO3' (Garbers et a/., 1982). HCO3" was suggested not to bind directly to sAC 
due to there being no stimulation of AC by HCO3" in broken cell preparations. It 
was proposed that HCO3" aids in the transport of Ca^* into the spermatozoa 
and that it is the increase in Ca^* concentrations that gives rise to the 
stimulation of sAC. 
However Chen et a/, showed that mammalian sAC is activated by 
HCO3" without the addition of any other factors (Chen et a/., 2000). HCOs' 
binds directly to sAC and activates it in a pH-independent manner. HCO3' was 
also shown to stimulate prokaryotic Class lllb ACs from multiple prokaryotic 
species. It was hypothesised that the characteristic Class lllb AC threonine 
(Thr) polymorph of the substrate-defining Asp and a Lys residue in the active 
site coordinate the binding of HCO3" in Class lllb ACs (Cann et a/., 2003). 
An alternative hypothesis for the site of HC03 ' binding on AC was on 
the metal ion of the active site, displacing two H2O molecules (Steegborn et 
a/., 2005). HCOs' is postulated to close the active site by inducing a 4-5 A 
movement of the p7-p8 loop and a shift of the a1 helix that aids the binding of 
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the catalytic metal ion. HCO3" does not stimulate other Class Ilia AGs by this 
theory due to the increased negative charge caused by the substrate-defining 
Asp residue near the metal ion. Further work on proving that sAC is activated 
by HCOa' showed that sAC is also responsive to C O 2 (Townsend et a/., 2009). 
Ci activated specific activity of sAC was greatest at pH 8.5, suggesting that 
HCOa' is an activator, however relative Ci fold stimulation of sAC was greatest 
at pH 6.5, suggesting that C O 2 is an activator. An assay performed under 
conditions of Ci disequilibrium proved that sAC is activated by both HCO3' and 
C O 2 (Townsend et a/., 2009). 
2.3.5 s A C function in vivo 
sAC was demonstrated to be an important factor for sperm maturation 
when a sAC knockout mutant was generated. The female knockout mutants 
had normal fertility whereas the male knockout mutants had normal sperm 
morphology but drastically impaired sperm motility that was restored by cAMP 
loading (Esposito et a/., 2004). As sAC is expressed in numerous somatic 
tissues (see Sections 2.3.5.1 to 2.3.5.5) the knock out mutant mice should 
have displayed somatic phenotypes. Farrell et a/, used immunological and 
molecular methods to identify the existence of another somatic isoform of sAC 
in mice that utilises a unique start site at exon 5 which escapes the knockout 
allele that removed exons 1 - 5 (Farrell ef a/., 2008). Hess et al. (Hess et a/., 
2005) demonstrated that rescued sperm from knockout males were not 
hyperactive and could fertilise an egg in vitro. Using a specific sAC inhibitor, 
they identified that the induction of protein tyrosine phosphorylation and 
motility are sAC dependent events whereas acrosomal endocytosis is not sAC 
dependent. 
2.3.5.1 SAG and V-ATPase 
HGO3' responsive sAC was shown to be involved in the recycling of 
vacuolar H* ATPase (V-ATPase) in the male reproductive tract. An increase in 
the pH of the epididymal lumen elevates the HGO3" concentrations that 
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activate sAC and increase cAMP concentrations. This in turn leads to the 
accumulation of V-ATPase at the apical surface of the epididymal and vas 
deferens clear cells (Pastor-Soler et a/., 2003). The accumulated V-ATPase 
pumps into the epididymal lumen to maintain spermatozoa in a quiescent 
state (Pastor-Soler et a/., 2003). As sAC is expressed in numerous other 
tissues including the kidney and choroids plexus, it may play an important part 
in a cAMP-signal transduction pathway by indirectly sensing pH via HCOa' 
concentrations. Indeed, further studies found sAC localised to numerous 
cellular compartments that contain cAMP targets such as the nuclei (Zippin et 
a/., 2003). 
2.3.5.2 sAC and CFTR channels 
sAC has been demonstrated to be involved in the regulation of the 
HCOa-transporting cystic fibrosis transmembrane conductance regulator 
(CFTR), the defective HCOaVCI" channel in airway epithelial cells of C F 
sufferers. Studies performed in Calu-3 cells showed that HCOa'-increased 
cAMP levels and the addition of a sAC specific inhibitor (2-hydroxyestradiol (2-
HE)), but not a tmAC inhibitor (SQ22536) blocked increases in cAMP, 
suggesting that sAC is functional in Calu-3- cells (Wang et a/., 2005). HCO3" 
also increased the conductance of CFTR to CI" and the increase in 
conductance was blocked by 2-HE and a CFTR channel inhibitor, 
glibenclamide (Wang et a/., 2005). These findings demonstrate that levels of 
HCO37CO2 regulate CFTR through the sAC pathway. 
2.3.5.3 sAC and airway cilia 
sAC has been demonstrated to be expressed in the cilia of human 
tracheal cells using RT-PCR, Western blotting and immunofluorescence 
(Schmid et a/., 2007). HCO3" was observed to increase the accumulation of 
cAMP in human tracheal cells and cAMP accumulation was blocked in the 
presence of a sAC specific inhibitor (KH7) and a PKA specific inhibitor but not 
by a tmAC specific inhibitor (SQ22536) (Schmid et a/., 2007). The addition of 
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HCO37CO2 to tracheal cells caused a reduction of intracellular pH and 
decreased the cilia beat frequency (CBF). However, cAMP production 
increased C B F via the sAC pathway as demonstrated by a greater decrease in 
CBF seen in the presence of KH7 (Schmid et a/., 2007). sAC was therefore 
shown to be located in ainway cilia and regulated by HCO3". 
2.3.5.4 sAC and nerve growth factor 
Nerve growth factor (NGF) and cAMP are both involved in neuronal 
differentiation through accumulation of cAMP that activates Rap1 and 
neuritogenesis (Heidemann et a/., 1985). However a link between NGF and 
cAMP was unknown. Stessin ef a/, demonstrated, in PC12 cells, that NGF 
accumulation of cAMP was dependent on intracellular Ca^*, which in turn 
activated Rap1. The addition of a sAC specific inhibitor (KH7) rather than a 
tmAC specific inhibitor blocked the activation of Rap1 (Stessin et a/., 2006). 
This finding identified sAC as involved in NGF signalling through a distinct 
cAMP-dependent pathway to tmACs. 
2.3.5.5 sAC and axonal outgrowth 
Netrins are a family of signalling molecules that stimulate axonal 
outgrowth and growth cone attraction or repulsion. These in turn are required 
for the development of the nervous system and axonal regeneration after an 
injury. Addition of netrin-1 leads to the accumulation of cAMP in growth cones 
and inhibition of PKA reduces the effect of netrin-1 (Hopker a/., 1999). Wu et 
al. demonstrated that netrin-1 accumulation of cAMP in growth cones was 
blocked with the addition of sAC specific inhibitors, KH7 and 2-HE (Wu ef a/., 
2006). Thus in response to netrin-1, sAC was shown to be important in 
mediating axonal outgrowth. 
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2.3.5.6 Inhibitors of sAC 
The metabolites of the steroid hormone oestrogen, catechol oestrogens 
(CEs), inhibit the production of cAMP in sAC rich cell extracts (Braun, 1990). 
C E s bind non-competitively to a hydrophobic patch near the active site of the 
enzyme, distinct from the binding site of P-site inhibitors (Steegborn et a/., 
2005). C E s form a chelating interaction with the Mg "^ in the active site, 
distorting the shape of the active site and fixing the enzyme in a non-
productive conformation. 
A/-Methylanthraniloyl (MANT)-GTP, a fluorescence probe that was used 
to study conformational changes in G proteins and AC toxins (Sarfati et a/., 
1990; Jameson and Eccleston, 1997) inhibited the Class II AC E F from 8. 
anthracis and CyaA from B. pertussis with a Ki of approximately 10 pM (Sarfati 
ef a/., 1990). It was hypothesised that the MANT group interacts with a 
hydrophobic pocket In the active site (Sunahara et al., 1998) although a model 
has yet to be developed. MANT-GTP and other MANT-nucleotides showed 
discrimination between tmACs and sAC, whereby tmACs were inhibited but 
sAC was surprisingly insensitive to inhibition (Gille et al., 2004). 
A sAC specific inhibitor was discovered by a screen of combinatorial 
chemical compound library and was termed KHZ (Hess et al., 2005). KH7 has 
an I.C.50 of approximately 3-10 pM and was used to detemnine that sperm 
capacitation and in vitro fertilisation are sAC dependent (Hess et al., 2005). 
2.4 Mycobacterium tuberculosis C l a s s III A C s 
2.4.1 The mechanism of tuberculosis infection 
Tuberculosis is a disease that has been documented extensively 
throughout history. The gram-positive bacterium Mycobacterium tuberculosis is 
the causative agent of tuberculosis and, interestingly, 30% of its genome is 
devoted to either lipid synthesis or metabolism (Cole ef al., 1998). In 2000 the 
World Health Organisation reported that 2 billion people are infected with M. 
tuberculosis and that there are approximately 8 million new cases of infection a 
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year (Russell, 2003). Tuberculosis is second only to HIV as the main killer 
among infectious diseases and because of this there is a large amount of 
research into its mechanism of infection, with the hope that ultimately there will 
be the production of an effective anti-tuberculosis therapy. 
Inhaled M. tuberculosis bacilli target the macrophages of the alveoli and 
are phagocytosed into phagosomes inside the macrophage. As the body's first 
line of defence, macrophages phagocytose foreign particles and follow a well-
defined sequence of steps leading to acidification and fusion of phagosomes to 
lysosomes. However, M. tuberculosis is able to survive dormant in the 
phagosome until the host is immuno-compromised, by blocking phagosomal 
acidification and lysosomal fusion. During normal phagosome maturation, the 
internalised early phagosome binds markers such as early endosomal antigen 
1 (EEA1) and the monomeric G-protein, Rab5. As the phagosome matures to 
a late phagosome, cathepsin D, lysosomal membrane protein 1 (LAMP1), V-
ATPase and Rab7 also bind to the phagosome and causes the transportation 
of the phagosome into the late endosome and fusion with the lysosome (Rink 
et al., 2005). Work done on Mycobacterium avium showed that infected 
phagosomes failed to acidify below pH 6.3 due to inhibition of fusion with V-
ATPases, however, phagosomal acquisition of LAMP1 still occurred, (Sturgill-
Koszycki ef al., 1994) suggesting that phagosome activity was not affected, but 
that maturation of an early phagosome into a late phagosome is somehow 
blocked. This hypothesis was backed up by the detection of Rab5 on M. 
tuberculosis infected phagosomes and the conspicuous absence of Rab7 (Via 
ef al., 1997). Thus the bacterium is able to survive dormant inside the 
phagosome while living off the nutrients endocytosed by the cell. M. 
tuberculosis infected phagosomes also inhibit the assembly of actin in the 
membrane, which is a requirement for phagosomal maturation and membrane 
fusion, whereas avirulent or dead mycobacteria infected phagosomes 
nucleated actin (Anes ef al., 2003). Anes ef al. also showed that the addition of 
certain lipids such as ceramide and sphingosine reversed the actin assembly 
inhibition, suggesting a possible mode of anti-tuberculosis therapy. 
Further work on actin assembly regulation found that increased levels of 
cAMP inhibited actin assembly and conversely decreased levels of cAMP 
stimulated actin assembly (Kalamidas ef al., 2006). The authors argue that the 
34 
Introduction Phillip Holliday 
phagosome cAMP-PKA system behaves as a molecular switch to regulate 
actin assembly and phagosome maturation. High intracellular levels of cAMP 
have been identified from work done on virulent and avirulent Mycobacterium 
microti infected macrophages as a factor that inhibits the fusion of phagosome 
and lysosome (Lowrie ef al., 1975). It was further shown that Mycobacterium 
bovis BCG and Mycobacterium lepraemurium also inhibited phagolysosome 
fomnation by increasing cAMP levels (Lowrie et al., 1979). There are only two 
systems in the cell that can elevate cAMP levels, the first is activation of AC 
and the second is inactivation of a PDE. 
The complete genome of the M. tuberculosis H37Rv strain contains 
approximately 4,000 genes (Cole et al., 1998) with 15 genes putatively 
assigned as ACs based on sequence homology (McCue ef al., 2000). It was 
suggested that due to this large number of ACs, M. tuberculosis may sense 
intracellular and extracellular signals via the cAMP pathway. As elevated 
cAMP levels halt phagosome-lysosome fusion, pathogenesis in M. 
tuberculosis may involve AC, such as with the AC CyaA from S. pertussis, 
which is part of the edema factor that causes whooping cough (Mock and 
Ullmann, 1993). 
So far, of the 15 putative M. tuberculosis AC genes, 10 have been 
characterised as ACs and the remaining 5 genes have yet to be characterised. 
The characterised ACs all have catalytic domains that dimerise to form a 
homodimer with two catalytic centres (Figure 2.2). 
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Figure 2.2: Structure of a typical prokaryotic Class lllb AC forming a 
homodimer with two catalytic centres from the two cytoplasmic domains, C. Ad 
- adenosine, P - phosphate group. Me - divalent metal cofactor. 
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2.4.2 Rv0386 
The rv0386 gene encodes Rv0386, classified as a Class I lie AC due to a 
shortened 'arm' region (Castro ef a/., 2005). The AC catalytic domain is at the 
N-terminus, followed by an AAA-ATPase domain, a tetratricopeptide repeat-
like region and a helix-turn-helix (HTH) DNA-binding domain at the C-terminus. 
The AAA-ATPase domain is similar to the transcriptional regulator of 
Streptomyces coelicolor (Horinouchi ef a/., 1990) and the HTH DNA-binding 
domain suggest that Rv0386 may be linked to transcriptional regulators. 
Rv0386 has glutamine (Gin) 57 and Asn 106 as the substrate defining 
residues instead of Lys and Asp. Mutational analyses of the substrate defining 
residues showed that both Q57 and N106 are required for substrate binding. 
Rv0386 also has a 20% guanylyl cyclase (GC) activity compared to AC 
activity, the highest in all the characterised M. tuberculosis ACs. Rv0386 must 
use a novel substrate binding mechanism to bind both ATP and GTP and it 
was proposed that it was an amide switch of both Q57 and N106 (Figure 2.3) 
(Castro et a/., 2005). 
2.4.3 Rv1900c 
Rv1900c is a Class I lie AC composed of a N-terminal a/p-hydrolase 
domain and a C-terminal AC catalytic domain (Sinha ef a/., 2005). Purified 
Rv1900c has a specific activity of 1.3 pmol mg"^  min"^  in the presence of ATP 
and Mn^ "" and does not accept Mg^ "" as a metal cofactor. This could be due to 
the metal coordination sphere of the active site being too large for the smaller 
Mg^ "^  ion. The M. tuberculosis genome encodes a Mn^" transporter which may 
sustain sufficiently high concentrations of intracellular Mn *^ for activity (Cole ef 
a/., 1998). Rv1900c also has a high G C side activity of 7% of AC activity. This 
is probably due to the substrate specific residues in the active site, N342 and 
D395, not specifying adenine. This was shown to be the case by mutation of 
the residues, which did not alter activity. Therefore there may be other factors 
that influence nucleotide specificity such as electrostatic gradients, shape 
complementarity, and size constraints. 
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Figure 2.3: Hypothesised binding of ATP and GTP to the active site of Rv0386. 
Gin 57 and Asn 106 act as an amide switch that allows Rv0386 to bind to 
either ATP (A) or GTP (B). 
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The transition state stabilising residue, H402, the equivalent of the 
mammalian asparagine, does not appear to bind substrate, as seen from an X-
ray crystal structure of Rv1900c with the nonreactive ATP analogue, a.p-
methyleneadenosine 5'-triphosphate (AMPCPP). However, the lack of 
transition state stabilisation does not affect the affinity or rate of catalysis of 
Rv1900c for ATP. The crystal structures of unliganded and AMPCPP-bound 
Rv1900c ACs show that only one of the two active sites is used for catalysis. 
The other active site is kept in an inactive conformation by the catalytic 
residues forming a network of hydrogen bonds. Rv1900c is thus intrinsically 
asymmetric, having two identical active sites in sequence but not in structure. 
This asymmetry may have led to the formation of pseudoheterodimeric 
mammalian ACs that use one active site for catalysis and the other as a 
regulatory site (Sinha etal., 2005). 
2.4.4 Rv1647 
Rv1647 is a Class I lie AC that has greater sequence similarity to fungal 
and protist ACs than to eukaryotic ACs (Shenoy ef al., 2005). Purified Rv1647 
from amino acids 97 to 328 has a 200-fold greater specific activity in the 
presence of Mn *^ than Mg^ "". The optimum pH for activity was 8.5, the optimum 
temperature was 37 °C, the activation energy was 74.4 ± 4.8 kJ mo\'\ and 
there was no G C side-activity detected. The catalytic activity of the enzyme 
was increased 2-2.5-fold in the presence of detergents such as CHAPS (3[(3-
Cholamidopropyl)dimethylammonio]-propanesulfonic acid) and specific activity 
also increased in the presence of 500 mM NaCI suggesting that dimerisation 
may be dependent on hydrophobic interactions. Rv1647 was shown to be a 
homodimer through the generation of active site mutants. 
C1-like mutants were generated by mutation of the substrate binding 
residues, K187 and D241, and a C2-like mutant was generated by mutation of 
a metal binding residue, D147. These mutants were barely active by 
themselves, but when reconstituted to form a C1/C2-like AC, specific activity 
was high demonstrating that Rv1647 acts as a homodimer and that the 
catalytic residues are similar to the catalytic residues of mammalian ACs 
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(Figure 2.4). Mutations to G C substrate specific residues did not give Rv1647 
G C activity. Rv1647 has an orthologue from Mycobacterium leprae, ML1399 
that has also been cloned, expressed, purified and assayed. ML7399 is a 
functional gene in the M. leprae genome, despite being flanked by 
pseudogenes, as shown by Western blot analysis of cell-free extracts. Thus 
Rv1647 and its conserved orthologues may be important and essential ACs in 
mycobacteria. 
2.4.5 Rv1318c, Rv1319c, Rvl 320c and Rv3645 
M. tuberculosis H37Rv has four Class lllb ACs, Rvl318c, Rvl319c, Rvl320c 
and Rv3645, characterised by the substitution of the substrate specific Asp for 
a Thr and an arm region extended by one residue compared to Class Ilia ACs 
(Linder and Schultz, 2003). The four M. tuberculosis Class lllb ACs all have an 
N-terminal membrane anchor consisting of six transmembrane regions, then a 
HAMP domain (histidine kinase, adenylyl cyclase, methyl accepting 
chemotaxis proteins and ghosphatases) followed by the C-terminal AC 
domain. HAMP domains contain two amphiphilic helices of about 50 amino 
acids each joined by a short linker. HAMP domains are speculated to function 
as autonomous switches between two signalling states (Aravind and Ponting, 
1999). All four enzymes have specific activity in the presence of Mn *^ with a 
small G C side-activity detected in Rvl319c and Rv3645 (Linder ef al., 2004). 
The HAMP domain in Rv1319c reduced activity by 70% compared to catalytic 
domain of Rvl 319c only, whereas in Rv3645 the activity was increased 21-
fold. 
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Figure 2.4: Schematic representation of d - C a like complementation of Rv1647 
proteins. Red block represents substrate binding residue, black block 
represents metal binding residue and blue block represents mutated residue. 
Wild type dimer forms two catalytic pockets with functional substrate binding 
and metal binding residues. Ci-like RV1647KI87E/D24IC substrate binding double 
mutant protein was complemented with the C2-like RV1647DI47A metal binding 
single mutant protein demonstrating that Rv1647 has a similar catalytic 
mechanism to other known Class III AGs. 
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2.4.6 Rv1264 
Rv1264 is a Class lllc AC that has an N-terminal domain followed by a 
linker and then the C-terminal AC domain. The N-terminus is similar to six 
other N-terminal AC domains, one from Brevibacterium liqufaciens, two from 
Streptomyces, Rv2212 from M. tuberculosis, and two DNA sequences from M. 
smegmatis, which are probably homologues of the M. tuberculosis ACs. Both 
the holoenzyme and the isolated catalytic domain (amino acids 211-397) were 
expressed, purified, and assayed (Linder ef al., 2002). Rv1264i.397 and 
Rvl 264211-397 were both active in the presence of Mn *^ with Mg *^ not 
supporting activity and there was no G C side-activity detected. The 
temperature optimum for specific activity was 37 °C and the optimum pH was 
7.3. The specific activity of the holoenzyme was 300-fold less than Rv12642ii-
397, with Vmax decreased by 3 % and Kmopp) decreased 6-fold. This suggests 
that the N-terminal domain inhibits the catalytic activity of Rvl 264. Studies of 
the holoenzyme AC activity at different pH values showed that there was a 40-
fold increase in specific activity from pH 8.0 to pH 6.0 and a 12-fold increase in 
Vmax (Tews ef al., 2005). Assays of Rvl2642i 1-397 gave uniform AC activity 
between pH 8.0 and 5.5. Thus pH sensitivity is mediated by the N-terminal 
domain of Rvl 264. 
Analyses of the crystal structure of the active and inhibited states of 
Rvl 264 provide a mechanism for pH sensing. The transition from the inhibited 
state to the active state is marked by a change of tertiary structure. The two 
catalytic domains are rotated 55" and translated by 6 A with respect to the N-
termini. This movement forms two catalytic sites with the catalytic residues 
moving by 25 A. Further X-ray crystallography work on the regulatory N-
terminal domain gave a 1.6 A crystal structure of the protein, which has a 
helical bundle surrounded by a disk-shaped dimer (Findeisen ef a/., 2007). The 
regulatory domain must also be a defined distance from the catalytic domain to 
mediate pH sensitivity of the AC. The regulatory domain could also act as a 
sensor of the changing lipid environment due to the discovery that oleic acid 
binds to a hydrophobic pocket on the regulatory domain. 
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As M. tuberculosis must survive in the acidic phagosome during host 
invasion, it is feasible that Rv1264 acts as a pH sensor in the phagosome and 
results in adaptation of M. tuberculosis. An Rv1264 homologue from S. 
coelicolor (cya) was linked with a physiological role in the acid stress 
response. The cya mutant of S. coelicolor did not neutralise an acidic 
environment, unlike the wildtype, and stopped growth and sporulation 
(Susstrunk et a/., 1998). Thus the n/1264 mutant M. tuberculosis was 
characterised for virulence. However both the wild type and mutant infected 
mouse organs showed characteristic mycobacterial growth, therefore deletion 
of Rv1264 does not affect the course of infection of M. tuberculosis in mouse 
organs (Dittrich et a/., 2006). The authors do note that although the results 
suggest that Rv1264 is not a virulence factor, one of the other 14 
mycobacterial AGs may be compensating for the loss of Rv1264 activity. 
2.4.7 Rv2212 
Rv2212 is a Class lllc AC that has the same domain composition as the 
pH sensing Rv1264, with an N-terminus that is 21% identical to that of Rv1264 
and a C-terminal catalytic domain that is 29% identical (Linder et a/., 2002). 
Both the holoenzyme and the isolated catalytic domain (amino acids 212-388) 
were expressed, purified, and assayed (Abdel Motaal et a/., 2006). Both 
recombinant ACs were active in the presence of Mn^ "" but not Mg^ "", there was 
no GC side-activity detected and the optimum pH was 6.5. The specific 
activities of Rv2212i.388 and Rv2212212-388 were similar demonstrating that the 
N-terminal domain is not autoinhibitory as in Rv1264. The N-terminal domain 
of Rv2212 also does not act as a pH sensor since the activity at pH 6.5 is only 
five-fold greater than at pH 9.0, whereas in Rv1264 the fold activity from pH 
9.0 to pH 6.0 is 110-fold (Tews et a/., 2005). This suggests that the two similar 
N-termini are probably connected differently or have additional regulatory 
inputs. An AC from B. liquefaciens has an identical domain composition as 
Rv1264 and Rv2212 and was shown to be strongly stimulated by pyruvate, a-
ketocarbonic acids, glycine, alanine, and lactate (Takai et a/., 1974). Various 
metabolites were assayed with Rv2212 and fatty acids such as palmitic, oleic, 
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linoleic, linnolenic, and arachidonic acids were found to cause a large 
stimulation. The stimulation was caused by an increase in substrate affinity 
with Vmax unaffected and it was specific to the Rv2212 holoenzyme. The 
unsaturated fatty acids also increased pH sensitivity in Rv2212 from 5-fold to 
20-fold. The stimulation was dependent on the presence of the N-terminal 
domain. The stimulation was not seen in the presence of detergents and so is 
not wholly due to the amphipathic nature of Rv2212. 
2.4.8 Rv1625c 
Rv1625c is the most studied of the M. tuberculosis AGs due to it 
corresponding to a half of a mammalian AC. At the N-terminus of Rv1625c 
there is a six transmembrane domain followed by the catalytic domain at the 
C-terminus. A soluble catalytic AC construct was generated from the end of 
the transmembrane domain, D204, to the C-terminus and this construct formed 
a homodimer with two catalytic centres. Rv1625c204-443 had Km values of 150 
[JM in the presence of 2 mM Mn^* and 417 pM in the presence of 20 mM Mg^*. 
Vmax values were 2100 nmol cAMP mg'^  min"^  with Mn^ "^  and 27 nmol cAMP 
mg"^  min"^  with Mg^*. The optimum pH for specific activity was 7.2, optimum 
temperature was 37 °C, and the activation energy was 67.5 kJ/mol. 
Rv1625c204-M3 has no G C activity and forskolin did not activate the enzyme 
(Guo et a/., 2001). The Rv1625c holoenzyme was expressed successfully in 
both E. CO// and HEK (human embryonic kidney) 293 cells, with a specific 
activity of 1.2 pmol cAMP mg"^  min'^  using 75 pM Mn-ATP for E. coli 
expressed protein and 65 nmol cAMP mg"^  min'^  using 65 pM Mn-ATP for HEK 
293 expressed protein. The residues K296 and D365 are required for ATP 
binding and when they were mutated to OTP substrate binding residues, along 
with a phenylalanine residue to form a K296E/F363R/D365C triple mutant, the 
mutant protein did not demonstrate G C activity but did show impaired AC 
activity (Shenoy et a/., 2003). This loss of activity was due to the triple mutant 
existing as a monomer, thus suggesting that the substrate defining residues 
are also required for dimerisation to occur. The monomeric triple mutant 
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protein was also used to form crystals for X-ray diffraction at a resolution of 3.4 
A(Ketkar a/., 2004). 
To study the structural relationship between Rv1625c and mammalian 
ACs, point mutations were inserted into Rv1625c to form mammalian C i - and 
C2-like domains. RV1625CN372A and RV1625CR376A mutants correspond to 
mammalian Ci domains due to the lack of one transition-state stabilising 
residue. RV1625CD256A and RV1625CD3OOA correspond to mammalian C2 
domains due to the lack one metal-binding Asp. Combination of the Ci-like 
domain RV1625CN372A with the C2-like domain RV1625CD3OOA resulted in AC 
activity of 2.5 pmol cAMP mg'^  min'\ comparable to wild type activity (Under et 
a/., 2004). An attempt to create a forskolin binding site equivalent to that found 
in mammalian ACs types l-VII was made by creating an 
RV1625CD3OOS/RV1625CN372T heterodimer. The heterodimer was active at 75 pM 
ATP but was not activated in the presence of 100 pM forskolin. Chimerisation 
of the C2-like RV1625CD3OOA with mammalian AC Ci domains did not give 
functional reconstitutions, however chimerisation with the Paramecium GC C2 
domain gave an AC activity of 6.8 nmol cAMP mg"^  min"^  using Mn^ "^ . 
Work on the role of the membrane domain of Rv1625c showed that the 
membrane domains stabilise the enzyme, lowering the Km value to 20 pM 
Mn^^-ATP. Production of a mammalian-like Rv1625c holoenzyme, with a head-
to-tail sequence, gave a Km value of 16 pM Mn *^ and a Vmax value of 3.5 pmol 
cAMP mg'^  min'^  (Quo et a/., 2005). Thus the mammalian-like tandem 
sequence is kinetically favourable compared to Rv1625c monomer. 
Replacement of the Rv1625c membrane domains with membrane domain 1 or 
2 from rabbit type V AC formed chimeric proteins that were active, 
demonstrating that the membrane domains of Rv1625c and rabbit type V AC 
are compatible. 
The role of Rv1625c in pathogenesis in vivo has also been investigated. 
An ARv1625c mutant of M. tuberculosis H37Rv was infected into mice and the 
infection was observed through mycobacterial growth in the organs and 
granuloma formation in the lungs. However the ARv1625c mutant was 
indistinguishable from the wild type strain and so it can be considered not a 
virulence factor on its own (Guo et a/., 2005). The authors suggest that 
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Rv1625c may affect a different stage of infection or that one of the other 14 
AGs from M. tuberculosis may compensate for the loss of Rv1625c. 
Cellular regulation of Rv1625c has been hypothesised to work via the 
bacterial stress response. Polyphosphates (poly-P) of a mean chain length of 
72 residues were demonstrated to inhibit not only Rv1625c but other Class III 
ACs as well (Guo et a/., 2009). Interestingly, Class I AGs are not inhibited by 
poly-P, suggesting that poly-P binds to the catalytic site and also allow bacteria 
with different classes of ACs to have different levels of regulation. 
2.5 Inorganic carbon and cAMP 
Ci plays an important role in the physiology of all organisms. The 
predominate forms of Ci that are biologically active are HCOa' and CO2. These 
Ci forms are involved in numerous physiological roles in bacteria, plants and 
animals, for example as a substrate in photosynthetic carbon fixation in plants 
(Falkowski, 1997), maintaining pH homeostasis in all organisms (Roos and 
Boron, 1981), as a metabolite in carbon metabolism in all organisms (Smith 
and Ferry, 2000), as an activator of virulence in pathogenic organisms (Bahn 
and Muhlschlegel, 2006), as an activator of sperm maturation (Esposito et a/., 
2004), and as an alarmone in Drosophila (Jones ef a/., 2007; Kwon et a/., 
2007). Owing to the physiological importance of Gi, considerable work has 
been performed to elucidate the molecular mechanism of Ci sensing in 
organisms. The two seven transmembrane receptors, Gr21a and Gr63a in 
Drosophila confer CO2 responsiveness in Drosophila neurons (Jones et a/., 
2007; Kwon et a/., 2007). GO2 sensitivity is also observed in mice GG-D* 
expressing olfactory neurons that allow mice to detect CO2 at near-
atmospheric concentrations (approximately 0.038 %) (Hu et a/., 2007). 
Carbonic anhydrase (GA) is required for CO2 sensing and the authors 
hypothesise that CO2 is converted into HGO3" which in turn increases cGMP 
(3', 5'-cyclic guanosine monophosphate) levels and the opening of cGMP-
sensitive cyclic nucleotide-gated channels. GO2 avoidance in Caenorhabditis 
involves CO2 sensing via the cGMP-activated channel subunits TAX-2 and 
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TAX-4, however a CO2 receptor has yet to be identified (Bretscher ef a/., 2008; 
Hallem and Sternberg, 2008). 
In mammalian systems it has long been known that increased levels of 
CO2 affect cellular cAMP levels. In rabbit carotid bodies (CB), a high partial 
pressure of CO2 (PCO2) and low pH gave an increase in cAMP levels (Perez-
Garcia et a/., 1990). This rise in cAMP arose because of AC activation as 
shown by the treatment of the CBs with forskolin, which also increased cAMP 
levels and released dopamine. Further experiments on changes in rat spleen 
in response to CO2 showed that on administration of CO2 the spleen 
contracted and cAMP levels increased. This was due to CO2 stimulating the a-
adrenoreceptors which caused the contraction of the spleen and the 
stimulation of the p-adrenoreceptors which increased cAMP levels (Lehotay 
and Murphy, 1974). The addition of p-adrenoreceptor inhibitors and agonists 
was separately shown to stimulate the adrenoreceptors. Elevated PCO2 does 
not always cause an increase in cAMP levels. Work done on coronary ligation 
in dogs induced an increase in PCO2 of the ischemic tissues post-ligation, 
which also severely decreased levels of cAMP but did increase cGMP levels 
(Stewart ef a/., 1978). A possible explanation of the decrease in cAMP levels 
could be due to the arrest of blood flow to the heart which would diminish the 
delivery of adrenergic hormones. 
The first biochemical evidence of a link of Ci to ACs was in studies 
designed to study Ca^* induced stimulation of cAMP in guinea pig 
spermatozoa (Garbers et a/., 1982). It was found that HCOs' was required for 
Ca^"" stimulation to occur and that HCO3' increased cAMP levels by 25-fold. 
The first AC demonstrated to be stimulated by HCO3" was mammalian sAC 
(Section 2.3.4). A knockout strain in mice caused male sterility that impaired 
sperm motility but not spermatogenesis (Esposito et a/., 2004). This suggested 
a link with HCO3" which is required for sperm maturation and mobilisation. The 
presence of HCOs' caused a 7-30-fold stimulation in specific activity of the 
truncated sAC. A crystal structure of sAC has not been obtained, however the 
Ci mechanism of regulation was studied with a prokaryotic Class 11 lb AC that is 
also stimulated 2.5-fold by HCO3" (Chen ef a/., 2000), CyaC from Spirulina 
platensis. A crystal structure with ATP analogues in the presence and absence 
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of HCO3' was solved, however the addition of HCOs' caused the CyaC crystals 
to dissolve so the mechanism of HCO3' stimulation was suggested from flash 
soaking of HCOs -induced conformational changes of the crystals (Steegborn 
et a/., 2005). The suggested mechanism of HC03' stimulation of CyaC is 
through the recruitment of a second metal ion into the active site (see Figure 
2.5). The authors suggested that the addition of HCOz dissolved the crystals 
due to HCO3' causing a structural change (Steegborn et a/., 2005). Thus 
HCO3' was not detected in the CyaC crystal structure and the HC03' binding 
site is unsolved. 
51 
Introduction Phillip Holliday 
Figure 2.5: Active site of a typical mammalian Glass Ilia AC (Tesmer ef a/., 
1999). ATP is in black, metal ions are in green, hydrogen bonds are in red, 
C l a residues are in pink and G2a residues are in blue. Amino acid labelling is 
from their positions in canine type V AC for C l a and rat type II AC for C2a. 
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2.5.1 Ci stimulated Prokaryotic Class lllb A C s 
Regulation of ACs with HCO3" had been thought to be limited to Class 
lllb ACs where there is a Thr or Ser (serine) in the substrate defining position 
of the active site, for example in mammalian sAC (Chen et a/., 2000) and the 
prokaryotic ACs, CyaC from S. platensis (Chen ef a/., 2000), CyaBI from 
Anabaena PCC 7120 (Cann et a/., 2003) and Slr1991 from Synechocystis 
P C C 6803 (Masuda and Ono, 2004). 
However more recent work on HCO3" stimulation of Class lllb ACs has 
identified that the Ci species that is stimulating AC is not HCO3' but CO2 
(Hammer et a/., 2006). An assumption was made in previous work that the Ci 
activating species for Class lllb ACs was HCO3' and not CO2 as the ionic Ci 
form was more likely to bind to the active site (Hammer et a/., 2006). 
The final proof that CO2 was the Class lllb AC activating form of Ci was 
from assays conducted under conditions of Ci disequilibrium. The Ci 
disequilibrium was achieved by reducing the temperature of the assay, which 
slowed the acquisition of the Ci equilibrium, and shortening the assay period, 
such that the Ci fonn added to the assay (either HCO3" or CO2) remained 
mostly in that form added. The shortened assay period was elucidated by 
measuring the acquisition of the Ci equilibrium in a weakly buffered solution 
with the addition of HCO3' or CO2 and in the presence or absence of CA. CO2 
was demonstrated to be the Ci form that stimulated a model Class lllb AC, 
Slr1991 of Synechocystis P C C 6803. This experiment was repeated with 
another Class lllb AC, CyaBI from Anabaena P C C 7120, previously thought to 
be stimulated by HCO3", and this enzyme was also proven to be stimulated by 
CO2 solely (Hammer et a/., 2006). These two enzymes are the first identified 
signalling molecules that respond directly to CO2. 
Thus in all previous work on Ci stimulation of Class lllb ACs quoted in 
this section, HCO3' was assumed to be the activating form of Ci. For clarity, 
from now on in this thesis, the term Ci will be used instead, as the stimulating 
forms of Ci were not identified in these earlier studies. 
54 
Introduction Phillip Holliday 
2.5.1.1 CyaC from S. platensis 
Secreted cAMP was found in media containing S. platensis, a 
filamentous cyanobacterium (Sakamoto et a/., 1991). The increase in cAMP 
concentrations were observed to encourage the formation of algal mats 
(Ohmori et a/., 1992). S. platensis has at least three genes that code for ACs, 
cyaA, cyaB, and cyaC (Yashiro et a/., 1996). The CyaC AC is a Class 11 lb AC 
that contains an N-terminal receiver domain of the R1 response regulator 
protein, a transmitter domain of the sensory kinase protein, a receiver domain 
of the R2 response regulator protein, and a C-terminal AC domain (Kasahara 
et a/., 1997). CyaC was assayed for Ci stimulation and the addition of Ci 
stimulated CyaC 2.5-fold with an E.C.50 value of 18.8 ± 1.6 mM (Chen et a/., 
2000). 
2.5.1.2 CyaBI from Anabaena F C C 7120 
The cyanobacterium Anabaena P C C 7120 has six different genes that 
code for ACs in its genome, cya>A, cyaB1, cyaB2, cyaC, cyaD, and cyaE 
(Katayama and Ohmori, 1997). The AC from cyaB1 is a Class lllb AC and 
forms a homodimer. At the N-terminus, there are two GAP domains, GAF-A 
and GAF-B, followed by a PAS (period clock protein, aryl hydrocarbon receptor 
and single-minded protein) domain and then the catalytic AC domain 
(Kanacher et a/., 2002). GAF domains are associated with mammalian cyclic 
nucleotide PDEs and GAF domains specifically bind and hydrolyse cyclic 
nucleotides, whereas PDEs degrade other cyclic nucleotides (Soderling and 
Beavo, 2000). In the CyaBI AC, GAF-B specifically binds to cAMP and 
activates the AC, thus acting as an autoregulatory switch. This switch is 
important in the control of homeostasis at limiting Na* (Cann, 2007). 
Ci stimulates the CyaBI AC domain with a maximal 2-fold stimulation 
and an E.C.50 value of 9.6 mM (Cann et a/., 2003). This occurs because Ci 
lowers substrate affinity but increases reaction velocity. Ci was hypothesised 
to stimulate Class lllb ACs that have a substrate defining Thr by mimicking the 
carboxyl group of the substrate defining Asp found in Class Ilia ACs. This was 
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thought to occur through Ci binding to the substrate defining Lys (K646), which 
is conserved in Glass 11 lb ACs. This theory was supported by a point mutation 
of Lys-646 to Ala, which removed the residue that hypothetically bound Ci and 
completely ablated Gi sensitivity. A point mutation of Thr-721 to Asp, which re-
introduced the carboxyl group to mimic a Class Ilia AC also ablated Ci 
stimulation. Gi stimulation assays on other Class I lib ACs such as GyaB from 
Stigmatella and Rv1319c from Mycobacterium demonstrated a fold stimulation 
which supported this hypothesis (Gann ef a/., 2003). ACs that contained the 
substrate defining Asp polymorph (Class Ilia AGs) were shown to be 
unresponsive to Ci at the assayed conditions such as the mammalian tmACs 
(Chen ef a/., 2000) and Rv1625 from Mycobacterium (Cann ef a/., 2003) which 
again supported the hypothesis that Glass lllb ACs were the only group of AGs 
that were responsive to Gi. 
2.5.1.3 Slr1991 from Synechocystis P C C 6803 
Synechocystis P C C 6803 is an unicellular organism that moves by 
twitching in response to light which is dependent upon an increase in 
intracellular cAMP levels (Terauchi and Ohmori, 2004). Motility occurs due to 
the Sigma factor SigF, which is responsible for biogenesis of pili and the type 
IV pili structural component PilAI (Bhaya ef a/., 2000). Slr1991 (also known as 
Gyal) consists of an N-terminal Forkhead-associated domain and a G-terminal 
Class lllb AG (Terauchi and Ohmori, 1999). It is hypothesised that cAMP is 
involved in light transduction in Synechocystis, whereby cAMP produced by 
Slr1991 binds to the SYCRP1 protein to form the cAMP-SYCRPI complex, 
which controls the biogenesis of pili (Yoshimura ef a/., 2002) for motility. 
Slr1991 has a Km for ATP of 2.2 ± 0.3 pM at pH 7.5 and Vmax was 66.3 ± 2.2 
pmol cAMP nmol protein'^  min'^  (Masuda and Ono, 2004). 
Interestingly, Slr1991 has been demonstrated to be inhibited by Ci. 
Assays conducted at pH 7.5 showed that Ci increased Km 15-fold to 33.9 ± 8.1 
pM and Vmax decreased two-fold to 40.5 ± 3.2 pmol cAMP nmol protein"^ min'^  
(Masuda and Ono, 2005). Slr1991 was the first identified Class lllb AG to be 
inhibited by Gi and it was hypothesised that Gi suppressed Slr1991 activity by 
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lowering ATP affinity to the active site and decreasing ATP turnover rate. It 
was suggested that Ser-173 and Tyr-178 are the possible residues responsible 
for the Ci inhibition, which sit adjacent to the substrate defining Lys that 
confers Ci sensitivity (Masuda and Ono, 2005) although mutational studies 
have so far not been conducted. 
However, a repeat analysis of the Ci dependence assay for Slr1991 by 
Hammer ef a/, in the presence of 20 mM Ci, with an assay time of 40 minutes 
was shown to stimulate Slr1991 2-fold by 1.2 mM CO2 (Hammer ef a/., 2006). 
This stimulation of Slr1991 was contrary to the findings of Masuda ef a/, but 
was explained by the authors as probably due to the use of a shorter assay 
time that did not allow Ci activation of the enzyme (Hammer ef a/., 2006). CO2 
gave an apparent E.C.50 of 52.7 ± 1.0 mM and increased Km from 11.4 ± 0.7 
pM to 16.2 ±1.2 pM but also increased Vmax from 0.74 ± 0.01 nmol cAMP mg"^  
min"^  to 1.13 ± 0.03 nmol cAMP mg"^  min"\ thus increasing /Ccat (Hammer ef a/., 
2006). To further prove that CO2 was the activating Ci species, assays with 
Slr1991 were conducted with 40 mM Ci with a pH range of 6.5 to 8.5, thus 
increasing the CO2 from 0.3 mM at pH 8.5 to 15.5 mM at pH 6.5. Fold 
stimulation of Slr1991 increased from 1.1 at pH 8.5 to 2.4 at pH 6.5 (Hammer 
ef a/., 2006). CO2 stimulation was definitively proved by assaying Slr1991 
under conditions of Ci disequilibrium. A fold stimulation was only observed with 
the addition of 20 mM CO2 (Hammer ef a/., 2006) (see Section 2.5.1 for details 
of Ci disequilibrium assays). 
2.5.2 Are Class Ilia A C s stimulated by C O 2 ? 
The new finding that CO2 and not HCO3" is the activating Ci form for 
Class 11 lb ACs raises intriguing questions about previous results on ACs that 
demonstrated Ci unresponsiveness. The mammalian tmACs were postulated 
to be unresponsive to Ci as compared to basal activity based on the 
insensitivity of type V Class Ilia AC (Chen ef a/., 2000). The prokaryotic Class 
Ilia ACs were also postulated to be unresponsive to Ci as compared to basal 
activity based on the insensitivity of Rv1625c from Mycobacterium (Cann ef a/., 
2003). The common factor from these Ci assays was that the assays were 
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conducted at pH 7.5 and thus their Ci insensitivity may be due to the low CO2 
concentrations at pH 7.5 that were unable to activate the AC, rather than 
unresponsiveness to Ci. New investigation into this area would elucidate 
whether Class Ilia ACs are stimulated by CO2. A model Class Ilia AC for a 
CO2 stimulation experiment would be Rv1625c from M. tuberculosis H37Rv 
(Section 2.4.8), which was previously shown to be unresponsive to Ci as 
compared to its basal activity (Cann ef a/., 2003). Rv1625c is a good model for 
investigating CO2 stimulation in mammalian Class Ilia ACs for several reasons. 
Firstly, mammalian tmACs are difficult to express in prokaryotic systems as 
they are not post-translationally modified, unlike Rv1625c which expresses 
well in E. coli. Secondly, mammalian tmACs are difficult to assay as they 
function as heterodimers and thus require two catalytic domains to be active 
whereas Rv1625c is a homodimer and therefore only needs one catalytic 
domain. Thirdly, mammalian tmAC activating factors such as Gsa (Sunahara ef 
a/., 1997) or forskolin (Seamon et a/., 1981) are required to observe any 
activity of mammalian tmACs, whereas Rv1625c does not require any 
activating factors. The identification of a CO2 sensor in M. tuberculosis would 
aid in the understanding of the possible role for CO2 in pathogenesis, even if 
the process of pathogenesis is not identified. 
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2.6 Aims of this thesis 
All Class lllb ACs studied to date that are activated by Ci were 
previously thought to be regulated by HC03' but have more recently shown to 
actually be regulated by CO2. HC03' and CO2 are in a pH-dependent 
equilibrium (the Ci equilibrium). All Class Ilia ACs that were assayed for Ci 
sensitivity were insensitive to HCO3'. However, since Class lllb ACs have been 
demonstrated to be regulated by CO2 and not HCO3", Class Ilia ACs may be Ci 
sensitive with CO2 as the regulatory form of Ci. 
This thesis investigates the hypothesis that Class Ilia ACs, like Class 
lllb ACs are regulated by CO2. This thesis aims to investigate the following 
points: 
• Is Rv1625c204^3, a model bacterial Class Ilia AC, , regulated by Ci in the 
form of CO2 in vitro? 
• If Rv1625c204^3 is stimulated by CO2 in vitro, is that CO2 stimulation also 
observed in vivo? 
• What are the assay conditions that are required for CO2 to bind to 
Rv1625c204^3? 
• Which amino acid(s) of the catalytic domain of Rvl 625c204-443 is/are the 
CO2 binding site? 
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3 Methods and Materials 
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3.1 Molecular Biology techniques 
3.1.1 Isolation of plasmid DNA 
Plasmid DNA containing the recombinant protein gene can be isolated 
from bacteria to allow digestion of the recombinant protein gene, mutagenesis 
of the gene, ligation into another plasmid and transformation into bacteria. 
E. CO// were grown in 5 mL luria broth (LB) containing appropriate 
antibiotics at 30 °C overnight. The culture was harvested by centrifugation at 
5,445 g for 5 min at 4 °C and the DNA was extracted using a Qiagen Mini-prep 
kit (Qiagen). The bacterial pellet was resuspended in 250 | J L Buffer PI and 
transferred to a microcentrifuge tube. 250 pL Buffer P2 was added and the 
mixture was inverted six times. 350 pL Buffer N3 was then added and the 
mixture was inverted six times. The mixture was centrifuged at 15,700 g for 10 
min. The supernatant was removed and added to a QIAprep spin column. The 
spin column was centrifuged at 15,700 g for 1 min and the flow-through was 
discarded. 0.5 mL Buffer PB was added to the spin column, the column was 
centrifuged at 15,700 g for 1 min and the flow-through was discarded. 0.75 mL 
Buffer PE was added to the spin column, the column was centrifuged at 
15,700 g for 1 min and the flow-through was discarded. The spin column was 
centrifuged a second time at 15,700 g for 1 min and the residual flow-through 
discarded. The spin column was placed into a clean microcentrifuge tube. 50 
pL Buffer E B was added to the centre of the resin and left to stand for 1 min. 
The spin column was then centrifuged at 15,700 g for 1 min and the eluted 
DNA was stored at -18 °C. 
3.1.2 Digestion of DNA with restriction enzymes 
Digestion of DNA with restriction enzymes allows the isolation at 
specific recognition sites. A plasmid digested with the same restriction 
enzymes would allow ligation of the DNA sequence into the plasmid. 
DNA was digested with the appropriate restriction enzymes. The 
appropriate 10x buffer was used with 3 U of restriction enzyme (Fermentas). 
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H 2 O was added to make the total volume of the restriction digest such that 
enzyme solution constitutes no more than 10 % of total volume. Digests were 
incubated at 37 °C for 30 min. 
3.1.3 Removal of 3' phosphate from DNA 
Phosphatase treatment removes 5' and 3' phosphate groups from the 
vector DNA which prevents the cut vector from recircularisation. 
1 U calf intestine alkaline phosphatase (CIAP) (Fermentas) was added 
to cut vector DNA and the mixture was incubated at 37 °C for 30 min. CIAP 
was then deactivated by heating the mixture at 75 °C for 10 min. DNA was 
then separated by electrophoresis (Section 3.1.5) on a 1.5 % agarose gel and 
the appropriate bands were excised. 
3.1.4 Ligation of insert DNA and vector DNA 
Ligation of the insert DNA and the vector DNA allows the recombinant 
protein gene to be inserted into a vector for expression of recombinant protein. 
A 3:1 molar ratio of cut insert DNA and cut vector DNA was incubated 
with 5 pL of 2x rapid ligation buffer and 3 U (1 pL) of T4 DNA ligase 
(Promega). The ligation mixture was incubated at 25 °C for 60 min. 
3.1.5 DNA electrophoresis 
Agarose gel electrophoresis separates DNA by size. An electric field 
moves the negatively charged DNA through an agarose matrix. 
A 1.5 % (w/v) agarose gel was produced by adding 0.75 g agarose 
(Sigma Aldrich) to 50 mL Tris- (tris(hydroxymethyl)aminomethane) acetate-
EDTA (TAE) electrophoresis buffer (40 mM Tris-acetate, 1 mM EDTA 
(ethylenediaminetetraacetic acid)) and boiling the mixture until the agarose 
dissolved. 1.5 pM ethidium bromide was added to the liquid agarose mixture 
when cool. The agarose mixture was poured into a Biorad Mini-Sub Cell GT. 
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6x Orange G loading buffer (0.1 % (w/v) Orange G, 15 % (w/v) Ficoll 400, 1x 
TAE) was added to DNA samples which were subsequently loaded onto the 
agarose gel. 2.5 pL of a 1 kb DNA ladder was added to a lane and the gel was 
electrophoresed at 20 V/cm until the DNA bands were separated. 
3.1.6 DNA purification from agarose gel 
DNA separated by agarose gel electrophoresis can be purified from the 
agarose gel to obtain the DNA band of interest for ligation into a plasmid. 
The DNA band of interest was excised from the agarose gel using a 
scalpel and the gel piece was placed into a microcentrifuge tube. 600 pL 
binding buffer (6 M sodium perchlorate, 50 mM Tris pH 8.0, 10 mM EDTA) 
(Sigma Aldrich) was added and the agarose was melted by heating at 37 °C. 5 
pL of silica matrix (Promega) was added to the mixture which was then 
incubated for 10 min at room temperature. The mixture was centrifuged at 
15,700 g for 1 min and the supernatant was discarded. The pellet was 
resuspended in 125 pL binding buffer. The mixture was centrifuged at 15,700 
g for 1 min and the supematant was discarded. The pellet was resuspended in 
1.5 mL wash buffer (20 mM Tris pH 8.0, 2 mM EDTA. 400 mM NaCI, 50 % 
(v/v) ethanol). The mixture was centrifuged at 15,700 g for 1 min and the 
supernatant was discarded. The pellet was again resuspended in 1.5 mL wash 
buffer, centrifuged at 15,700 g for 1 min and the supernatant was discarded. 
Any remaining liquid was removed with a paper towel. The pellet was 
resuspended in 5 pL ultrapure water and incubated for 10 min at 37 °C. The 
mixture was centrifuged at 15,700 g for 1 min and the supernatant containing 
the purified DNA was transferred into a new microcentrifuge tube. 
3.1.7 Pfu DNA polymerase P G R 
PGR is a technique that amplifies a DNA fragment of interest using a 
pair of primers that complementarily bind to the start and end of the DNA 
region that is to be amplified, and using thermal cycling, melts the DNA double 
strands to form the template for replication and elongates using DNA 
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polymerase, which forms two identical DNA strands from the original strand. 
This process can be repeated numerous times to amplify the amount of DNA. 
Pfu DNA polymerase is from the hyperthermophilic bacterium Pyrococcus 
furiosus and has superior proofreading properties compared to Taq DNA 
polymerase due to a 3' to 5' exonuclease proofreading activity. This allows for 
higher fidelity of DNA amplification, however the DNA products are blunt-
ended. 
The polymerase chain reaction (PGR) mixture was made up of 5 ng 
template DNA, 2.5 pL 10x buffer, 200 pM dNTPs, 25 pmol fon /^ard primer, 25 
pmol reverse primer, 1 U Pfu DNA polymerase (all Promega) and H 2 O added 
to make a total volume of 25 pi-
The PGR process was performed on an Eppendorf Mastercycler 
Gradient PGR machine using the following programme: Initial denaturation at 
95 °G for 2 min; 30x cycle of denaturation at 95 °G for 15 s, annealing at 55 °G 
for 30 s and extension at 72 °G for 2 min per kb of DNA; and a final extension 
at 72 °G for 5 min. 6x Orange G DNA loading dye (Promega) was added, the 
PGR products were separated using a 1.5 % (w/v) agarose gel and the 
appropriate bands were excised. 
3.1.8 Taq DNA polymerase P G R 
Taq DNA polymerase is from the thermophilic bacterium Thermus 
aquaticus that has low replication fidelity, however has a faster amplification of 
DNA compared with Pfu DNA polymerase and the DNA products of Taq DNA 
polymerase have an adenine overhang at the 3' end, which is required for 
TOPO Gloning (Section 3.1.12). 
The PGR mixture was made up of 5 ng template DNA, 2.5 pL lOx 
buffer, 1.25 pL 20x MgGb, 200 pM dNTPs, 25 pmol fonward primer, 25 pmol 
reverse primer, 1 U Taq DNA polymerase (all Promega) and H2O added to 
make a total volume of 25 pL. 
The PGR process was performed on an Eppendorf Mastercycler 
Gradient PGR machine using the following programme: Initial denaturation at 
95 °G for 2 min; 30x cycle of denaturation at 95 °G for 15 s, annealing at 55 °G 
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for 2 min and extension at 72 °C for 2 min per kb DNA; and a final extension at 
72 °C for 5 min. The PGR products were separated using a 1.5 % (w/v) 
agarose gel and the correct bands were excised. 
3.1.9 Taq DNA polyermase Adenylation of DNA 
Adenylation of DNA fragments is required for TOPO cloning (Section 
3.1.12). DNA products of Taq DNA polymerase have a 3' end adenine 
overhang. A short extension of DNA amplified using Pfu DNA polymerase 
allows for high fidelity DNA with a 3' end adenine overhang. 
The reaction was made up of 500 ng purified blunt-end DNA, 2.5 pL 10x 
buffer, 1.25 pL 20x MgCb, 200 pM dATP, 1 U Taq DNA polymerase (all 
Promega) and H2O added to make a total volume of 25 pL. 
The PGR process was performed on an Eppendorf Mastercycler 
Gradient PGR machine using the following programme: Extension at 72 °G for 
10 min. The PGR products were separated using a 1.5 % (w/v) agarose gel 
and the appropriate bands were excised. 
3.1.10 DNA mutagenesis 
To mutate a particular amino acid of a recombinant protein, the 
mutation can be inserted into the isolated and restricted DNA by two PGRs, 
one with the forward primer and a reverse mutagenic primer and one with the 
reverse primer and a forward mutagenic primer. The mutagenic primers 
contain complementary base pairing and a codon for adenine for the specific 
mutation. The two PGR products are rejoined by PGR with the forward and 
reverse primers. 
Two PGR experiments were set up, PGR 1 with 25 pmol forward primer 
and 25 pmol reverse mutagenic primer and PGR 2 with 25 pmol forward 
mutagenic primer and 25 pmol reverse primer, 5 ng DNA, 200 pM dNTPs and 
1 U Pfu DNA polymerase enzyme (all Promega). PGR products were run on a 
1.5 % (w/v) agarose gel and the appropriate bands were excised and purified. 
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Purified DNA from PCR 1 and 2 were used to set up another PCR using 
25 pmol forward primer and 25 pmol reverse primer, 200 pM dNTPs and 1 U 
Pfu DNA polymerase enzyme. PCR product was separated using a 1.5 % 
(w/v) agarose gel and the appropriate band was excised and purified. 
3.1.11 Preparing competent ce l ls for transformation 
To allow for the transformation into E. coli cells of a DNA vector 
containing a cloned DNA product of the desired recombinant protein, the E. 
coli cells must be made competent to be able to take up extracellular DNA. 
E. coli BL21 cells were grown in 2 mL LB containing 100 pg/mL 
ampicillin and 50 pg/mL kanamycin at 30 °C overnight. 0.25 mL of overnight 
culture was grown in 25 mL LB containing appropriate antibiotics at 30 °C until 
ODeoo = 0.4. The culture was cooled to 0 °C then the cells were harvested by 
centrifugatlon at 2,700 g for 10 min at 4 °C. The supematant was discarded 
and the pellet was resuspended in 15 mL solution of 80 mM MgCl2and 20 mM 
CaCb. The cells were again harvested by centrifugation at 2,700 g for 10 min 
at 4 °C. The supernatant was discarded and the competent cells were 
resuspended in 1 mL 0.1 M CaCb. 
3.1.12 T O P O Cloning of P C R products and Transformation into 
Mach-Ti competent ce l ls 
TOPO cloning allows the cloning of DNA fragments into the TOPO 
vector without the addition of DNA ligases. The TOPO vector is linearised, has 
a 5'-(C/T)CCTT-3' overhang and DNA topoisomerase I covalently linked to the 
vector. The DNA fragment must be adenylated to allow the DNA fragment to 
ligate to the 3' thymine overhand of the vector. 
Adenylated PCR products were inserted into pCR2.1-TOPO vector. 0.5 
pL pCR2.1-TOPO vector (Invitrogen), 500 ng insert DNA and 1 pL salt solution 
were mixed and incubated at 25 °C for 30 min. 20 pL of Machl-TI competent 
cells were added to the TOPO cloning reaction and the mixture was incubated 
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at 0 °G for 20 min. The mixture was heatshocked at 42 °G for 30 s then 
incubated at 0 °G for 2 min. 200 pL of pre-warmed (37 °G) SOG medium (2 % 
(w/v) bacto-tryptone, 0.5 % (w/v) bacto-yeast extract, 10 mM NaGI, 2.5 mM 
KGI, 10 mM MgGl2 and 20 mM glucose) was added and the mixture was 
shaken at 37 °G for 30 min. The mixture was plated onto pre-warmed (37 °G) 
LB agar plates containing 50 pg/mL kanamycin and 1 mM 5-bromo-4-chloro-3-
indolyl-p-D-galactopyranoside and the plates were incubated at 30 °G 
overnight. 
3.1.13 Transformation of DNA vector into competent ce l ls 
A DNA vector containing the desired cloned DNA fragment of a 
recombinant protein must be transformed into competent cells such as E. coli 
BL21 cells, to allow the expression of the recombinant protein through growth 
of the E. coli cells containing the transformed DNA. 
DNA was added to competent cells and incubated for 20 min at 4 °G. 
The cells were heatshocked at 42 °G for 45 s then incubated for 2 min at 4 °G. 
800 pL SOG prewarmed to 37 °G was added and the mixture was shaken for 
30 min at 37 °G. The mixture was plated onto a 37 °G prewarmed LB agar 
plate containing appropriate antibiotics and the plates were grown at 30 °G for 
less than 14 h. 
3.1.14 Preparation of E . co / /g lycero l s t o c k s 
To maintain E. coli cells transformed with the desired recombinant 
protein DNA, the cells must be stored at -140 °G in LB containing 40 % 
glycerol, which is a cryogenic. 
E. coli cells were grown in 5 mL LB containing appropriate antibiotics at 
30 °G overnight. The cells were harvested by centrifugation at 5,445 g for 5 
min at 4 °G. The bacterial pellet was resuspended in 1 mL LB containing 40 % 
glycerol. The stock was placed in a Gryovial tube and stored at - 140 °G. 
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3.1.15 DNA sequencing 
To identify that the correct DNA fragment has been cloned into the DNA 
vector or that the correct mutation has been inserted into the DNA fragment, 
the purified DNA is sequenced and compared to the theorectical DNA 
sequence. 
Purified DNA (Section 3.1.1) was sequenced using 3.2 pmol fonward 
and 3.2 pmol reverse primers at DBS Genomics (Durham University) using a 
48-capillary 3730 DNA Analyzer. 
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3.2 Prote in B i o c h e m i s t r y 
3.2.1 Protein quantification by Bradford a s s a y 
To quantify the amount of recombinant protein that was purified the 
Bradford assay method, which is a spectroscopic, colorimetric protein assay 
was used. The Coomassie dye changes from an unstable red form to a stable 
blue form on binding with protein. The disadvantage of the Bradford assay is 
that it is only linear for small quantities of protein. 
Protein was quantified using the bovine serum albumin (BSA)-calibrated 
Bradford assay method (Bradford, 1976). BSA concentrations of 0 - 20 pg/pL 
measured at 595 nm were used to generate a standard line and 
concentrations of sampled proteins were kept within this range (Figure 3.1). 
3.2.2 Protein quantification by UV absorbance 
Another method to quantify the amount of recombinant protein that was 
purified is to measure its UV absorbance at 280 nm. Amino acids with aromatic 
rings, such as tryptophan, tyrosine and phenylalanine, absorb UV at 280 nm. 
Therefore to calibrate the UV absorbance, a protein extinction coeffieient must 
be calculated. 
Protein was quantified at 280 nm using a quartz cuvette in a S2100 
Diode Array Spectrophotometer and the concentration was calculated by 
dividing the absorbance by the protein extinction coefficient, obtained by 
entering the protein sequence into Protean (DNA Star). The 
spectrophotometer was blanked using appropriate dialysis buffer. 
3.2.3 S D S - P A G E 
SDS-PAGE is a technique that separates proteins by their 
electrophoretic mobility. SDS binds and unfolds protein, giving it a uniform 
negative charge. The polyacrylamide gel has a specific pore size, which 
separates the protein mixture by size and charge. 
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Protein molecular weight and purity were assessed using sodium 
dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) (Davis, 
1964; Ornstein, 1964). 2x loading buffer (100 mM Tris-HGI pH 6.8, 200 mM 
dithiothereitol, 4 % (w/v) SDS, 0.2 % (w/v) bromophenol blue, 20 % (v/v) 
glycerol) was added to protein, loaded onto a 18% (w/v) resolving gel with a 
5% (w/v) stacking gel and electrophoresed at a voltage of 18 V/cm. The gel 
was stained with Goomassie Brilliant Blue G (3 mM Goomassie Brilliant Blue 
G, 12 M methanol and 2 M glacial acetic acid) then destained with destaining 
solution (12 M methanol and 2 M glacial acetic acid). The destained gel was 
photographed using a Biorad Gel Doc 2000. 
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Figure 3.1: Standard curve of BSA for the quantification of protein in the 
Bradford assay. 
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3.2.4 His-tag staining of proteins 
To identify that the protein with the correct molecular weight is the 
desired expressed protein with a C-terminal His-tag, the SDS-PAGE gel was 
stained with a His-tag stain. This stain binds specifically to the oligohistidine 
domain of a His-tagged recombinant protein and can be visualised at 560 nm. 
2 pg protein was run on a 18% (w/v) resolving gel with a 5% (w/v) 
stacking gel at a voltage of 18 V/cm. The gel was fixed with 200 mL Fixing 
Solution (9 M ethanol and 2 M glacial acetic acid) for 1 h at 25 °C. The Fixing 
Solution was decanted and the gel was washed twice with ultra pure H2O. The 
gel was incubated with 25 mL InVision His (histidine)-tag In-gel Stain for 1 h at 
25 °C. The stain was decanted and the gel was washed twice with 200 mL 20 
mM phosphate buffer pH 7.8 for 10 min. The gel was then imaged by 
excitation at 560 nm using a Typhoon 9400 Variable Mode Imager 
(Amersham). 
3.2.5 pH measurements 
pH measurements and various pH values were measured at the 
temperature stated in the results using a pH meter (Hamilton Biotrode) 
connected to a computer with a PC card (Orion pH SensorLink) in a final 
volume of 100 pL. All pH measurements were accurate to ±0.02 pH units 
(manufacturers specifications). The Orion pH SensorLink program has a time-
driven acquisition mode that can measure pH values every second. The pH 
meter was calibrated using standard pH buffered solutions at pH 4, 7 and 10 
(SLS). NaCI/NaHCOs/COa was added to AC assays after the stated time and 
measurements taken for the time interval stated in the results. 
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3.2.6 Expression and purification of Rv1625c204-443 wild type and 
mutant proteins 
E. CO// cells transformed with a pQE30 vector containing the desired 
recombinant protein gene are grown in LB broth and induced with the addition 
of IPTG, a lactose metabolite that triggers transcription of the lac operon and 
the recombinant protein gene. The expression of the recombinant protein also 
inserts an oligomeric His-tag at the G-terminal. The recombinant protein can 
then be purified on a His-tag affinity column, which specificially binds the His-
tagged recombinant protein. The Recombinant protein is eluted from the 
column by the addition of imidazole and is dialysed with the appropriate buffer. 
pQE30-Rv1625c204^3 wt in E. coli BL21 [pREP4] and pQE30-
Rv1625c204^3 mutants in E. coli Ml5 [pREP4] obtained from glycerol stocks 
(Section 3.1.14) were grown in 100 mL LB broth containing 100 pg/mL 
ampicillin and 50 pg/mL kanamycin overnight at 30 °G. The overnight culture 
was added to 8 x 1 L LB containing 100 pg/mL ampicillin and 50 pg/mL 
kanamycin and grown at 30 °G to O.D.eoo = 0.6. RV1625C204-M3 protein 
production was induced with 30 pM isopropyl-p-D-thiogalactopyranoside 
(IPTG) and incubated at 30 °G for 3 h. The culture was harvested by 
centrifugation at 12,000 g for 10 min at 4 °G, washed once with 20 ml per 1 L 
culture of bacterial wash buffer (50 mM Tris 
[tris{hydroxymethyl}aminomethane]-HGI pH 8.5, 1 mM EDTA), centrifuged at 
5,445 g for 20 min at 4 °G and the bacterial pellet stored overnight at -80 °G. 
Gells were brought to 4 °G in a water bath then resuspended in 20 mL per 
original 1 L culture of cell lysis buffer (50 mM Tris-HGI pH 8.5, 300 mM NaGI, 
10 mM 1-thioglycerol and 2 mM MgGb). The cells were broken by sonication at 
74 W for 150 s at 4 °G. Gell debris was removed by centrifugation at 50,000 g 
for 30 min at 4 °G. 0.5 mL of nickel-nitrilotriacetic acid (Ni-NTA) slurry per 
original 1 L culture was added to the supernatant and the mixture was 
incubated for 2 h at 4 °G. The mixture was centrifuged at 405 g for 1 min and 
the slurry poured into a Polyprep column for washing. The columns were 
washed with lOx bed volume wash buffer A (50 mM Tris-HGI pH 8.5, 10 mM 1-
thioglycerol, 2 mM MgGb, 400 mM NaGI and 5 mM imidazole), lOx bed 
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volume wash buffer B (wash buffer A + 15 mM imidazole), lOx bed volume 
wash buffer G (wash buffer B + 10 mM NaGI) and eluted with 5x bed volume 
elution wash (wash buffer G + 150 mM imidazole). The eluates were dialysed 
against 50 mM Tris-HGI pH 8.5, 10 mM NaGI, 2 mM MgGb, 2 mM 1-
thioglycerol and 20% glycerol for 1 h at 4 °G and changed three times (Guo et 
a/., 2001). 
3.2.7 E x p r e s s i o n and purification of CyaBI595^59 and SIrl991120-337 
wild type and mutant proteins 
pQE30-GyaB1595-859 wt in E. coli Ml5 [pREP4], pQE30-Slr1991120-337 wt 
in E. coli Ml5 [pREP4] and pQE30-Slr1991120-337 mutants in E. coli Ml5 
[pREP4] obtained from glycerol stocks (Section 3.1.14) were grown in 100 mL 
LB broth containing 100 pg/mL ampicillin and 50 pg/mL kanamycin overnight 
at 30 °G. The overnight culture was added to 8 x 1 L LB containing 100 pg/mL 
ampicillin and 50 pg/mL kanamycin and grown at 30 °G to O.D.eoo = 0.6. 
Protein production was induced with 300 pM IPTG and incubated at 30 °G for 
3 h. The culture was harvested by centrifugation at 12,000 g for 10 min at 4 G, 
washed once with 20 ml per 1 L culture of bacterial wash buffer (50 mM Tris-
HGI pH 8.5, 1 mM EDTA), centrifuged at 5,445 g for 20 min at 4 °G and the 
bacterial pellet stored overnight at -80 °G. Gells were purified following the 
same procedure as Rv1625c204^3 (section 3.2.6). 
3.2.8 E x p r e s s i o n and His-tagged purification of Rvl6260212.443 
K296E/F363R/D365C 
pRSET-Rvl 6250212^3 in E. coli BL21 (G43) [pREP4] obtained from a 
glycerol stock (Section 3.1.14) was grown in 100 mL LB broth containing 100 
pg/mL ampicillin overnight at 30 °G. The overnight culture was added to 8 x 1 
L LB containing 100 pg/mL ampicillin and grown at 30 °G to O.D.eoo = 0.6. 
Protein production was induced with 500 pM IPTG and incubated at 37 °G for 
3 h. The culture was harvested by centrifugation at 12,000 g for 10 min at 4 °G, 
washed once with 20 mL per 1 L culture of phosphate-buffered saline. 
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centrifuged at 5,445 g for 20 min at 4 °C and the bacterial pellet stored 
overnight at -80 °C. Cells were brought to 4 °C in a water bath then 
resuspended in 20 mL per original 1 L culture of cell lysis buffer (20 mM Tris-
HCI pH 8.0, 100 mM NaCI, 5 mM 2-mercaptoethanol (2-ME) and 2 mM 
phenylmethylsulfonyl fluoride (PMSF)). The cells were broken by sonication at 
74 W for 150 s at 4 °C. Cell debris was removed by centrifugation at 50,000 g 
for 30 min at 4 °C. 0.5 mL of Ni-NTA slurry per original 1 L culture and 250 mM 
NaCI was added to the supernatant and the mixture was incubated for 2 h at 4 
°C. The mixture was centrifuged at 405 g for 1 min and the slurry poured into a 
Polyprep column for washing. The columns were washed with lOx bed volume 
wash buffer A (20 mM Tris-HCI pH 8.0, 5 mM 2-ME and 500 mM NaCI), lOx 
bed volume wash buffer B (20 mM Tris-HCI pH 8.0, 5 mM 2-ME, 100 mM NaCI 
and 10 mM imidazole) and eluted with 5x bed volume elution wash (20 mM 
Tris-HCI pH 8.0, 5 mM 2-ME, 100 mM NaCI, 150 mM imidazole and 10 % 
glycerol). The eluates were dialysed against 20 mM Tris-HCI pH 8.0, 5 mM 2-
ME and 10% glycerol for 1 h at 4 °C and changed three times. The dialysed 
protein was concentrated to 1 mL and subjected to anion-exchange 
chromatography on a Biorad Biologic Duo Flow FPLC system using a Q-
Sepharose column (25 x 1 cm). The column was equilibrated with dialysis 
buffer and the protein was injected into the column. The column was washed 
with 50 mL dialysis buffer at a flowrate of 3 mL/min and then a linear salt 
gradient of 0-500 mM NaCI was applied for a total volume of 175 mL. The 
gradient was increased to 1 M NaCI in a total volume of 50 mM and finally the 
column was washed with 25 mL dialysis buffer. 5 mL fractions were collected 
at the start of the linear salt gradient. The fractions containing eluted protein 
were pooled and dialysed into the Superdex 200 running buffer (20 mM 
HEPES (N-(2-hydroxyethyl)piperazine-N'-(2-ethanesulfonic acid)-NaOH pH 
7.5, 5 mM 2-ME and 10 % glycerol) and concentrated to 130 pL. The protein 
was injected into a Superdex 200 gel filtration column. 30 mL of running buffer 
at a flowrate of 0.5 mL/min was used to elute the protein. 0.25 mL fractions 
were collected. Fractions containing pure protein were pooled and 
concentrated to 14 mg/mL (Ketkar etal., 2004). 
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3.2.9 Express ion and purification of mammalian 7C1a 
pProEx-HAH6-7C1a263-476 in E. coli BL21 (DE3) obtained from glycerol 
stocks (Section 3.1.14) were grown in 100 mL LB broth containing 50 pg/mL 
ampicillin overnight at 25 °C. The overnight culture was added to 8 x 1 L LB 
containing 50 pg/mL ampicillin and grown at 25 °C to O.D.eoo = 0.4. AC protein 
production was induced with 30 pM IPTG and incubated at 25 °C for 19 h. The 
culture was harvested by centrifugation at 12,000 g for 10 min at 4 °C, washed 
once with 20 ml per 1 L culture of bacterial wash buffer (50 mM Tris-HCI pH 
8.5, 1 mM EDTA), centrifuged at 5,445 g for 20 min at 4 °C and the bacterial 
pellet stored overnight at -80 °C. Cells were brought to 4 °C in a water bath 
then resuspended in 20 mL per original 1 L culture of Solution A (20 mM Tris-
HCI pH 8.0, 5 mM 2-ME, 2 mM MgCb and 1 mM PMSF). 0.1 mg/mL lysozyme 
was added and incubated for 30 min at 4 °C. The cells were broken by 
sonication at 74 W for 90 s at 4 °C. Cell debris was removed by centrifugation 
at 50,000 g for 30 min at 4 °C. 0.5 mL of Ni-NTA slurry per original 1 L culture 
and 100 mM NaCI was added to the supernatant and the mixture was 
incubated for 2 h at 4 °C. The mixture was centrifuged at 405 g for 1 min and 
the slurry poured into a Polyprep column for washing. The columns were 
washed with lOx bed volume wash buffer A (Solution A + 400 mM NaCI), 20x 
bed volume wash buffer B (Solution A + 100 mM NaCI + 20 mM imidazole), 
and eluted with 6x bed volume elution wash (Solution A + 100 mM NaCI + 150 
mM imidazole). The eluates were dialysed against Solution B (50 mM Tris-HCI 
pH 8.5, 10 mM NaCI, 2 mM MgCb, 2 mM 1-thioglycerol) and 20% glycerol for 
1 h at 4 °C and changed three times. The dialysed protein was concentrated to 
1 mL and subjected to anion-exchange chromatography on a Biorad Biologic 
Duo Flow FPLC system using a Q-Sepharose column (25 x 1 cm). The column 
was equilibrated with Solution B and the protein was injected into the column. 
The column was washed with 50 mL Solution B at a flowrate of 2 mUmin and 
then a linear salt gradient of 100-500 mM NaCI was applied for a total volume 
of 175 mL. The gradient was increased to 1 M NaCI in a total volume of 50 mM 
and finally the column was washed with 25 mL Solution B. 5 mL fractions were 
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collected at the start of the linear salt gradient. Fractions containing pure 
protein were pooled and concentrated to 5 mg/mL (Yan and Tang, 2002). 
3.2.10 Expression and purification of mammalian 2C2a 
pQE60-2C282i-io9o in E. coli M15 (DE3) [pREP4] obtained from glycerol 
stocks (Section 3.1.14) were grown in 100 mL LB broth containing 50 pg/mL 
ampicillin and 50 pg/mL kanamycin overnight at 30 °C. The overnight culture 
was added to 8 x 1 L LB containing 50 pg/mL ampicillin and 50 pg/mL 
kanamycin and grown at 30 °C to O.D.eoo = 0.4. AC protein production was 
induced with 30 pM IPTG and incubated at 25 °C for 15 h. The culture was 
harvested by centrifugation at 12,000 g for 10 min at 4 °C, washed once with 
20 ml per 1 L culture of bacterial wash buffer (50 mM Tris-HCI pH 8.5, 1 mM 
EDTA), centrifuged at 5,445 g for 20 min at 4 °C and the bacterial pellet stored 
overnight at -80 °C. Cells were brought to 4 °C in a water bath then 
resuspended in 20 mL per original 1 L culture of lysis buffer (50 mM Tris-HCI 
pH 8.0, 10 mM 2-ME, 50 mM NaCI and mixed protease inhibitors). 0.2 mg/mL 
lysozyme was added and incubated for 30 min at 4 °C. The cells were broken 
by sonication at 74 W for 90 s at 4 °C. Cell debris was removed by 
centrifugation at 50,000 g for 30 min at 4 C. 0.5 mL of Ni-NTA slurry per 
original 1 L culture and 100 mM NaCI was added to the supernatant and the 
mixture was incubated for 2 h at 4 °C. The mixture was centrifuged at 405 g for 
1 min and the slurry poured into a Polyprep column for washing. The columns 
were washed with 15x bed volume wash 1 (lysis buffer + 2 mM MgCb + 400 
mM NaCI + 5 mM imidazole), 12x bed volume wash 2 (50 mM Tris-HCI pH 8.0, 
10 mM 2-ME, 2 mM MgCb, and 15 mM imidazole), 8x bed volume wash 3 (50 
mM Tris-HCI pH 8.0, 10 mM 2-ME, 10 mM NaCI and 15 mM imidazole) and 
eluted with 8x bed volume elution wash (50 mM Tris-HCI pH 8.0, 10 mM 2-ME, 
2 mM MgCb, 10 mM NaCI and 150 mM imidazole). The eluates were dialysed 
against buffer A (50 mM Na-HEPES pH 8.0, 2 mM MgCb, 1 mM EDTA and 2 
mM dithiothreitol) for 1 h at 4 °C and changed three times. The dialysed 
protein was concentrated to 1 mL and subjected to anion-exchange 
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chromatography on a Biorad Biologic Duo Flow FPLC system using a Q-
Sepharose column (25 x 1 cm). The column was equilibrated with buffer A and 
the protein was injected into the column. The column was washed with 50 mL 
buffer A at a flowrate of 2 mUmin and then a linear salt gradient of 0-300 mM 
NaCI was applied for a total volume of 120 mL. The gradient was increased to 
1 M NaCI in a total volume of 50 mM and finally the column was washed with 
25 mL buffer A. 5 mL fractions were collected at the start of the linear salt 
gradient. Fractions containing pure protein were pooled and concentrated to 1 
mg/mL (Whisnant et a/., 1996). 
3.2.11 Adenylyl cyclase assays 
AC protein was assayed for specific activity using radiolabelled [a-^^P] 
ATP and measuring the amount of [2,8-^H] cAMP produced over a specific 
time and with a specific amount of protein. These assays allow for the 
measurement of specific activity with variation of pH value, temperature, 
protein concentration and time. To measure the amount of [2,8-^H] cAMP 
produced, the [2,8-^H] cAMP must be separated from unconverted [a-^^P] ATP 
and counted on a scintillation counter. Running the reaction mixture through a 
Dowex 50W-X4 resin column and an Aluminium oxide (type WN-3) column 
separates the [2,8-^H] cAMP for counting (Section 4.4). 
Proteins were assayed in a final volume of 100 pL. Reactions typically 
contained 22% glycerol, 50 mM Tris-HCI pH 7.5, with 2 mM Mn^ "" as co-factor 
and 200 pM [a-^^P] ATP (25 kBq) and 2 mM [2,8-^H] cAMP (150 Bq) unless 
otherwise stated. For the pH dependence assay for Rvl625c204-443, the buffers 
used were 50 mM MES (2-morpholinoethanesufonic acid) (pH 6.5) Tris (pH 7.0 
and 7.5) and C H E S (2-(cyclohexyamino)ethanesulfonic acid) (pH 8.0 and 8.5). 
Further details are stated in the results. All assays were started by addition of 
substrate and stopped with stop buffer (1 M Tris-HCI pH 7.5, 3 mM ATP, 3 mM 
cAMP, 1.5 % (w/v) SDS) (Salomon et a/., 1974). Error bars are stated with 
figure. If an error bar is not seen, the data point is bigger than the eror bar. All 
error bars are standard error of the mean. Assays were separated using a two 
column chromatography method. Reactions were decanted into columns (0.4 x 
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15 cm) containing 1 mL Dowex 50W-X4 resin pre-equilibrated with 5 mL H2O 
and left to flow under gravity. Columns were washed with 5 mL H2O and eluted 
with 2 mL H2O into columns (0.4 x 15 cm) containing 1 mL Aluminium oxide 
(type WN-3) pre-equilibrated with 5 mL 20 mM Tris-HCI pH 7.5. Columns were 
eluted with 3 mL 20 mM Tris-HCI pH 7.5 into 6 mL scintillation vials. 3 mL 
Ecoscint XR scintillation fluid was added and vials were shaken well and 
counted with a Packard Liquid Scintillation Analyzer 1600 TR. Data were 
analysed using Excel and Prism. 
3.2.12 Error bars of graphs 
All error bars are standard error of the mean (SEM). SEM represents 
the precision of the mean. The number of replicates (n) is stated in the figure. 
The p-value is calculated by One-way ANOVA with Dunnett's post test, 
performed using GraphPad Prism version 5.02 for Windows, GraphPad 
Software, San Diego California USA, www.qraphpad.com. If the mean of the 
data is significantly different compared to the other data ranges, the data are 
highlighted with (*p<0.05). 
3.2.13 Preparation of 100 mM NaHCOa pH 6.5 for AC assays 
To add CO2 to AC assays, 100 mM NaHCOa was added at pH 6.5, 
where 38.7 % of the total Ci was CO2. 
100 mM NaHCOa was prepared to a final volume of 10 mL with the 
addition of 50 mM MES pH 6.5 at 37 °C. The solution was buffered to pH 6.5 
using approximately 3 x 50 pL 1 M HCI and the pH measured (Section 3.2.5). 
Final pH adjustments were made using 1 M HCI or 1 M NaOH. The buffered 
solution was used immediately in AC assays. 
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3.2.14 Preparation of CO2 saturated H2O for Ci dis-equilibrium AC 
assays 
Another method to prepare CO2 for Ci dis-equilbrium AC assays where 
the added Ci is mostly CO2 with a low concentration of NaHCOa in the solution. 
50 mL of H2O on ice was gently bubbled with 10 % (v/v) CO2 gas for 1 
h. The H2O was saturated with CO2 after this time and the concentration of 
CO2 was approximately 30 mM based on titration against NaOH (data not 
shown). 
3.2.15 p-galactosidase assay 
To measure in vivo cAMP levels, a plasmid containing LacZ gene was 
transformed into E. coli cells containing the plasmid with Rv1625204-443 
recombinant gene. In vivo CO2 stimulation of Rv1625c would increase cAMP 
levels. cAMP will bind to the lac operon of LacZ and up-regulate the 
transcription of p-galactosidase. On addition of the substrate ortho-nitrophenol-
P-D-galactopyranoside (ONPG), p-galactosidase converts the substrate into 
ortho-nitrophenol (ONP), a yellow substance which can be quantified. 
pCTXPILacZ was transformed into E. coli M15 [pREP4] pQE30-
Rv1625c204^3 cells. E. coli M15 [pREP4] pQE30-Rv1625c204-443, pCTXLacZ 
was grown in 200 mL LB with 100 pg/mL ampicillin, 50 pg/mL kanamycin and 
5 (jg/mL tetracycline at 30 °C until O.D.eoo = 0.6. E. coli Ml5 [pREP4] pQE30-
pCTXPILacZ was grown in 200 mL LB with 5 pg/mL tetracycline at 30 °C until 
O.D.600 = 0.6. pQE30-Rv1625c204^3, pCTXPILacZ and pQE30, pCTXPILacZ 
were induced with 30 pM IPTG for 3 h. Cells were centrifuged at 4,000 g for 10 
min and resuspended into 192 mL LB Tris-HCI pH 7.1 and aliquoted into 50 
mL tubes containing 12 mL LB. Tubes were bubbled with either 10 % (v/v) CO2 
in air or air for 30 min at 30 °C. Cell membranes were disrupted with the 
addition of 30 pM sodium deoxycholate and 120 pM toluene to 8.4 mL cell 
culture. Samples were shaken for 10 min at 30 °C. Enzyme assay was 
performed by adding 2 mL 0.1 M sodium phosphate (pH 7.0) and 0.2 mL 0.01 
M ONPG to 2 mL lysed cell culture. Samples were incubated for 15 min at 30 
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°C. Reactions were stopped with the addition of 0.5 mL 2 M sodium carbonate 
and centrifuged at 15,700 g for 5 min. Absorbance was read at 420 nm. A 
standard curve was generated using 0-250 pM ONP and absorbance 
measured at 420 nm. 
3.2.16 CO2 Binding Assays 
To identify CO2 binding to ACs, radiolabelled NaH^^COa was added to 
AC protein. The ^'*C02 bound protein was separated from unbound ^''C02 and 
NaH '^^ COa through gel filtration with G50 sephadex columns. 
1 mL (50% w/v) of G50 sephadex was decanted into 0.8 mL Handee 
Centrifuge columns and centrifuged with cap on at 1,500 g for 30 s . The eluant 
was discarded. 450 pM protein in 50 mM MES pH 6.5 was incubated for 30 
min with 30 mM NaH '^^ COa (185 kBq) pH 6.5 in a total volume of 50 pL. The 
protein-C02 mixture was applied to the Handee Centrifuge column and spun at 
1,500 g for 30 s into a microcentrifuge tube containing 50 pL 2 M NaOH. 1 mL 
H2O and 2 mL scintillation fluid were added to the eluant and the mixture was 
counted on a scintillation counter (Lorimer, 1979). 
3.2.17 IVIodification of K296C with 2-carboxyethyl 
methanethiosulfonate 
To mimic CO2 forming a carbamate with K296 of Rv1625c, the mutated 
K298C was modified with 2-carboxyethyl methanethiosulfonate (Section 6.3) 
which produced a mimic that would not be stimulated by CO2. 
12 mg Rv1625c204^3 K296C (4 mg/mL) was dialysed into 70 mM CHES 
pH 9.5, 2 mM MgCb. 50 pL 0.2 M MTSCE was added to the protein and mixed 
at 25 °C for 2 h. The reaction was monitored by assaying 10 pL protein with 50 
pL Ellman's reagent (4 mg/mL in 0.1 M Tris pH 8.0) and measuring the 
absorbance at 412 nm. A further additon of 50 pL 0.2 M MTSCE (Davis et a/., 
1999) was added to the mixture to ensure complete modification. To remove 
excess MTSCE, the mixture was dialysed with dialysis buffer (Section 3.2.6a) 
at 4 °C for 1 h and changed three times. 
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3.3 Physica l Chemistry 
3.3.1 Mass spectroscopy 
Mass spectroscopy is an analytical technique that determines the 
elemental composition of a molecule. It is a qualitative and quantitative 
technique that identifies the molecular weight of a protein and thus is used as 
confirmation that the expressed recombinant protein is the correct protein. 
100 pg protein in 50 mM Tris-HCI pH 7.0 was analysed by Micromass 
LCT E S (electrospray)-TOF (time of flight) mass spectroscopy (MS). The 
sample was placed on HPLC (High Performance Liquid Chromatography) C4 
column with a flow rate of 0.2 mL/min. The protein was washed with 0.5 % 
formic acid in H2O and then washed with a linear gradient of CH3CN with 0.5 
% formic acid. The protein was eluted with 100 % CH3CN and loaded onto the 
mass spectrometer. 
3.3.2 CD spectroscopy 
CD spectroscopy is a technique that can determine the structure of 
macromolecules, such as the secondary structure of proteins, through the 
differential absorption of left and right-handed circularly polarised light. 
Protein was dialysed with AC assay dialysis buffer without MgCb for 3 h 
with the buffer changed every hour. ATP was buffered using 50 mM MES pH 
6.5. Protein samples were mixed in a microcentrifuge tube with conditions 
stated in the results to a final volume of 500 pL and pipetted into a 700 pL 
cuvette. 10 mM MgCb was added to both the 20 pM protein sample and the 20 
pM protein with 5 mM ATP sample and the final volumes were made up to 510 
pL. Circular dichroism (CD) spectra were recorded using a JASCO J-810 
Spectropolarimeter scanning at 50 nm s'^ with a band pass of 2 nm and 
response time of 4 s. Points were recorded at 1 nm intervals from 250-350 nm. 
N2 gas was pumped through the machine for 1 h prior to use and remained 
running during experimentation. Spectrum Measurement for Windows was 
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used to analyse data. Spectra were normalised to 0 degree cm'^ dmol 
residue'^ at 350 nm and the blank spectrum was subtracted from all spectra. 
3.3.3 FTIR ATR spectroscopy 
IR spectroscopy measures the amount of energy if IR light absorbed by 
a sample with a range of wavelengths. FTIR spectroscopy is a measurement 
technique that collects numerous IR spectra at once, by IR light passing 
through an interferometer, which performs a fourier transformation 
(mathematical transformation). The ATR adapter allows samples to be 
examined directly in the solid or liquid state without further preparation. 
Protein was dialysed with dialysis buffer without MgCb and glycerol for 
3 h with the buffer changed every hour (Section 3.2.6). Protein samples 
typically contained as stated in results, 3 mM protein, 20 mM MgCb, 5 mM 
ATP pH 6.5 and 3 mM CO2. The blank spectra samples typically contained as 
stated in results, 20 mM MgCb, 5 mM ATP pH 6.5 and 3 mM CO2. 30 mM CO2 
solution was obtained by bubbling CO2 gas from dry ice into H2O for 60 min. 
Fourier transform infrared (FTIR) spectra were collected using a Perkin Elmer 
Spectrum 100 FTIR Spectrophotometer with a Miracle ATR (ZnSe) accessory 
(Pike Technologies Inc.) with 64 scans. Points were recorded at 1 cm"^  
intervals from 1000-4000 cm'^. Spectrum for Windows was used to analyse the 
data. Samples were mixed in a microcentrifuge tube to a total volume of 5 pL 
and pipetted directly onto the ATR crystal. H2O and protein spectra were 
subtracted from sample spectra using Spectrum for Windows to obtain new 
spectra from 2320-2400 cm'^ and data were nomrialised to 100 % 
transmittance at 2500 cm"\ 
3.3.4 HCO3' ratiometric europium complex spectroscopy 
Luminescence probe spectroscopy is a technique that measures a 
concentration change of a molecule. Light excitation of the probe bound to the 
molecule causes an electron to be raised to a higher energy state. A return of 
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the electron to the original energy state is accompanied by an emission of a 
photon, which can be measured and quantified. 
HCOz ratiometric luminescence spectra were recorded using a 
Fluorolog 3-11 Spectrophotometer and data were analysed using DataMax for 
Windows v2.1. Excitation and emission slits were 3 nm and 1.5 nm 
respectively and the bandpass was 1 nm. An excitation wavelength of 408 nm 
(sensitisation of the complex via acridone chromophore) was used to obtain 
the luminescence spectra. Points were recorded at 1 nm intervals from 570-
720 nm with a 0.25 s integration time. EuL"^ probe (Bretonniere et a/., 2004) 
was kindly donated by Dr. Robert Pal and Prof. David Parker (Durham 
University) and was resuspended to 10 mM in H2O. Samples were made to a 
final volume of 50 pL and pipetted into a Fluorimeter Sub Micro Cell. A 
standard curve was generated from 0.1-30 mM NaHCOs pH 6.5 using 100 pM 
EuL''. Protein samples typically contained 500 pM protein, 50 mM MES pH 6.5, 
100 pL EuL"*, 100 mM MgCh and 10 mM ATP pH 6.5. Ratios of intensity 
calculated at wavelengths 616 nm and 592 nm and at wavelengths 616 nm 
and 712 nm were used to obtain the quantitative HCOa' ratios. 
3.3.5 Crystallisation of Rv1625c2i2^3 K296E/F363R/D365C protein 
Protein X-ray crystallography is a method to determine the arrangement 
of a protein within the protein crystal. By measuring the 2D X-ray diffraction 
pattern of the protein crystal at a synchrotron, a 3D model of the electron 
density of the protein can be solved. 
Crystallisation trials were set up using the hanging-drop vapour-
diffusion method. Screens were performed using 24 well VDX plates with 
siliconised glass circle cover slides. The protein was diluted to 30 mg/mL in 20 
mM HEPES)-NaOH pH 7.5 containing 5 mM 2-ME and 5 % (v/v) glycerol. The 
plate was set up using 5-10 % polyethylene glycol (PEG) 8000 in 0.1 M Tris 
pH 8.5 and 0-6 % glycerol in 500 pL reservoir solution. A second plate was set 
up using 5-10 % P E G 6000 in 0.1 M Tris pH 8.0 and 0-6 % (v/v) glycerol in 
500 pL reservoir solution. The crystals were set up by mixing 1 pL protein with 
1 pL reservoir solution and 2 pL protein with 1 pL reservoir solution (Ketkar et 
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a/., 2004). Crystals appeared within 7 days at 20 °C and were left to grow for a 
further 1 month. Optimal sized crystals were cryo-protected by consecutively 
coating the crystal with reservoir solution containing 5-30 % glycerol. Cryo-
protected crystals were immediately frozen in liquid nitrogen. The frozen 
crystals were stored -140 °C before transport to a synchrotron for X-ray 
diffraction. 
3.3.6 Exposure of Rv1625c2i2^3 K296E/F363R/D365C protein 
crystals to CO2 
Optimal sized crystals from the crystallisation trials where chosen to 
expose to CO2. The crystals were cryo-protected by consecutively coating the 
crystal with reservoir solution containing 5-30 % glycerol 3-4 times. The cryo-
protected crystal was immediately placed in a CO2 chamber (Figure 3.2) and 
exposed to between 3-5 bar CO2 for between 2-10 minutes. The crystal was 
then immediately removed from the CO2 chamber and frozen in liquid nitrogen. 
The frozen CO2 exposed crystals were stored at -140 °C before transport to a 
synchrotron for X-ray diffraction. 
3.3.7 X-ray diffraction and data collection of Rv1625c2i2^3 
K296E/F363R/D365C protein crystals 
X-ray diffraction data of CO2 exposed protein crystals were collected at 
beam line X06DA equipped with a Mar225 CCD detector at the Swiss Light 
Source (Paul Scherrer Institut, Villigen, Switzerland). Data were processed and 
scaled with HKL2000 (Otwinowski and Minor, 1997). The structure was solved 
with molecular replacement using the CCP4 programme package 
(Collaborative Computational Project, 1994) and a 3D model was generated 
(Section 6.6). 
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Figure 3.2: CO2 chamber used for exposing protein crystals to CO2. Cyro-
protected protein crystals were exposed to between 3-5 bar CO2 for between 
2-10 minutes prior to being frozen in liquid nitrogen and transported to a 
synchrotron. 
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3.4 Table of DNA primers. 
Protein Primer Sequence 
Rv1625c204^ 
R310A MJC233 
MJC234 
G T T G T C A G C G G C G T T C C G G C G C C C C G G C C T G A C C A T A C G 
C G T A T G G T C A G G C C G G G G C G C C G G A A C G C C G C T G A C A A C 
H315A MJC231 
MJC232 
C C G C G G C C C C G G C C T G A C G C G A C G C A A G C A C T G G C G G A C 
G T C C G C C A G T G C T T G C G T C G C G T C A G G C C G G G G C C G C G G 
K334A MJC223 
MJC224 
A A T G T C G C A G C G C A A T T G G C G G A T C C A C G C G G C A A C C C G 
C G G G T T G C C G C G T G G A T C C G C C A A T T G C G C T G C G A C A T T 
R337A MJC235 
MJC236 
G C G C A A T T G A A G G A T C C A G C G G G C A A C C C G G T G C C G C T G 
C A G C G G C A C C G G G T T G C C C G C T G G A T C C T T C A A T T G C G C 
R344A MJC237 
MJC238 
G G C A A C C C G G T G C C G C T G G C G G T G G G C C T G G C C A C C G G C 
G C C G G T G G C C A G G C C C A C C G C C A G C G G C A C C G G G T T G C C 
R360A MJC239 
MJC240 
G C G G G T G T G G T G G G T T C T G C G C G G T T C T T C T A C G A C G T G 
C A C G T C G T A G A A G A A C C G C G C A G A A C C C A C C A C A C C C G C 
R361A MJC241 
MJC242 
G G T G T G G T G G G T T C T C G A G C G T T C T T C T A C G A C G T G T G G 
CCACACGTCGTAGAAGAACGCTCGAGAACCCACCACACC 
V366A MJC262 
MJC263 
C G A C G G T T C T T C T A C G A C G C G T G G G G C G A C G C G G T C A A T 
A T T G A C C G C G T C G C C C C A C G C G T C G T A G A A G A A C C G T C G 
R395A MJC243 
MJC244 
CCAGACGAGGTTTACGAGGCGCTCAAGGACGACTTCGTG 
C A C G A A G T C G T C C T T G A G C G C C T C G T A A A C C T C G T C T G G 
K397A MJC225 
MJC226 
G A G G T T T A C G A G C G T C T C G C G G A C G A C T T C G T G T T G C G C 
GCGCAACACGAAGTCGTCCGCGAGACGCTCGTAAACCTC 
K405A MJC245 
MJC246 
GACTTCGTGTTGCGCGAGGCGGGCCACATAAACGTCAAG 
C T T G A C G T T T A T G T G G C C C G C C T C G C G C A A C A C G A A G T C 
K411A MJC227 
MJC228 
CGCGGCCACATAAACGTCGCGGGGAAAGGCGTAATGCGC 
G C G C A T T A C G C C T T T G C C C G C G A C G T T T A T G T G G C C G C G 
K413A MJC229 
MJC230 
CACATAAACGTCAAGGGGGCGGGCGTAATGCGCACGTGG 
C C A C G T G C G C A T T A C G C C C G C C C C C T T G A C G T T T A T G T G 
SIM 991120^37 
D136A MJC208 
MJC209 
ATTACGGTGTTGGTGGCGGCCATGCGTAACTTCACCGGC 
GCCGGTGAAGTTACGCATGGCCGCCACCAACACCGTAAT 
D181A MJC210 
MJC211 
G T G G A T A G C T A C A T C G G T G C C G C G G T C A T G G C C A T C T G G 
C C A G A T G G C C A T G A C C G C G G C A C C G A T G T A G C T A T C C A C 
Vector 
pQE30 MJC104 
MJC108 
GAGCGGATAACAATTTCAC 
GTTCTGAGGTCATTACTGG 
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3.5 S o u r c e s of Materials. 
All chemicals used were from Sigma Aldrich unless otherwise stated. 
All equipment used was from S L S unless otherwise stated. 
Mini-prep kit was from Qiagen. 
Restriction enzymes, restriction buffers, DNA ladders and protein 
ladders were from Fermentas 
Ligation enzymes, ligation buffers, DNA polymerase, PCR buffers and 
trypsin were from Promega. 
dNTPs and agarose were from Bioline. 
TOPO cloning kit and His-tag In-gel Stain were from Invitrogen. 
Cryovial tubes were from Simport. 
Polyprep columns and Dowex resin and Prep-a-gene matrix were from 
Biorad 
Radiochemicals were from Amersham and Perkin Elmer. 
Scintillation vials were from Starstedt. 
Scintillation fluid was from National Diagnostics. 
Fluorimeter Sub Micro Cell was from Starna. 
Handee Centrifuge columns were from Pierce. 
Q-Sepharose and Superdex columns were from G E Healthcare. 
MTSCE was from Toronto Research Chemicals. 
VDX plates and cover slides were from Hampton Research. 
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4 Investigation into in vitro and in vivo inorganic 
carbon stimulation of Rv1625c204^3 
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4.1 Introduction 
Class lllb ACs were previously thought to be the only sub-group of ACs 
responsive to Ci and the Ci form that caused this response was HCO3" (Cann 
et a/., 2003). Experiments conducted on Class Ilia ACs for Ci sensitivity 
showed a non-response to Ci (Chen et a/., 2000; Cann et a/., 2003). Further 
work has identified that the Ci species that caused the Ci response in Class 
lllb ACs is CO2 (Hammer et a/., 2006). As these two biologically active forms 
of Ci are in an equilibrium that is affected by pH, a further investigation into the 
response of Class Ilia ACs to CO2 should be conducted at reduced pH, where 
the total percentage of CO2 in Ci is greater. It is important to identify a potential 
Ci sensitivity in Class Ilia ACs as all mammalian tmACs and a large number of 
prokaryotic ACs are in this sub-group and a Ci sensitivity in Class Ilia ACs 
would suggest that these ACs are involved in CO2 sensing in mammals and 
prokaryotes. 
The catalytic domain of Rv1625c, a Class Ilia AC from M. tuberculosis 
has been previously expressed and characterised as a recombinant protein 
(Guo et a/., 2001) and was therefore investigated for Ci sensitivity. There is a 
link between elevated cAMP levels and virulence (Lowrie ef a/., 1975) seen in 
vivo, which underpins the importance of identifying the role of ACs in 
pathogenesis of M. tuberculosis. Thus if Rv1625c is a CO2 sensor, then it may 
be involved in M. tuberculosis pathogenesis as increased CO2 concentrations 
are found at the site of M. tuberculosis infections. 
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4.2 Purification and analys is of Rv1625c204-443 
An alignment of the catalytic domain of Class III a-d ACs (Figure 4.1) 
shows the conserved residues required for catalysis. The T to D polymorphism 
of the Class 11 lb ACs and Class Ilia ACs was thought to confer HCO3' 
sensitivity to the AC, hence Class Ilia ACs were thought to be non-responsive 
to HCOa' (Cann et a/., 2003; Linder and Schultz, 2003). 
The catalytic domain of the Class Ilia AC from M. tuberculosis 
Rv1625c204^3 was overexpressed in E. coli and purified by affinity 
chromatography to homogeneity to generate a recombinant protein. The 
protein was analysed for purity by MS and SDS-PAGE. 
The SDS-PAGE gel of the expressed and purified Rvl 625c204-443 
recombinant protein (Figure 4.2A(1)) shows a single protein band at 
approximately 30 kDa. The theoretical weight of Rv1625c204^3 is 26790 Da. 
The His-tag stained gel (Figure 4.2A(2)) suggests that the protein band is the 
correctly expressed protein as there is a His-tag attached to the protein and it 
has not been proteolysed at the N-terminus. 
The MS data (Figure 4.2B) confirms that the actual molecular weight of 
the purified protein matches the theoretical molecular weight of 27690 Da for 
Rvl 625C204-443 and proved that the purified protein is Rv1625c204^3- The data 
also shows that there was no contaminating protein. 
4.3 Control pH a s s a y s for A C a s s a y s 
Class 11 lb ACs were previously thought to be stimulated by HCO3", 
however we have found that they are actually stimulated by CO2. This 
suggested that Class Ilia ACs, previously thought to be non-responsive to 
HCOs', may respond to CO2 instead. To assess whether Rv1625c204^3, a 
Class Ilia AC, might respond to CO2, a pH dependence assay was conducted. 
The percentage of Ci in the form of CO2 and HCOs' varies depending on the 
pH of the solution (Figure 4.3). 
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Figure 4.1: Alignment of the catalytic domains of C lass III A G s and comparison 
of their adenine binding mechanisms. The C lass Ilia A C is Rv1625c of M. 
tuberculosis H37Rv, the C l a s s 11 lb A C s are C y a B I of Anabaena P C C 7120, 
Slr1991 of Synectiocystis P C C 6803 and human s A C . The C l a s s lllc A C is 
Rv1624 of M. tuberculosis H37Rv. The C l a s s 11 Id A C is CyaA of Leishmania 
donovani. Numbers denote amino acid sequence number. Arrows indicate 
conserved metal binding Asp residues. Triangle indicates conserved substrate 
binding Lys residue. Square indicates conserved transition state binding Arg 
residue. Circle indicates the polymorphic Asp/Thr of C lass llla/b A C s . 
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I • i 
a M y c o b a c t e r i a R v l 6 2 5 c 252 VLFADIVGFTERASST APADLVRFLDRLYSAFDELVDQHGLEKIKVSGDSYM 
Anabaena C y a B l 602 VLFSDIRGYTTLTENL GAAEWSLLNQYFETMVEAVFNYEGTLDKFIGDALM 
b S y n e c h o c y s t i s S l r l 9 9 1 132 VLVADMRNFTGMAOQV EEELLSMLIGNWFRQAGHILREAGSWVDKYIGDAVM 
Human s A C l 4 3 LMFVDISGFTAMTEKFSTAMYMDRGAEQLVEILNYYISAIVEKVLIFGGDILKFAGDALL c M y c o b a c t e r i a R v l 2 6 4 
d L e i s h m a n i a CyaA 
216 VAFADLVGFTQLGEW • 
934 LLFTDIESSTALWAAL. 
•SAEELGHLAGRLAGLARDLTAPPVWF.IKTIGDAVM 
. .PQLMSDAIAAHHRVIROLVKKYGCYEVKTIGDSFM 
a M y c o b a c t e r i a R v l 6 2 5 c 304 W. . SGVPRPRPDHTQALADFALDMTNVAAQLKDPRGN 
Anabaena C y a B l 654 AV. 
b S y n e c h o c y s t i 3 S l r l 9 9 1 185 A I . 
Human s A C l 103 AL. 
FGAPLPLTENHAWQAVQSALDMRQRLKEFNQR 
.WFHGYNEATPAEIIQILHAVNRLQAMTAXLNQ 
• W KVERKQLKNinVVIKCSLEIHGLFEA 
c M y c o b a c t e r i a R v l 2 6 4 
d L e i s h m a n i a CyaA 
269 LV CPDPAP LLDTVLKLVEW DTDNN 
986 lACRSAHSAVSLACEIQTKLLKHDW..GTEALDRAYREFELARVDTLDDYEPPTARLSEE 
.PWAGWGSRRFFYDVW.GDAVN. . .VASRMEST 
Anabaena C y a B l 688 RIIQPQPOIKIGIGISSGEWSGNIGSHKRHDYTV. .IGDGVN.. .LSSRLETV 
b S y n e c h o c y a t i s S l r l 9 9 1 219 KYELPFP.LRIGTGINTGYAMVGNTGSGDHPDYTA. .IGDTVN.. -AAFRLESA 
Human sA C l 133 KEVEEGLDIRVKIGLAAGHITMLVFGDETRNYFLV. .IGQAVDD. .V..RLAQN 
c M y c o b a c t e r i a RV1264 694 FPRLRAGVASG. . .MAVSRAGD WFGSPVN. . .VASRVTGV 
d L e i a h m a n i a CyaA 1044 EYAALWCGLRVRVGIHTGLTDIRYDEVTKGYDY... .YGDTSN.. .MAARTEAV 
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At pH 6.5, the percentage of Ci in the form of CO2 is 38.7% and the 
percentage of Ci in the form of HCOa' is 61.3%. However raising the pH to 7.5 
decreases the percentage of Ci in the form of CO2 to 5.9% and increases the 
percentage of Ci in the form of HCO3' to 93.9%. Thus by lowering the pH value 
of Ci , the percentage of Ci in the form of CO2 can be selectively increased in 
comparison to HCO3". 
Since pH played an important role in determining the percentage of CO2 
or HCO3", it is important that during the A C a s s a y s the pH of the mixture is 
stable and accurate. To demonstrate that the pH at various pH values 
remained constant even with the addition of Ci , pH control a s s a y s were 
performed using a mock A C assay (without enzyme added) and measuring the 
pH of the solution every minute for 70 minutes. 
The pH controls for the A C a s s a y s (Figure 4.4) demonstrates that at the 
five pH values, pH 6.5-8.5, the pH of the assay remained stable during the 30 
minute pre-incubation period, the addition of substrate, and the 40 minute 
assay period. The pH value of the assay was also similar both in the presence 
of NaHCOs and NaCI. At all pH values, the pH value decreased during the first 
three minutes. This was because the assay mixture was kept at 0 °C until it 
was incubated in a 37 °C water bath. On increasing temperature, buffered 
solutions decrease in pH. 
It can therefore be assumed that any changes in the specific activity of 
Rv1625C204-W3 in the assay will be due to the response of the enzyme to Ci 
and not a change in the pH value. 
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Figure 4.2: A) 1) S D S - P A G E gel of Rv1625c204^43. 2 [ig of protein was applied 
to each lane with nnolecular weight standards on the left of each gel and the 
gel was stained with Coomassie Brilliant Blue G. 2) His-tag stained S D S -
P A G E gel of Rv1625c204-443. B) MS data for Rv1625c204-443 
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Figure 4.3: Percentage of total Ci in the form of CO2 and HCO3" at different pH 
values. 
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4.4 AC assays 
The A C a s s a y s were all conducted using similar methodologies with 
minor changes, depending on the assay , that are mentioned in the figure 
captions. The assay mixture typically contained 50 mM buffer, 2 mM metal 
(usually MnCl2), salt (usually 20 mM NaCI/NaHCOa) 22 % glycerol and protein. 
The concentration of protein added to the assay was adequate to maintain a 
substrate conversion of < 10 %, so as to reduce the inhibitory effects of the 
formed products on the A C . The a s s a y s were incubated for 30 minutes in a 
water bath (usually at 37 °C), then removed from the water bath and placed on 
ice. 200 pM A T P (spiked with 25kBq [a-^^P] ATP) was added to the assay 
mixture and immediately returned to the water bath for the assay time (usually 
40 minutes). The assay was stopped with the addition of stop buffer that 
contained S D S to disrupt the protein and A T P to compete with [a-^^P] ATP for 
catalysis. A tracer amount of [2,8-^H] cAMP (150 Bq) was added and used as 
a control for calculating recovery of [2,8-^H] cAMP. The reactions were 
decanted into Dowex 50W-X4 columns which bound [a-^^P] A T P and not [2,8-
^H] cAMP. [2,8-^H] cAMP was eluted off the Dowex columns into aluminium 
oxide columns which further purified the [2,8-^H] cAMP from eluted [a-^^P] 
ATP. Ecoscint X R scintillation fluid was added to the eluted [2,8-^H] cAMP and 
counted on a scintillation anaylzer. 
4.5 pH dependence assay of Rv1625c204^3 in the presence of 
Ci 
Having completed the control pH a s s a y s for the A C a s s a y s and finalised 
the conditions for the A C assay , a series of pH dependence assay ranging 
from pH 6.5 to 8.5 was performed to ascertain the effect of Ci on the specific 
activity of Rv1625c204^3 at various pH values. The graph (Figure 4.5) shows 
that in the presence of NaCI, the optimal pH value was approximately 8.0, 
however in the presence of NaHC03 the optimal pH value was 6.5. 
Interestingly, there was a 5-fold stimulation in specific activity due to the 
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presence of Ci that decreased with increasing pH until the stimulation 
disappeared at pH 7.5 and higher. This finding may explain why Rv1625c204-w3 
was previously shown to be non-responsive to Ci a s the a s s a y s were done at 
pH 7.5 where there was no observable Ci stimulation of the enzyme (Cann ef 
a/., 2003). 
There are three possible explanations for the Ci stimulation of 
Rv1625c204^3 at pH 6.5 and pH 7.0. Firstly, the effect may be due to the 
cation, Na"" stimulating the enzyme at lower pH values. This hypothesis can be 
tested by running a cation dependence assay with RV1625C204-M3 and using a 
different cation, such as to observe its effect on Rv1625c204-443 at low pH. 
Secondly, the effect may be due to the anion, HCOa' being better able to 
ionically interact at lower pH by stabilising the substrate or the active site of the 
enzyme and thus increasing specific activity. Thirdly, the stimulation may be 
due to the other biologically active form of Ci , CO2 that forms 38.7 % (7.74 
mM) of the total Ci at pH 6.5 and 16.6 % (3.32 mM) of the total Ci at pH 7.0. 
This hypothesis may be tested by performing an assay where predominately 
HCO3" or CO2 was present. 
4.6 Cation dependence assay of Rv1625c204.443 at pH 6.5 
To test the hypothesis that the cation may be stimulating RV1625C204-M3. 
a salt dependence assay was conducted using sodium salts and potassium 
salts at pH 6.5. Figure 4.6 shows that the presence of NaCI or KCI did increase 
the specific activity of the enzyme, probably due to the stabilisation of the 
protein structure by interactions with the salt and thus increasing enzyme 
turnover. However, NaHCOa and KHCO3 both stimulated the enzyme 4-fold as 
compared to their associated CI' salts, thus proving that the stimulation was 
independent of the cation used and that Ci dose can cause the stimulation. 
The specific activities of Rv1625c204^3 in the presence of NaCI and NaHCOa 
were comparable with the values at pH 6.5 of the pH dependence assay 
(Figure 4.5). The first theory of cation dependence has been proved to cause a 
small fold stimulation compared to the stimulation observed with the addition of 
Ci , and it would be an interesting experiment to fully investigate this effect. 
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Figure 4.4: pH control figure for A C a s s a y s measured over 70 minutes. 200 pM 
A T P was added after 30 minutes (arrow). pH value was measured every 
minute. The assay mixture contained 50 mM buffer, 2 mM MnCb and either 20 
mM NaHCOa (square) or 20 mM NaCI (triangle). A) 50 mM M E S pH 6.5 B) 50 
mM Tris pH 7.0 C ) 50 mM Tris pH 7.5 D) 50 mM Tris pH 8.0 E ) 50 mM Tris pH 
8.5. 
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Figure 4.5: pH dependence assay of Rv1625c204^3 in the presence of Ci. 1.81 
pM Rv1625c204-443 was assayed at 37 °C at varying pH values in the presence 
of 200 pM A T P and 2 mM MnCb for 40 minutes with a pre-incubation time of 
30 minutes. The assay contained either 20 mM NaHC03 (square) or 20 mM 
NaCI (triangle). Error bars are standard error of the mean (D=8). 
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Figure 4.6: Cation dependence assay of Rv1625c204^3 at pH 6.5. 433 nM 
Rv1625c204-443 was assayed at 37 °C at pH 6.5 (50 mM M E S ) with 2 mM Mn^" 
in the presence of 200 pM A T P and 20 mM salt for 40 minutes with a pre-
incubation time of 30 minutes. Error bars are standard error of the mean (n=6) 
(*p<0.05). 
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108 
Investigation into in vitro and in vivo Ci stimulation of Rv1625c Phillip Holliday 
However the explanation of Ci stimulation was investigated, with two 
theories left to test, the theory that H C O 3 ' may stabilise the protein and cause 
the stimulation and the theory that C O 2 may be the Ci form causing the 
stimulation at pH 6.5 in Figure 4.5. 
4.7 Ci dis-equilibrium assays 
An assay with Ci in dis-equilibrium (Cooper and Filmer, 1969) would 
identify which form of Ci caused the stimulation of Rv1625c304^43 as the added 
Ci would be predominately in the form of H C O 3 " or C O 2 . Thus if HCOs' 
stimulated Rv1625c204^3 then the second theory of stabilisation of the protein 
at lower pH is correct and if C O 2 stimulated Rv1625c204-443 then the third 
theory is correct. The Ci dis-equilibrium was achieved by slowing the 
acquisition of the Ci equilibrium in the assay mixture so that R v l 625c204-443 
would be subjected to predominately H C O 3 ' or C O 2 , depending on which Ci 
form was added to the assay and there were two methods for accomplishing 
this. Firstly, lowering the temperature of the assay slowed the acquisition of the 
Ci equilibrium. This was done by running the assay at 0 °C compared with the 
normal assay temperature of 37 °C. Secondly, the assay time was reduced so 
that the Ci equilibrium would not be reached within the shortened assay time 
and Rv1625c204^3 would be subjected to Ci that was predominately in the 
form added. To identify the length of the shortened time period for the assay, 
dis-equilibrium pH control a s s a y s at 0 °C were initially conducted. These dis-
equilibrium pH control a s s a y s at 0 °C were conducted by adding either HC03', 
C O 2 or NaCI, to the assay mixture that contained only 5 mM buffer so that the 
acquisition of Ci equilibrium could be monitored with a pH probe every second 
for 80 seconds. Thus a time period whereby the Ci equilibrium had not been 
reached was chosen where the Ci was predominately in the form added. The 
Ci equilibrium was observed through a change in the pH of the weakly buffered 
solution as an increase in pH corresponded with the loss of H"" from the 
solution due to the formation of C O 2 and a decrease in pH corresponded with 
the release of H* from the solution due to the formation of H C O 3 * . Carbonic 
anhydrase (CA), a zinc-metalloenzyme that speeds up the acquisition of the Ci 
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equilibrium was added to assays to demonstrate the complete acquisition of 
the Ci equilibrium, as observed by a steady pH value. CA has a rate constant 
for converting CO2 to HCO3" of between 10'' and 10^ reactions per second 
(Chirica, 1997). Thus the limiting factor of the acquisition of the Ci equilibrium 
will be the diffusion rate of CO2 to the active site of CA. 
Figure 4.7A shows the Ci dis-equilibrium pH control assay with the 
addition of 20 mM NaHCOa after 20 seconds (arrow). In the presence of CA, 
the Ci equilibrium was observed to be reached 3 seconds after addition of 
NaHCOa, as demonstrated by a stable pH value. In the absence of CA, the Ci 
equilibrium was observed to be almost reached 60 seconds after addition of 
NaHCOs. The addition of NaHCOa increased the pH of the weakly buffered 
solution because CO2 was formed from the added HCO3" to maintain the Ci 
equilibrium, which removed an H"" ion from the buffer to forni H2O thus 
increasing pH. 
Figure 4.7B shows the Ci dis-equilibrium pH control assay with the 
addition of 20 mM CO2 after 20 seconds (arrow). In the presence of CA, the Ci 
equilibrium was observed to be reached 3 seconds after addition of CO2, seen 
again by a stable pH value. In the absence of CA, the Ci equilibrium was 
observed to be reached 60 seconds after addition of CO2. The addition of CO2 
decreased the pH of the weakly buffered solution because HCO3" was formed 
from the added CO2 to maintain the Ci equilibrium, which added an H"" ion to 
the buffer thus decreasing pH. 
Figure 4.7C shows the Ci dis-equilibrium pH control assay with the 
addition of 20 mM NaCI after 20 seconds (arrow). Both in the presence and 
absence of CA there was no change in pH. This control assay showed that the 
changes in pH were not due to a dilution effect from the addition of a solution 
to the assay mixture. 
From these Ci dis-equilibrium pH control assays a time period of 10 
seconds was chosen whereby the Ci equilibrium was not reached in the assay 
mixture. Thus the Ci in the assay mixture was predominately in the form in 
which it was added and the Ci form that stimulated Rv1625c204^3 should be 
identifiable. 
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Figure 4.7: Ci dis-equilibrium pH control assays. pH curves of (A) HCO3", (B) 
CO2 and (C) Cr in 5 mM MES pH 6.4 in the presence and absence of carbonic 
anhydrase (CA) at 0 °C. 20 mM NaHCOa/COa/NaCI was added after 20 
seconds (arrow) and pH was measured every second for a further 60 seconds. 
The assay either had 132 U CA (square) or no CA (triangle). (D) pH curve of 
Rv1625c204-443 in 100 mM MES pH 6.5 at 0 °C with the addition of either 20 
mM NaHCOa (square), CO2 (circle) or NaCI (triangle) after 5 seconds (arrow) 
and pH was measured every second for a further 10 second. 
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Figure 4.8: Ci dis-equilibrium assay of Rv1625c204-443- 36 |JM RV1625C204^3 
was assayed at 0 °C at pH 6.0 (100 mM MES) with 2 mM Mn *^ in the presence 
of 100 mM NaCI, 200 \^M ATP for 10 seconds and the addition of 20 mM 
CO2/HCO37CI". Error bars are standard error of the mean (n=20) (*p<0.05). 
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The final pH control assay to perform was to determine the buffer 
concentration required to maintain the assay pH at 6.5 with the addition of Ci. 
This was done so that the stimulation observed in the Ci dis-equilibrium 
assay was due to the added Ci and not a change in pH. Figure 4.7D shows 
that with 100 mM MES the pH of the assay is stable for 10 seconds after the 
addition of Ci and NaCI. The final conditions that will be used for the 10 second 
Ci dis-equilibrium assay are much changed from the usual AC assay for 
Rvl 625C204-443, which demonstrates the difficulty in identifying the Ci form that 
is causing the stimulation. With the many alterations in conditions for the 10 
second assay, the specific activity of Rv1625c204^3 obtained from the 10 
second assay may not be comparable to its specific activity in other assays. 
Figure 4.8 shows the results of the 10 second Ci dis-equilibrium assay 
of Rv1625c204-443- The figure shows that Rvl 625c204^43 was stimulated by the 
addition of CO2 and not HCO3" as compared with the NaCI control. The units of 
the assay were not standard specific activity (nmol cAMP/mg/min) due to two 
reasons: a large concentration of protein was required for the assay to work 
and a short time period was used to maintain Ci dis-equilibrium. Therefore 
converting the raw data into specific activity would not produce a useful value. 
Instead, the amount of product formed was used for the figure. The stimulation 
of Rv1625c204-443 was only 1.25-fold, much smaller than the 5-fold stimulation 
seen in the pH dependence assay (Figure 4.5) and in the salt dependence 
assay (Figure 4.6). This result may be due firstly, to the low assay 
temperature, low pH of the solution and high buffer concentration used in the 
assay that were outside of the enzyme's optimal conditions thus adversely 
affecting Rv1625c204-443. Secondly, the result may be due to the high protein 
concentration and high salt concentration used in the assay to make it work. 
As the assay conditions were far from optimal, more protein was required to 
measure the activity of Rvl 625c204-443 and more salt was required to stabilise 
the large amount of protein. These high concentrations have unknown effects 
on the protein. Thirdly, the result may be due to the short assay period. The 
activity of Rv1625c204^3 is unlikely to be in a linear relationship with time. In 
addition, CO2 stimulation may be time dependent, explaining the low fold 
stimulation. The most probable answer is that the reason for the low fold 
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stimulation with the 10 second Ci dis-equilibrium assay is a combination of all 
the reasons stated. 
This set of results undoubtedly proved that CO2 was the Ci form that 
stimulated Rv1625c204-443 and demonstrated that Rv1625c204^43 was the first 
Class Ilia AC to be identified as being stimulated by CO2. 
This finding compares similarly with Class lllb ACs that are stimulated 
by CO2 (Hammer et a/., 2006) and raises questions about whether other Class 
Ilia ACs are also stimulated by C02. Since Class Ilia and lllb ACs are 
stimulated by CO2, Class lllc and Mid ACs may also be stimulated by CO2. 
Characterisation of the CO2 stimulation of Rv1625c204^3 was conducted to 
ascertain any potential physiological relevance of the CO2 response. 
4.8 CO2 dose dependence assays on Rv1625c204-443 
The CO2 stimulation was characterised biochemically by identifying the 
E.C.50 value for CO2 stimulation of Rv1625c204^3 and the kinetic parameters 
for CO2 stimulation on Rv1625c204-443- Standard AC assay conditions were 
used, with an assay time of 40 minutes. 
Figure 4.9 shows the CO2 dose dependence assay of Rv1625c204^3 at 
pH 6.5 from 0 to 11.6 mM CO2. This assay was performed in order to ascertain 
whether the CO2 stimulation of Rv1625c204-443 was a physiologically relevant 
activation by measuring whether the CO2 stimulation of Rv1625c204-443 was 
within the values of physiological CO2 concentrations in prokaryotes. Problems 
with CO2 de-gassing from the Ci stock solution limited the highest CO2 
concentration used in the assay, which explains why the curve did not form a 
sigmoidal shape and thus the calculated E.C.50 value was only an apparent 
E.C.50 value based on the available data. There was also an inhibition of 
Rv1625c204^3 specific activity observed at higher Ci concentrations (data not 
shown) of unknown origin. 
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Figure 4.9: CO2 dose dependence assay of Rv1625c204^3 at pH 6.5. 433 nM 
Rv1625c204^3 was assayed at 37 °C for Ci sensitivity at pH 6.5 (50 mM MES) 
with 2 mM Mn^ "" in the presence of 200 pM ATP and a total salt concentration 
of 30 mM for 40 minutes with a pre-incubation time of 30 minutes. Error bars 
are standard error of the mean (n=12), (*p<0.05) compared to the 0 mM added 
CO2 value (first point on figure). 
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Figure 4.10: Kinetic parameters of Rv1625c204^3 at pH 6.5. 433 nM 
Rv1625c204^43 was assayed at 37 °C to ascertain Km and Vmax at pH 6.5 (100 
mM MES) with 2 mM Mn *^ and a total salt concentration of 20 mM for 40 
minutes with 30 minutes pre-incubation. The assay contained either 20 mM 
NaHC03 (7.74 mM CO2) (square) or 20 mM NaCI (triangle). Error bars are 
standard error of the mean (n=8). 
Table 4.1: Kinetic parameters of Rv1625c204-443 in the presence and absence 
of CO2. 
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The specific activities at 0 mM added CO2 and 20 mM added CO2 do 
not correspond with the values seen in the pH dependence assay (Figure 4.5) 
or the cation dependence assay (Figure 4.6) because the total salt 
concentration of the CO2 dose dependence assay was 30 mM compared to 20 
mM for the pH and cation dependence assays, however the CO2 stimulation 
was similar (4-fold for CO2 dose dependence assay compared with 5-fold for 
the pH and cation dependence assays). 
The CO2 E.C.50 (app) was 13.2 ± 0.6 mM, which was a value that was 
higher than physiological levels of CO2 and thus, the physiological relevance of 
the CO2 E.C.50 (app) value was difficult to identify from the limited data. The 
high E.C.50 (app) value may be an artefact of the incomplete CO2 dose 
dependence assay curve due to the problems of CO2 degassing discussed 
before. 
A different technique that measured the CO2 Kd value was conducted 
using an equilibrium dialysis assay (data not shown), however, the experiment 
failed due to CO2 degassing from the equipment at pH 6.5. 
4.9 Kinetic parameters of Rv1625c204-443 at plH 6.5 
Assays to identify the effect of CO2 on the affinity (via Km) of Rv1625c204-
443 for ATP were conducted to compare the mode of CO2 stimulation of Class 
Ilia ACs with Class lllb ACs. Figure 4.10 shows the kinetics assay in the 
presence and absence of CO2 with a substrate concentration ranging from 10-
1000 [iM. The maximum ATP concentration used was 1 mM as higher 
concentrations of substrate caused a decrease in the observed specific activity 
due to a smaller ATP:[a-^^P] ATP ratio, which led to less [2,8-^H] cAMP being 
formed in relation to cAMP and thus a false decrease in specific activity. 
Analysis using non-linear regression gave identical kinetic values (Km and 
Vmax) for Rv1625c204-443 as stated in Figure 4.10. The results show that CO2 
increased Km for ATP 3-fold. Thus CO2 decreased the affinity of Rvl 625c204^43 
for substrate compared to basal enzyme activity. However, CO2 also increased 
Vmax 2-fold, which increased the maximum amount of substrate that can be 
catalysed compared to basal enzyme activity. Thus the kinetic effect of CO2 
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stimulation is increasing the turnover number (/Ccat) of the enzyme 2-fold. The 
Hill Slope of Rv1625c204-443 both in the presence and absence of CO2 was 
approximately 1, suggesting that there is no increased or decreased 
cooperation between the two ATP binding sites of Rv1625c204^3 and the 
efficiency of the enzyme {i<catlKm) decreased in the presence of CO2 (Table 
4.1). Therefore CO2 stimulation of Rv1625c204^3 decreases the efficiency of 
the enzyme in catalysing ATP to cAMP, however, it increases the turnover of 
the enzyme, thus making the enzyme work harder, but less efficiently 
compared to basal enzyme activity. This finding that CO2 stimulates a Class 
Ilia AC through increasing /Ccat was similar to the CO2 stimulation seen in Class 
lllb ACs and thus supports the idea that both Class Ilia and Class lllb ACs 
have a similar CO2 response mechanism (Hammer ef a/., 2006). 
4.IOCO2 regulation of a mammalian Class Ilia AC 
As a prokaryotic Class Ilia AC has been shown to be stimulated by CO2 
in vitro, other Class Ilia ACs may also be regulated by CO2. A reconstituted 
mammalian Class Ilia AC comprising of a Cidomain from AC7 and a C2 
domain from AC2 was investigated. The Ci domain for AC7 and the C2 domain 
from AC2 were overexpressed in E. coli and purified by affinity 
chromatography to homogeneity to generate recombinant proteins. The 
proteins were analysed for purity by SDS-PAGE. 
The SDS-PAGE gel (Figure 4.11) of the expressed and purified 7Ci and 
2C2 recombinant proteins shows a single protein band at approximately 24 
kDa for 7Ci (Figure 4.11 (1)) and a single protein band at approximately 30 
kDa for 2C2 (Figure 4.11 (2)). The theoretical weight of 7Ci is 23931 Da and of 
2C2 is 30610 Da. The SDS-PAGE gel suggests that the protein bands are the 
correctly expressed proteins. 
The reconstituted 7C1.2C2 mammalian AC was assayed for CO2 activity 
with a pH dependence assay in the presence and absence of Ci from pH 6.5 to 
8.5. Figure 4.12 shows that the optimal pH value for basal activity of the 
reconstituted AC is pH 7.5. However, in the presence of Ci, there is a 2.5-fold 
Ci stimulation at pH 6.5 that decreases to a 1.8-fold Ci stimulation at pH 7.0. 
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Figure 4.11: SDS-PAGE gel of mammalian ACs. 2 pg of (1) 7Ci 263-476 and (2) 
2C2 821-1090 was applied to each lane with molecular weight standards on the 
left of each gel and the gel was stained with Coomassie Brilliant Blue G. 
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Figure 4.12: pH dependence assay of the reconstituted 7C1.2C2 mammalian 
AC in the presence of Ci. 2 pM 7Ci 263-476 and 350 nM 2C2 821-1090 were 
assayed at 30 °C at varying pH values in the presence of 1 mM ATP, 10 mM 
MgCl2 and 10 pM forskolin for 20 minutes. The assay also contained either 20 
mM NaHCOs (data not shown) or 20 mM NaCI (triangle). The squares 
represent Ci fold stimulation. Error bars are standard error of the mean (n=6). 
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At pH 7.5 and higher there is no Ci stimulation. This result is similar to 
the pH dependence assay of Rv1625c204^3 where Ci stimulation was seen at 
pH 6.5 and 7.0 and suggests that CO2 is the Ci species causing the 
stimulation. This is an interesting discovery, as mammalian tmACs were 
previously thought to be non-responsive to Ci owing to their insensitivity to 
HCO3". If tmACs are sensitive to CO2, they would be the first identified CO2 
sensors in mammals. However, further work into CO2 regulation of tmACs 
would be required to confirm this proposal. 
4.11 /n vivo CO2 stimulation of Rv1625c204-443 
If Rv1625c is a possible CO2 sensor in M. tuberculosis, it is important to 
also demonstrate in vivo CO2 stimulation of Rv1625c as well as in vitro CO2 
stimulation. It was difficult to observe the affect of CO2 on Rv1625c in M. 
tuberculosis because the M. tuberculosis genome has at least 15 A C genes 
(Cole et a/., 1998). Work done previously on M. tuberculosis pathogenesis in 
vivo by infecting mice with a Rv1625c knockout strain demonstrated that 
Rv1625c alone was not a virulence factor, probably due to redundancy with 
the other 14 A C s (Guo a/., 2005). Therefore, CO2 responsiveness of 
Rv1625c activity in vivo was observed using E . coll as the host cell. 
A plasmid containing the Rv1625c204^3 gene was transformed into E. 
CO// , since the E . coli genome has a C lass I A C gene cya that is downregulated 
by cAMP and so any A C response will not be due to the endogenous Cya A C 
(Inada et a/., 1996). To measure any in vivo CO2 stimulation of Rv1625c204-443, 
a plasmid containing the lacZ gene behind a C R P promoter was also 
transformed into E . coli. (Figure 4.13) cAMP binds to the C R P and up-
regulates the transcription of p-galactosidase. Adding O N P G , a substrate that 
p-galactosidase converts to galactose and ONP, which is a yellow coloured 
product that can be quantified. Thus, in this assay an increase in cAMP due to 
CO2 stimulation of Rv1625c204^3 in E . coli cells will produce an increase in 
ONP. An ONP standard curve was generated (Figure 4.14A), which was used 
to ascertain the concentration of ONP produced in the in vivo p-galactosidase 
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assay . The p-galactosidase a s s a y s for Rv1625c204^3 and LacZ in E . coli and 
the control experiment of LacZ in E. coli were incubated at pH 7.1 in either 10 
% (v/v) CO2 in air or air for 30 minutes. The negative control was LacZ in E.coli 
that did not contain the recombinant A C gene. The amount of ONP produced 
was recorded and is shown in Figure 4.14B. The figure shows that in £ . coli 
cells, Rv1625c204-i43 was stimulated by CO2 as compared to Rv1625c204^3 in 
E . coli cells incubated in air. The CO2 stimulation of Rv1625c204^3 in E . coli 
cells is also greater than the negative control experiments of LacZ vector in E . 
coli cells incubated both in CO2 and air, thus demonstrating that the C R P in E . 
coli was not activated by CO2. The CO2 stimulation of R v l 625c204-443 was 
much lower in vivo compared to in vitro, which may be due to three reasons. 
Firstly, there may be a lag phase in vivo between CO2 sensing and 
transcription of lacZ that may account for the lower fold stimulation. Secondly, 
the growth media was buffered to pH 7.1, more alkaline than the in vitro 
a s s a y s at pH 6.5 and therefore there is less Ci in the form of CO2. Finally, the 
amount of CO2 that was sensed by Rv1625c204-443 in vivo was unknown and 
may be a lower amount than in the in vitro assays , possibly due to the transfer 
of CO2 into the medium being a limiting factor. 
The in vivo p-galactosidase assay shows that Rv1625c204^3 is 
stimulated by CO2 both in vitro and in vivo and R v l 625c is the first 
characterised bacterial A C to be stimulated by CO2 in vivo. Thus, R v l 625c 
may be a CO2 sensor for M. tuberculosis, however, further work done in vivo in 
M. tuberculosis would need to be carried out to prove this theory. 
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Figure 4.13: Diagram of in vivo CO2 stimulation of Rv1625c204-443- CO2 (green) 
enters E . coli, binds and stimulates Rv1625c204-443 on the pQE30 vector. cAMP 
(blue) is produced and binds to the C R P promoter on the p C T X L a c Z vector, 
which up-regulates the transcription of lacZ. p-galactosidase converts the 
added O N P G into galactose and ONP, a yellow compound that is quantified. 
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Figure 4.14: (A) Standard curve of ONP to determine the ONP concentration 
for the (3-galactosidase assay . (B) In vivo CO2 stimulation of Rv1625c204-443-
Amount of ONP produced with either Rv1625c204^3 with p C T X L a c Z in E. coli 
or p C T X L a c Z in E. coli incubated in either 10 % CO2 or air. Error bars are 
standard error of the mean (n=9) (*p<0.05). 
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4.12Conclusion 
Rv1625c204-i43 was stimulated by CO2 at pH 6.5 and is the first 
characterised C l a s s Ilia A C shown to be stimulated by CO2. Rv1625c204^3 
had an apparent E.C.50 for CO2 of 13.2 ± 0.6 mM, which was greater than the 
value of physiological CO2 in M. tuberculosis, but was an erroneous value due 
to an incomplete CO2 dose dependence assay . CO2 stimulated R v l 625c204-443 
by increasing Vmax and consequently /feat, but also decreased compared to 
basal enzyme activity. The CO2 stimulation was also observed in vivo by 
incubating Rv1625c204-443 transformed into £. coli cells in 10 % CO2 in air as 
compared to Rv1625c204-443 transformed into E . co/ /cel ls incubated in air. 
Identification of the conditions required for CO2 to bind to Rv1625c204^3 
was investigated next as this may elucidate the mechanism of CO2 stimulation 
of A C s , for example whether the metal co-factor or substrate are required for 
CO2 binding. Once the CO2 binding conditions have been identified, the actual 
CO2 binding site on Rv1625c204^3 will hopefully be identified. 
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5 Elucidation of AC CO2 binding conditions 
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5.1 Introduction 
Having demonstrated that CO2 stimulates a model Class Ilia AC in 
addition to Class lllb ACs, an investigation of the conditions for CO2 binding is 
required. CO2 may bind to apoprotein alone, or may have a requirement for 
metal co-factor, substrate or metal co-factor and substrate. Finding the CO2 
binding conditions would help to identify the CO2 binding site on the Class Ilia 
ACs and shed significant light on the mechanism of activation. 
Here, a number of spectroscopic techniques, such as CD spectroscopy, 
FTIR spectroscopy and HCO3' dependent luminescence probe spectroscopy, 
as well as a number of biochemical techniques, such as Ci stimulation of 
catalytic Rv1625c204^3 single mutant proteins, Mn "^ dose dependence assay 
on Rv1625c204^3 and ^*C02 binding assays on ACs, have been used to try 
and identify the conditions required for CO2 binding. Unlike AC assays, these 
techniques do not measure enzyme specific activity but other changes that 
occur on CO2 binding to protein such as a conformational change or changes 
in infrared properties. These changes can be measured in the absence of 
metal co-factor or substrate or both, to identify the requirements for binding. 
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5.2 Ci stimulation of catalytic Rv1625c204-443 single mutant 
proteins 
In the literature there are two opposing hypotheses to explain Ci 
stimulation of C l a s s 11 lb A C s . The first hypothesis is that Ci binds to the 
substrate defining Lys in the active site (Cann et a/., 2003) and the second 
hypothesis is that Ci binds to the metal ion in the active site which causes the 
recruitment of a second metal ion (Steegborn et a/., 2005). These two 
hypotheses were tested with Rv1625c204^3 to ascertain which hypothesis was 
correct for C lass Ilia A C s . 
According to the first hypothesis CO2 binds to the substrate defining 
Lys, thus mutating the Lys residue to Ala should ablate the CO2 stimulation. A s 
there are 4 other conserved catalytic amino acids between the studied C l a s s 
Ilia and C lass lllb A C s (see alignment in Figure 4.1, mammalian C l a s s Ilia A C 
active site in Figure 2.5 and R v l 625c204-443 active site in Figure 5.1), these 
residues may also represent potential CO2 binding sites and so were mutated 
to create single mutant proteins that were also assayed for CO2 dose 
dependency. 
The catalytic domains of the single Ala mutant proteins of Rv1625c204-
443 were overexpressed in E . coli and purified by affinity chromatography to 
homogeneity to generate recombinant mutant proteins. The mutant proteins 
were analysed for purity by S D S - P A G E (Figure 5.2). The S D S - P A G E gel of 
the mutant proteins shows a single protein band at approximately 30 kDa, 
which is consistent with the theoretical weight of Rv1625c204^3 of 26790 Da. 
Figure 5.3 shows the CO2 dose dependence curves for the Rv1625c204-
443 mutant proteins. As with the R v l 625c204-443 wt protein in Section 4.5, 
problems with CO2 de-gassing from the Ci stock limited the highest CO2 
concentration used in the assay , thus the CO2 dose dependence curves did 
not form a sigmoidal shape that is expected due to a simple binding of CO2 to 
the protein. The calculated E.C.50 values were only apparent E.C.50 values 
based on the available data. The concentration of mutant protein assayed 
differed in each assay so as to obtain a measurable amount of [2,8-^H] cAMP 
whilst also keeping the conversion rate below 10 %. However, E.C.50 value is 
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dependent on enzyme concentration, so to be able to compare the E.C.5o(app) 
values obtained for the different mutant proteins, the E.C.5o(app) value must be 
multiplied by enzyme concentration to produce an arbitrary value. This 
corrected value is stated with the E.C.5o(app) value. Figure 5.3A shows the 
CO2 dose dependence curve for the Rv1625c204^43 D256A mutant protein, 
which is a mutation of the Asp that binds metal ion B in the active site. The 
mutant protein was active, with a low specific activity but was also stimulated 
by C 0 2 a n d has an E.C.5o(app) value of 4.2 + 1.1 mM and a comparable value 
of 60.5 ± 15.8 mM pM protein. Figure 5.3B shows the CO2 dose dependence 
curve for the R v l 625c204-443 K296A mutant protein, which is a mutation of the 
Lys that specifies the substrate ATP . The mutant protein was active with an 
E.C.5o(app) value of 28.4 ± 7.3 mM and a comparable value of 204.5 ± 52.6 
mM pM protein. Figure 5.3C shows the CO2 dose dependence curve for the 
Rv1625c204^3 D300A mutant protein, which is a mutation of the Asp that binds 
metal ion A in the active site. The mutant protein was active, with a low specific 
activity and was stimulated by CO2 with an E.C.5o(app) value of 6.4 ± 1.1 mM 
and a comparable value of 46.1 ± 7.9 mM pM protein. Figure 5.3D shows the 
CO2 dose dependence curve for the Rv1625c204^43 D365A mutant protein, 
which is a mutation of the Asp that is required for substrate specificity of the 
A C for ATP . The mutant protein was still active and was stimulated by CO2 
with an E.C.5o(app) value of 5.3 ± 1.1 mM and a comparable value of 76.3 ± 
15.8 mM pM protein. Figure 5.3E shows the Ci dose dependence curve for the 
Rv1625c204^3 R376A mutant protein, which is a mutation of the Arg required 
for transition state stabilisation. The mutant protein was still active and was 
stimulated by CO2 with an E.C.5o(app) value of 13.2 ± 1.4 mM and a 
comparable value of 7.3 ± 0.8 mM pM protein. 
These CO2 dose dependence a s s a y s show that all the mutant proteins 
assayed were stimulated by CO2, suggesting that CO2 did not bind exclusively 
to any of these residues. The corrected E.C.5-(app) values imply that 
Rv1625c204-443 R376A binds CO2 the strongest and Rv1625c2^^3 K296A 
binds CO2 the weakest. However, as these comparable values were calculated 
from apparent E.C.50 values, the results are not conclusive and should not be 
analysed too carefully. 
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Figure 5.1: Active site structure of Rv1625c204^3. Catalytic amino acids are 
shown with their labelling (blue) with ATP (black) and metal ions (pink) in the 
active site. Hydrogen bonds are shown (red). 
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Figure 5.2: S D S - P A G E gel of Rv1625c204^3 mutant proteins. 2 pg protein was 
applied with molecular weight standards on the left of the gel and stained with 
Coomassie Brilliant Blue G . 1) D256A 2) K296A 3) D300A 4) D365A 5) R376A. 
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Figure 5.3: CO2 dose dependence assay of Rv1625c204^3 mutant proteins at 
pH 6.5. Rv1625c204^3 mutant proteins were assayed at 37 °C at pH 6.5 (50 
mM MES) with 2 mM Mn "^ in the presence of 200 pM ATP and a total salt 
concentration of 30 mM for 40 minutes with a pre-incubation time of 30 
minutes. E.C.5o(app) values are included in figures. Error bars are standard 
error of the mean (n=6), (*p<0.05) compared to 0 mM added CO2. A) 14.4 pM 
D256A, B) 7.2 pM K296A, C) 7.2 pM D300A, D) 14.4 pM D365A, E) 556 nM 
R376A. 
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Thus the first hypothesis that the substrate defining Lys exclusively binds 
CO2 is not correct for Rv1625c204-443- The second hypothesis of CO2 binding to 
nnetal ions in the active site was therefore tested. 
5.3 Mn^* dose dependence assay of Rv1625c204.443 
To observe the effect of CO2 on Mn^ "" affinity on Rv1625c204-443 and 
ascertain the effect CO2 has on metal recruitment into the active site a Mn^ "^  
dose dependence assay in the presence and absence of CO2 was performed. 
Figure 5.4 shows the affect of CO2 on the Mn^* dose dependence of 
Rv1625c204-443- In the presence of 20 mM NaHCOa pH 6.5 the CO2 stimulation 
increased up to 0.5 mM Mn^*, where specific activity levelled then started to 
decrease at 2 mM Mn^ "". There was an increase in the Hill slope of the Mn^* 
dose response to 6.6. In the absence of CO2, specific activity initially increased 
with increasing concentration of Mn^ "" but then decreased at 5 mM Mn^* with a 
Hill slope of 3.0. The doubling of the Hill slope in the presence of CO2 
suggests an increase in the co-operativity of the two binding sites. This result 
agrees with the hypothesis of Steegborn et al. that Ci recruits a second metal 
ion into the active site of the AC but it does not prove that CO2 is binding to 
that metal. 
5.4 CD spectroscopy 
To confirm whether a metal ion is required for CO2 binding to protein 
three spectroscopic techniques were used to observe CO2 binding to protein 
with the addition of a divalent metal ion, substrate, or metal ion and substrate. 
The first spectroscopic technique used to identify CO2 binding was CD 
spectroscopy. The CD spectra in the near UV (250-350 nm) describes the 
secondary structure of a protein through the differential absorbance of left and 
right handed circularly polarised light (Mathews, 2000). 
Rv1625C204-443 was analysed in the presence and absence of Ci under 
conditions that differed from conditions required for catalysis. A conformational 
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change in the secondary structure of the protein was hypothesised to occur 
when CO2 bound to the protein, which should be seen by CD spectroscopy, 
thus identifying the conditions that are required for CO2 binding to Rv1625c204-
443- Figure 5.5A shows the CD spectra of Rv1625c204-443 in the presence or 
absence of CO2, and with the addition of MgCb or ATP, or MgCb and ATP. 
Figure 5.5A demonstrates a conformational change due to the binding of ATP 
into the active site both in the absence and presence of metal ions. However 
with the addition of CO2, there was no observable conformational change that 
would suggest the binding of CO2 to the protein. A conformational change due 
to CO2 binding may be too small to be detected by CD spectroscopy. 
Alternatively CO2 binding does not cause a conformational change in the 
protein. Figure 5.5B shows the activity of Rv1625c204^43 using the conditions 
required for obtaining the CD spectra and showed that the enzyme was active 
in the presence of metal ions and was not active in the absence of metal ions. 
This result demonstrates that ATP can bind to the active site of the protein 
without metal present and thus without catalysis occurring but was 
uninformative with respect to requirements for CO2 binding. 
5.5 Expression and purification of Sir1991120^37 and CyaBlsgs. 
859 for FTIR spectroscopy 
As CD spectroscopy did not help identify the requirements for CO2 
binding, other spectroscopic techniques, such as FTIR spectroscopy was used 
to try and identify the requirements for CO2 binding. As CO2 is IR active, FTIR 
spectroscopy was used to measure a decrease in the CO2 signal due to CO2 
binding to the protein or the appearance of a new carbonyl peak formed by the 
bound CO2 on the protein, for example from the binding of CO2 to Lys to form 
a carbamate. Another spectroscopic technique used was the addition of a 
HCO3' dependent luminescent probe that would measure the amount of HCO3" 
in solution. Thus a quenching of the probe signal should be observed due to 
CO2 binding the protein and decreasing the amount of HCO3" in solution. 
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Figure 5.4: Mn^* dose dependence assay of Rv1625c204-443 at pH 6.5. 925 nM 
Rv1625c204^3 was assayed at 37 °C at pH 6.5 (50 mM MES) in the presence 
of 200 pM ATP and salt concentration of 20 mM for 40 minutes with a pre-
incubation time of 30 minutes. The assay contained either 20 mM NaHCOs pH 
6.5 (7.74 mM CO2) (square) or 20 mM NaCI pH 6.5 (triangle). Error bars are 
standard error of the mean (n=6) (*p<0.05). 
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Figure 5.5: A) Circular dichroism spectra of 20 pM Rv1625c204-443 at pH 6.5 in 
the presence of the following conditions: nothing (solid black line), CO2 (dotted 
black line), 10 mM MgCb (solid red line), 10 MgCb and 7.74 mM CO2 (dotted 
red line), 5 mM ATP (solid blue line), 5 mM ATP and 7.74 mM CO2 (dotted 
blue line), 5 mM ATP and 10 mM MgCb (solid green line) and 5 mM ATP, 10 
mM MgCb and 7.74 mM CO2 (dotted green line). B) AC assay of Rv1625c204-
443 in the absence and presence of 10 mM MgCb. Error bars are standard 
error of the mean (n=4) (*p<0.05). 
148 
Elucidation of AC CO2 binding conditions Phillip Holliday 
-2000 
o -o 
I- £ 
iD o 
S> E -4000 
.1 J ' 
8 -6000 H 
c 0) 
CD O -8000 
•S-10000 
350 
A.[nm] 
no metal 10 mM MgClj 
149 
Elucidation of AC CO2 binding conditions Phillip Holliday 
Figure 5.6: A) SDS-PAGE gel of 1) Slr1991 120-337 and 2) CyaB1595.859- 2 pg 
protein was applied with molecular weight standards on the left of each gel and 
stained with Coomassie Brilliant Blue G. B) MS data of 1) Slr1991120-337 and 2) 
Cya B1595-859• 
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These two techniques required large amounts of protein, such as 0.5 
mg protein per spectrum for FTIR spectroscopy and 6.4 mg protein per assay 
for the H C O 3 " dependent luminescent probe. As the yield of Rv1625c204^3 is 
typically 8 mg per 8 L culture, this protein was not suited to these experiments. 
Other ACs that were C O 2 stimulated and overexpressed in larger quantities 
were used to verify the techniques before investing time in Rv1625c204^3 
expression. 
Two Class 11 lb ACs that have been previously demonstrated to be 
stimulated by C O 2 , Slr1991120-337 from Synechocystis and CyaBI595^59 from 
Anabaena (Hammer ef a/., 2006) produced better yields from overexpression 
(approximately 50 mg per 8 L culture) and were therefore used for these 
spectroscopic techniques. 
The catalytic domains of the Class lllb ACs SIrl9911230-337 from 
Synechocystis and CyaB 1595^59 from Anabaena were overexpressed in E. coli 
and purified by affinity chromatography to homogeneity. The proteins were 
analysed for purity by MS and SDS-PAGE. 
The SDS-PAGE gels of the expressed and purified Sir 1991120-337 and 
CyaBI595-859 recombinant proteins (Figure 5.6A) show single protein bands at 
approximately 25 kDa and 30 kDa respectively. The theoretical weight of 
SIrl 991120-337 is 25595 Da and CyaBI595-859 is 30195 Da. 
The MS data (Figure 5.6B) show that the actual molecular weight of the 
purified proteins match the theoretical molecular weights of 25595 Da for 
SIrl 991120-337 and 30195 Da for CyaBI595.859 and proved that the purified 
proteins are SIrl991120-337 and CyaBl595-859 The data also show that there 
were no contaminating protein bands. 
5.6 FTIR spectroscopy 
C O 2 is IR active, therefore FTIR spectroscopy was used to identify the 
conditions for C O 2 binding to AC. C O 2 is a linear molecule that has three 
characteristic stretching modes. C O 2 can stretch symmetrically, with both 
oxygen atoms stretching in opposite directions, however this mode is not IR 
active. Another C O 2 stretching mode is asymmetrical stretching, with the 
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oxygen atoms stretching in the same directions. This mode can be observed at 
about 2345 cm'\ The final mode of stretching of CO2 is a vertical bend of the 
molecule, which is predicted at approximately 546 cm"^  (Schultz et a/., 1996). 
This mode lies in the 400-1500 cm"^  region of the spectrum which is called the 
fingerprint region owing to the unique signals formed by intra-molecular bonds 
of the molecule, which overlap each other, thus making identification of the 
vertical bend of CO2 difficult (Schultz et a/., 1996). FTIR spectroscopy can also 
be used to determine the secondary structure of proteins by looking at 
vibrations of the peptide backbone (Krimm and Bandekar, 1986). These 
vibrations form bands termed Amide I band and Amide II band. The Amide I 
band is the C=0 stretching mode of the peptide and is usually in the region 
1600-1700 cm"^  (Krimm and Bandekar, 1986). The Amide II band is the N-H 
bend and C-N stretch in the peptide backbone and is usually seen at 1550 cm' 
^ (Krimm and Bandekar, 1986). However, both these regions are masked by 
the H2O bending vibrations at 1650 cm"\ thus to observe the Amide bands 
samples need to be dissolved in D2O. The spectra of proteins in D2O were 
measured (data not shown), however the O-D stretching vibrations mask the 
asymmetric CO2 signal at 2345 cm'^ and as observed previously in the CD 
spectroscopy, there was no change in the structure of the protein on addition 
of CO2 under any conditions (data not shown). Therefore, the protein spectra 
were measured in H2O and the asymmetric CO2 signal at 2345 cm'^ alone was 
observed. When CO2 is added to a sample containing AC in the required 
conditions for CO2 binding, it is hypothesised that a CO2 signal should be 
visible at around 2345 cm'^ with another signal at a lower wavenumber visible 
due to CO2 bound to the protein. Therefore, the region around the asymmetric 
CO2 stretch was the main area of observation. 
Control FTIR spectra were obtained with no protein present and with the 
H2O spectrum subtracted to give the spectrum of the added factors only. As 
the CO2 signal is the target of the experiment, all spectra are focused into the 
region 2400 - 2320 cm"^  where CO2 peaks were observed. 
Figure 5.7A shows the spectrum of buffer only. As expected in the 
region 2400-2320 cm'^ there were no signals. Figure 5.7B shows the 
spectrum for buffer and MgCb and demonstrated that there were no additional 
signals in the region of interest. 
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Figure 5.7: FTIR spectra with the subtraction of the H2O spectrum of the 
control conditions with the following additions, A) 50 mM MES, B) 50 mM MES 
and 20 mM MgCb, C) 50 mM MES and 5 mM ATP, D) 50 mM MES and 3 mM 
CO2, E) 50 mM MES, 20 mM MgCb and 5 mM ATP, F) 50 mM MES, 20 mM 
MgCl2 and 3 mM CO2, G) 50 mM MES, 5 mM ATP and 3 mM CO2, H) 50 mM 
MES, 20 mM MgCb, 5 mM ATP and 3 mM CO2. 
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Figure 5.8: FTIR spectra with the subtraction of the protein and H2O spectrum 
of BSA with the following additions, A) 3 mM BSA and 20 mM MgCb, B) 3 mM 
BSA and 5 mM ATP, C) 3 mM BSA and 3 mM CO2, D) 3 mM BSA, 20 mM 
MgCl2 and 5 mM ATP, E) 3 mM BSA, 20 mM MgCb and 3 mM CO2, F) 3 mM 
BSA, 5 mM ATP and 3 mM CO2, G) 3 mM BSA, 20 mM MgCl2, 5 mM ATP and 
3 mM CO2. 
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Figure 5.9: FTIR spectra with the subtraction of the protein and H2O spectrum 
of CyaB1595-859 with the fol lowing addit ions, A) 3 mM CyaB1595-859 and 20 mM 
MgCl2, B) 3 m M CyaB1595-859 and 3 m M CO2, C) 3 m M CyaB1595-859. 20 mM 
MgCl2 and 3 m M CO2, D) 3 m M CyaB1595-859, 20 m M MgCb, 5 mM A T P and 3 
mM CO2. 
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Figure 5 .7C shows the spectrum for buffer and ATP and again 
demonstrated that there were no signals in the region of interest. There was a 
faint signal at about 2345 cm"^ which represented atmospheric CO2. Figure 
5.7D shows the spectrum of buffer and CO2. There was a signal at 2345 cm'^ 
corresponding to the asymmetr ic stretch of CO2. The spectrum was not flat 
owing to discrepancies in the subtraction of H2O and buffer f rom the spectrum. 
Figure 5 . 7E shows the spectrum of buffer, MgCb and ATP and as 
expected, there were no signals in the region of interest. Figure 5 .7F shows 
the spectrum of MgCl2 and CO2. Again, the asymmetr ic CO2 stretch was seen 
and there was also a small signal adjacent to that signal at 2355 c m " \ which 
was initially thought to be ^^C02, however, ^^C02 accounts for 1.1 % of 
atmospheric CO2 and thus would not be visible on the spectra. Therefore the 
signal at 2355 cm"^ must be an artefact of the subtraction of H2O f rom the 
spectrum. Figure 5 .7G shows the spectrum of buffer, ATP and CO2 and the 
asymmetr ic CO2 stretch was again seen at 2345 c m " \ The artefact at 2355 cm" 
^ due to H2O subtraction was also observed. Figure 5.7H shows the spectrum 
of MgCl2, ATP and CO2. The asymmetr ic CO2 stretch and the H2O subtraction 
artefact at 2355 cm'^ were observed, but there were no other discernible 
signals seen. 
These control spectra demonstrated that in the region 2400 - 2320 cm'^ 
the only signals visible were CO2 signals. The concentrat ion of CO2 added was 
the same as the protein concentrat ion, therefore, if CO2 bound to the A C a 
depletion of the CO2 signal would be visible. 
Before running FTIR spectra on A C protein, further controls using BSA 
were done to ascertain whether there were any signals in the 2400 - 2320 cm'^ 
region due to non-specif ic protein interactions with CO2. 
Figure 5.8 shows the region 2400 - 2320 cm"^ of the FTIR spectra of 
BSA with the protein and H2O spectrum subtracted to give the spectrum of the 
factors added. Figure 5.8A shows the spectrum of BSA and MgCl2. As with the 
control spectrum of buffer and MgCb, there were no signals in the region 2400 
2320 c m " \ al though atmospheric CO2 was visible at 2345 crn V Figure 5.SB 
shows the spectrum of BSA and ATP and again, no signals were visible in this 
region. Figure 5 .8C shows the spectrum of BSA and CO2 and there was an 
asymmetr ic CO2 stretch seen at 2345 c m ' \ Figure 5.8D shows the spectrum of 
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BSA, MgCb and ATP and there were no signals visible in this region. Figure 
5.8E shows the spectrum of BSA, MgCb and CO2 and there was an 
asymmetr ic CO2 stretch seen at 2345 cm"^ and also the H2O subtraction signal 
at 2355 cm'^ was observed. Figure 5.8F shows the spectrum of BSA and ATP 
and CO2 with the asymmetr ic CO2 stretch at 2345 cm"^ and the H2O 
subtraction signal at 2355 cm'\ Figure 5.8G shows the spectrum of BSA, 
MgCb, ATP and CO2 and the asymmetr ic CO2 stretch at 2345 cm"^ and the 
H2O subtraction signal at 2355 cm'^ were observed. 
These spectra demonstrate that there were no new CO2 signals formed 
in the region 2400 -2320 cm"^ due to non-specif ic protein interactions to CO2 
and no depletion of the CO2 signal was observed, thus any new signals or 
depleted CO2 signals seen in the spectra with A C would be due to specific CO2 
binding to the AC. Figure 5.9 shows the region 2400 -2320 cm'^ of the FTIR 
spectra of CyaB1595.859 with the protein and H2O spectrum subtracted to give 
the spectrum of the factors added. Figure 5.9A shows the spectrum with the 
addit ion of MgCb to the protein and as expected, there were no new signals in 
the spectrum. Figure 5.9B shows the addit ion of CO2 to the protein and the 
asymmetr ic stretch signal was visible at 2345 cm'\ There was a small signal 
adjacent to the CO2 peak at 2355 cm'^ which was the H2O subtraction signal. 
There were no other signals observed in the region. Figure 5.9C shows the 
addit ion of MgCh and CO2 and again, the asymmetr ic CO2 signal and the 
adjacent H2O subtraction signal at 2355 cm"^ were observed but no other 
signals were seen. 
Figure 5.9D shows the addit ion of MgCb ATP and CO2 and again, the 
asymmetr ic CO2 signal at 2345 cm"^ and the adjacent H2O subtraction signal 
at 2355 cm'^ were observed. There was also another signal at 2380 c m ' \ not 
seen in the other spectra that could have been CO2 bound to CyaB1595.859-
However, repeated FTIR analysis of these condit ions with CyaB1595.359 did not 
reproduce this signal, suggest ing that the signal was formed during the 
subtraction of protein and H2O f rom the spectrum. 
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Figure 5.10: A) Diagram of HCO3" binding to EuL'', excitation at 408 nm and 
emission measured at 616/592 nm. HCO3" and CO2 are in equil ibrium in 
solut ion. CO2 binding to SIrl991120-337 decreases binding of HCO3' to EuL'', 
decreasing luminescence. B) Structure of HCO3" dependent luminescence 
probe, EuL'*. 
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Figure 5 . 1 1 : HCO3" dependent luminescence probe spectroscopy. A) Ci dose 
dependence curve of the EuL'' complex as a function of the emission intensity 
ratio ( 6 1 6 / 5 9 2 nm). B-E) Intensity of E U L " complex spectra in the presence of 
SI r l 991120-337 with (red line) or without (black line) 5 m M NaHC03 pH 6 . 5 ( 1 . 9 4 
mM CO2) and the addit ion of (B) no addit ional factors, (C) 1 0 0 m M MgCb, (D) 
1 0 m M ATP and (E) 1 0 0 m M MgCb and 1 0 m M ATP. The emission spectra 
were obtained by excit ing EuL'' at 4 0 8 nm. 
1 6 4 
Elucidation of AC CO2 binding condit ions Phillip Holliday 
KH = 2.0 ± 0 .3 mM 
Total Ci [mM] 
1.4x10' 
1.2x10' 
1.0x10' 
8.0x10« 
6.0x10'-
B 
575 600 625 650 675 
Wavelength [X.] 
700 
1.4x10' 
1.2x10'-
1.0x10'-
8.0x10«-
6.0x10' 
4.0x10« 
2.0x10« 
0 
575 600 625 650 675 700 
Wavelength [X] 
1.4x10' 
1.2x10' 
1.0x10' 
8.0x10« 
6.0x10» 
4.0x10* 
2.0x10' 
0 iAJ 
575 600 625 650 675 700 
Wavelength [X] 
1.4x10' 
1.2x10' 
1.0x10 
8.0x10" 
6.0x10' 
4.0x10" 
2.0x10" 
575 600 625 650 675 700 
Wavelength [k] 
165 
Elucidation of A C CO2 binding condit ions Phillip Holliday 
Table 5 . 1 : HCO3' dependent luminescence probe as a function of the emission 
intensity ratios of A) 616/592 nm or B) 616/700 nm in the presence and 
absence of 5 mM NaHCOs pH 6.5 (1.94 m M CO2) with the fol lowing 
condit ions, i) basal, ii) 10 m M MgCb iii) 5 m M ATP and iv) 5 m M ATP and 10 
mM MgCb in the presence of the fol lowing proteins, 1) no protein and 2) 500 
MM SI r l991 120-337-
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A 
616/592 nm 1) No protein 2) S I r l S S I 
i) basa l 2.66 Ratio HCOs ibasal 3.69 Ratio HC03":basal 
+ HCO3" 3.09 1.15 3.94 1.07 
ii) MgCl2 2.43 Ratio HC03":MgCl2 3.89 Ratio HCOs' iMgCb 
+ HCOa" 3.41 1.40 4.15 1.07 
iii) A T P 3.00 2.95 
+ HCOa" 2.97 2.96 
Iv) ATP+MgCl2 3.15 3.24 
+ HCOa' 3.14 3.27 
B 
616/700 nm 1) No protein 2) Slr1991 
i) basal 4.93 Ratio HCOa ibasal 6.48 Ratio HCOa ibasal 
+ HCOa" 6.61 1.34 8.39 1.29 
ii) MgClz 5.28 Ratio HC03':MgCl2 7.67 Ratio HC03":MgCl2 
+ HCOa" 10.02 1.90 10.10 1.32 
IN) A T P 4.67 4.77 
+ HCOs" 4.76 4.65 
Iv) ATP+MgCl2 5.05 5.26 
+ HCOa' 5.11 5.41 
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FTIR spectroscopy was unable to aid in the identification of the CO2 
binding condit ions or the CO2 binding site on the AC due to issues with the 
substraction of the H2O and buffer spectrum which produced artefacts in the 
spectrum that made it difficult to identify potential new CO2 peaks or a 
deplet ion of the original CO2 peak. 
5.7 HCO3' dependent luminescence probe spectroscopy 
As CO2 binding may not cause a measurable conformational change by 
CD spectroscopy or a change in IR properties as measured by FTIR, a HCOa' 
dependent luminescent probe was used (Bretonniere et a/., 2004) to measure 
the amount of HCO3" in solut ion. Quenching of the probe signal due to CO2 
binding to the protein should occur as CO2 binds to the protein, reducing the 
HC03 ' in solution and therefore luminescence, thus al lowing for identification 
of the condit ions required for CO2 binding to protein (Figure 5.10A). 
The probe used for the HCO3" dependent luminescence spectroscopy 
functions by observing europium emissions on exciting the europium complex 
of the probe at specific wavelengths (Figure 5.10B). The complex, EuL"* has an 
acridone chromophore at tached, which improves the absorption of light and 
the movement of energy to the europium ion, thus intensifying the signal (Pal 
and Parker, 2007). As the excited europium ion relaxes back to the ground 
state energy level, energy is released as emitted light that gives the complex 
its characteristic emission spectra. 
The ratio of the AJ=1 transition (around 592 nm) or the AJ=4 transition 
(around 700 nm) with the AJ=2 (around 616 nm) transit ion gives a quantif iable 
measure of the concentrat ion of HCO3" in solution (Bretonniere etal., 2004). 
Figure 5.11 A shows the HCO3" dose dependence curve of the complex 
EuL'* and gave a Kd value of 2.0 ± 0.2 m M . This means that the probe will be 
able to measure small changes in HCO3" concentrat ion through a drop in 
luminescence, which will occur due to CO2 binding to protein. The small 
change in HCO3" concentrat ion can only be observed if an appropriate 
concentrat ion of protein is added. If the protein concentrat ion is too low, the 
change in HCO3" concentrat ion due to CO2 binding will be too small to 
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observe. The concentrat ion of protein used in these experiments was the 
max imum concentrat ion obtainable. Figure 5.1 I B shows the EUL" emission 
spectrum in the presence of 500 pM SIrl991120-337 with or without C i . The 
616/592 nm ratio increased in the presence of Ci from 3.69 to 3.94, confirming 
that HCO3" was present (Table 5.1 A) . Figure 5.11C shows the EuL" emission 
spectrum in the presence of SI r l 991120-337 and 100 m M MgCb with and without 
Ci. Again the 616/592 nm ratio conf irms that H C 0 3 ' was present on addit ion of 
Ci with an increase in ratio f rom 3.89 to 4.15 (Table 5.1A). Figure 5.1 I D shows 
the EuL"* emission spectrum in the presence of SIr l 991120-337 and 10 m M ATP 
with and without Ci . This spectrum demonstrates a magnif icat ion of the ratio, 
where the spectrum overlapped both in the presence and absence of Ci giving 
a ratio of 2.95 and 2.96 (Table 5.1 A) . The 616/592 nm ratios derived in the 
presence of ATP erroneously suggests that H C 0 3 ' was at the same 
concentrat ion both in the presence and absence of Ci . The explanation for this 
result was that the probe also binds to phosphate groups and so was binding 
to the added ATP, which caused a large excitation and masked any HCO3" 
binding to the probe. Figure 5.1 I E shows the EUL" emission spectrum in the 
presence of SI r l 991120-337, 100 mM MgCb and 10 m M ATP with and without 
Ci . This spectrum also shows a magnification of the signal and overlapping of 
the spectrum with its 616/592 nm ratio (3.24 and 3.27 (Table 5.1 A)) and thus 
also suggests that HCO3" was at the same concentrat ion both in the presence 
and absence of Ci . Thus the results from the EuL'' emission spectra in the 
presence of ATP and MgCb with ATP are not useful. The same results were 
seen when calculated with the 616/700 nm ratios (Table 5.1). 
The 616/592 nm and 616/700 nm ratios were calculated with the control 
spectra of no protein present, and the 616/700 nm ratio was also calculated for 
0.5 mM SIr l 991120-337 in the presence of no added co-factor, MgCU, A T P or 
MgCl2 and ATP (Table 5.1). These results agree with the initial f indings of the 
616/592 nm ratios with Slr1991120-337 that in the presence of A T P the spectra 
were distorted and that no difference can be seen between the ratios either in 
the absence or presence of Ci when ATP was present. 
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Figure 5.12: A) CO2 binding assays of Class Ilia and Class l l lb ACs. 30 m M 
NaH^^'COa at pH 6.5 (11.6 m M '^*C02) was assayed with the fol lowing 
addit ions: 450 pM SIrl991120-337, 450 pM SIrl991120-337 with 2 mM MgCl2, 450 
pM Slr1991120-337 with 200 pM ATP, 450 pM Slr1991120-337 with 2 m M MgCb 
and 200 pM ATP, 450 pM SI r l 991120-337 dm (D256A, D300A), 450 ^ M BSA 
and 50 pM buffer. B) CO2 binding assays with 30 m M NaH^^'COa at pH 6.5 
(11.6 m M '^'C02) with 450 pM CyaBlsgs-sss, 450 pM BSA or 50 mM buffer. C) 
CO2 binding assays with 30 mM NaH^'^COa at pH 6.5 (11.6 mM ^""COz) with 
450 pM Rv1625c204-443, 450 pM BSA or 50 mM buffer. Error bars are standard 
error of the mean (n=12) (*p<0.05). 
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Further analysis of the ratios of Table 5.1 showed a quenching of the 
probe signal in the presence of SI r l 991120-337- By calculating the HCO3" 
present:HC03" absent ratio (at 616/592 nm and 616/700 nm) of both the basal 
and MgCb condit ions, with and without SI r l 991120-337, a decrease in the new 
calculated ratios in the presence of SI r l 991120-337 was seen (Table 5.1) 
(compare column 4 with column 2). These calculated ratios suggest that the 
CO2 binding condit ions to SI r l 991120-337 apoprotein, are either in the presence 
of metal ion or in the absence of metal ion. However, there is no data for CO2 
binding in the presence of ATP or MgCb and ATP (due to the distortion in the 
spectra caused by ATP) that can support either hypothesis or rule out the 
requirement of A T P for CO2 binding. To further investigate whether CO2 is 
binding to apoprotein alone or binding in the presence of metal , another 
technique, '^*C02 binding assays was used. 
5.8 ^^COz binding assays 
'^*C02 binding assays have been used to identify CO2 binding to 
Rubisco (r ibulose-1,5-bisphosphate carboxylase/oxygenase) (Lorimer, 1979). 
This technique separates protein bound '^*C02 f rom unbound '^*C02 using a 
spin gel filtration column and thus, identifies how much CO2 is recovered with 
the protein. 
A large amount of protein is required for this assay to be able to recover 
enough ^''C02 f rom the gel fi ltration column to count on the scintil lation 
counter. Due to the requirement of large amounts of protein. Sir 1991120-337 was 
initially used to observe CO2 binding with the addit ion of different condit ions as 
compared to buffer and BSA. Measur ing the amount of recovered '^*C02 in the 
buffer containing BSA (Figure 5.12A) shows that the same amount of '^*C02 
was recovered in both and that '^*C02 was not binding non-specif ically to 
protein. Adding SIrl991120-337 showed a significant increase in the amount of 
'^*C02 recovered compared to the controls, proving that S I r l 991120-337 binds 
CO2. Repeating this assay in the presence of other condit ions such as metal 
co-factor, substrate, and both metal co-factor and substrate showed no 
significant change in the amount of '^*C02 recovered. 
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Indeed, the SIrl991120-337 D256A, D300A metal binding mutant protein 
also recovered ^^C02 further suggesting that metal is not required for CO2 
binding to the A C . SIrl991120-337 therefore, bound CO2 solely to the apoprotein 
and no additional cofactors or ions were required. This result disproves the 
hypothesis of Steegborn et al. that CO2 binds to a metal ion in the active site of 
the protein. 
The ^^C02 binding a s s a y s were repeated using the other C l a s s lllb A C , 
CyaBl595.859 (Figure 5.12B) and the C lass Ilia A C Rv1625c204^3 (Figure 
5.12C). In both c a s e s there was a significant increase in the amount of ^'*C02 
recovered with the A C proteins as compared to buffer and BSA. These ^'*C02 
binding a s s a y s prove that SIrl991120-337, CyaBI595-859 and Rv1625c204-443 all 
bind CO2 to the apoprotein and that CO2 binding to A C s does not require any 
other cofactors or ions. 
5.9 Conclusion 
CO2 binds to all C l a s s Ilia and C l a s s lllb A C proteins studied so far, 
however, the actual CO2 binding site has not been identified. CO2 was 
demonstrated not to bind to the catalytic amino acid residues in the active site 
of Rv1625c204^3, particularly the substrate defining Lys, but was shown to 
increase the affinity of R v l 625c204-443 to Mn^* and increase the co-operativity 
of the two binding sites in recruiting metal ions. Using spectroscopic 
techniques such a s CD spectroscopy and FTIR spectroscopy failed to identify 
whether metal ions or any other cofactors were required for CO2 binding. 
HCO3" dependent luminescence probe spectroscopy suggested that CO2 
bound the apoprotein and that metal may also be required. ^'^C02 binding 
a s s a y s proved that CO2 binds to the apoprotein and that CO2 binding to A C 
permits metal recruitment without CO2 binding to the metal. 
Elucidation of the CO2 binding site was the next aim. The most obvious 
CO2 binding site is likely to be an amine or amide sidechain group of an amino 
acid like Lys, Arg or His that form a carbamate with CO2, as was observed in 
Rubisco. Analysis of the possible amino acid residues in the active site of 
Rv1625c204^3 was conducted. 
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6 Investigation into potential CO2 binding sites 
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6.1 Introduction 
CO2 has been identified as binding to apoprotein and that no cofactor or 
substrate is required (see Chapter 5). In this chapter two hypotheses were 
investigated to explain CO2 binding to apoprotein. The first hypothesis is that 
CO2 is bound covalently to a single amino acid in the active site of Rv1625c204-
443- The second hypothesis is that CO2 is bound non-covalently in a pocl^et 
defined by multiple amino acids. If CO2 is bound to a single amino acid in the 
active site of Rv1625c204-443, it is most likely to form a covalent bond with an 
amino acid that has an amine or amide side group, such as Arg, Lys and His, 
to produce a carbamate. To test this hypothesis, 12 amino acids were tested 
by creating single mutant Rv1625c204^3 proteins that are conserved or near-
conserved residues, as compared with other CO2 activated C l a s s III A C s . 
Another potential CO2 binding site was mutated (Rvl 625c204^43 K296C) and 
modified with M T S C E to mimic the carbamate bond hypothesised to form 
through CO2 binding. The second hypothesis was investigated by analysing 
double and triple mutant Rv1625c204-443 proteins, identified by aligning the 
HCO3" binding residues of s A C (which also binds CO2) with Rv1625c204-443-
Finally Rv1625c protein crystals were grown and exposed to CO2 in an attempt 
to observe CO2 bound to the protein through X-ray diffraction. 
6.2 Analys is of potential CO2 binding residues in Rv1625c204. 
443 
CO2 is most lil<ely to form a covalent bond with the amine or amide side 
group of an amino acid to form a carbamate. The amino acids that fall into this 
category are Arg, Lys or His. From the sequence alignment of CO2 activated 
C l a s s lllb A C s (Figure 6.1), conserved or near-conserved Arg, Lys and His 
residues of Rv1625c204^3 were investigated. 
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Figure 6.1: Alignment of the catalytic domains of prokaryotic Class III AGs and 
the identification of potential CO2 binding amino acid side chains. The 
sequences of Class Ilia AC Rv1625c of M. tuberculosis H37Rv, the Class lllb 
AC Slr1991 of Synechocystis PCC 6803 and the Class lllb AC CyaB1 from 
Anabaena P C C 7120 are aligned for comparison. Numbers denote amino acid 
sequence number. Arrows indicate conserved metal binding Asp residues. 
Triangle indicates conserved substrate binding Lys residue. Circle indicates 
the polymorphic Asp/Thr of Class llla/b ACs. Highlight indicates residues 
mutated to Ala to form single mutant proteins for CO2 dependence assays. 
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i 
Rvl625c 204 DTARAEAVMEAEHDRSEALLANMLPASIAERLKEPERNIlADKYDEASVLFADIVGFTERAS 
S l r l 9 9 1 120 -TQT NVLH ERRLIT VLVADMRNFTGMAQ 
CyaBl 595 GERKEVTVLFSDIRGYTTLTE 
RV1625C 266 STAPADLVRFLDRLYSAFDELVDQHGLEKlTvSGDSYMW—SGVPSpR-PofflTQALADFAL 
S l r l 9 9 1 147 QVEEELLSMLIGNWFRQAGHILREAGSWVDKYIGDAVMAIWFHGYNEATPAEIIQILHAVNR 
CyaBl 616 NLGAAEWSLLNQYFETMVEAVFNYEGTLDKFIGDALMAV—FGAPLPLTENHAWQAVQSAL 
RV1625C 325 DMT^WAAQL^DPg GNPVPLgVG—LATGPWAGWGS-^FYDVWGDAVNVASRMES 
S l r l 9 9 1 209 LQAMTAKLNQKYE LPF-PLRIGTGINTGYAMVGNTGSGDHPDYTAIGDTVNAAFRLES 
CyaBl 676 DMRQRLKEFNQRRIIQPQPQIKIGIG—ISSGEWSGNIGSHKRMDYTVIGDGVNLSSRLET 
Rvl625c 380 -TDSVGQIQ—VPDEVYESL3D—OFVLREgGH-INvgcflcVMRTWY LIGRKV 
S l r l 9 9 1 267 ATKQAHFDLAMSEKTFSYLQDLPQWSATVQQHTIELKGYTNPITIYGLPFATLGTLLDHTSL 
CyaBl 7 36 -VTKEYGCDlILSEFTYQLCSDRIWVRQLDKIRVKGKHQAVNIYELISDRSTPLDDNTQEFL 
Rvl62 5c 4 27 AADPGEVRGAEPRTAGV 
S l r l 9 9 1 328 EDTTPASEGP 
CyaBl 7 97 FHYHNGRTAYLVRDFTQAIACFNSAKHIRPTDQAVNIHLERAYNYQQTPPPPQWDGVWTIFTK 
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Figure 6.2: SDS-PAGE gel of Rv1625c204-443 mutant proteins. 2 pg of each 
protein was applied to each lane with molecular weight standards on the left of 
each gel. Gels were stained with Coomassie Brilliant Blue G. Gel A): Lane 1) 
R310A 2) H315A 3) K334A 4) R337A 5) R344A 6) R360A. Gel B): Lane 7) 
R381A 8) R395A 9) K397A 10) R405A 11) K411A 12) K413A. 
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Figure 6.3: CO2 dependence assays for Rv1625c204-w3 mutant proteins. 
Assays were performed at 37 °C at pH 6.5 (50 mM MES) with 2 mM Mn *^ in 
the presence of 200 pM ATP and 20 mM NaCI or Ci for 40 minutes with a pre-
incubation time of 30 minutes. The bars on the left with vertical stripes 
represent the addition of 20 mM NaCI and the bars on the right with diagonal 
stripes represent the addition of 20 mM Ci. Error bars are standard error of the 
mean (n=6) (*p<0.05) compared to corresponding CI' value. A) 1.8 pM R310A, 
1.8 pM R360A, 1.8 pM K411A. 1.8 pM R405A, 1.8 pM K334A, 1.8 pM K413A. 
B) 1.8 pM H315A, 1.8 pM R344A, 1.8 pM K397A, 14.5 pM R395A, 3.6 pM 
R361A. 
180 
Investigation into potential CO2 binding sites Phillip Holliday 
> T 
O Q. 
O < 
2 « & (n o 
E 
N*^"^  N^ "^  ' b ^ ^ C ? ! ^ <b^^ 
4f ^ 4?" <^ <^ 
181 
Investigation into potential CO2 binding sites Phillip Holliday 
A sequence alignment of the catalytic domains of three prokaryotic 
Class Ilia and Class lllb ACs that are stimulated by CO2, Rv1625c204^43, 
Slr1991120-337 and CyaBl595-859. was used to identify the Arg, Lys or His 
residues that were conserved or that were near-conserved (Figure 6.8) and 
that may be potential CO2 binding residues. 
In total, 12 residues in Rv1625c204-i43 were identified that were potential 
CO2 binding sites due to conservation in the Class lllb ACs Slr1991 from 
Synechocystis P C C 6803 and CyaBl from Anabaena PCC 7120. Single Ala 
mutant proteins of each residue were created by site-directed mutagenesis. All 
the mutant proteins were overexpressed in E. coli and purified by affinity 
chromatography to homogeneity. The mutant proteins were analysed for purity 
by SDS-PAGE. 
The SDS-PAGE gel of the purified mutant proteins (Figure 6.2) shows a 
protein band at approximately 27 kDa for all mutant proteins, similar to the 
molecular weight of the Rv1625c204^3 wt protein. All the mutant proteins 
appeared pure except R395A and K397A, which had contaminating bands at 
approximately 25, 72 and 100 kDa for R395A and 25 kDa for K397A, but both 
mutant proteins were estimated to be 95 % pure by comparison of the intensity 
of the gel bands. 
CO2 dependence assays were performed on the 12 mutant proteins to 
ascertain if there was any ablation of CO2 stimulation. Ablation of activity 
would give direct evidence that the mutated residue was the CO2 binding site 
for Rvl 6250204-443-
Figure 6.3 shows firstly that all the mutant proteins were active, with 
varying basal specific activities and secondly, that all the mutant proteins were 
stimulated by CO2 with fold stimulation varying from 2-fold to 8-fold. 
Interestingly, a few of the mutant proteins (R310A, R360A, K411A, R405A and 
K334A) had higher basal specific activities than wt protein, suggesting that the 
mutations of these residues increase catalysis, most likely through the faster 
release of cAMP from the active site. Further work on the kinetics of these 
mutant proteins would need to be conducted to identify their mechanism of 
stimulation. It is also interesting to note the large increase in CO2 fold 
stimulation of certain mutant proteins (R310A and R337A) suggests that these 
residues may constrain the response of Rv1625c204^3 to CO2. Again further 
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work on the kinetics of these mutant proteins would need to be conducted to 
identify their function. Another interesting note is the large difference in basal 
specific activity of R360A and R361A, residues that are adjacent to each other, 
which suggest that R361 plays an important unknown role in catalysis, 
possibly in stabilising the enzyme structure. 
The CO2 dependence assays on the 12 selected Arg, Lys and His 
mutant proteins did not identify the CO2 binding site. This finding questions the 
theory that CO2 is binding to a single amino acid sidechain group to form a 
carbamate and it is unlikely that CO2 binds to a carboxylate group. CO2 has 
also previously been demonstrated to not require metal or substrate for 
stimulation, suggesting that CO2 does not bind to metal or substrate. It is 
possible that more than one residue is involved in CO2 binding, thus creating a 
single mutant protein will not help to identify the CO2 binding site as the other 
CO2 binding residue will still facilitate the CO2 stimulation of the enzyme. 
6.3 Modification of Rv1625c204-443 K296C to form a carbamate 
As the 12 potential CO2 binding amino acids were all shown to not 
affect CO2 activation, the substrate defining Lys of Rv1625c204-443. K296 was 
re-investigated. This was because the corresponding Lys in CyaBI of 
Anabaena P C C 7120 has previously been demonstrated to be required for Ci 
activity by the ablation of CO2 stimulation through a K646A point mutant 
protein (Cann et a/., 2003). The Rv1625c204^3 K296A mutant (Section 5.2) 
was previously shown to be stimulated by CO2 and thus was not solely 
responsible for CO2 binding. However K296A may be indirectly involved in CO2 
stimulation of Rvl 625c204-443, for example through stabilisation of the active 
site during catalysis or through being part of a CO2 binding pocket. 
Chemical modification of a catalytic amino acid was used to investigate 
a possible role for K296 as a redundant part of a CO2 binding pocket in 
Rv1625c204-M3- If CO2 forms a carbamate with the amine sidechain group of 
K296 in conjunction with other binding amino acid partners, it is reasonable to 
presume that the resulting carbamate will be important in enzyme activation. 
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Figure 6.4: Schematic diagram to demonstrate the isosteric resemblance of a) 
the hypothesised carbamate formation on Lys with CO2, and b) the 
modification of Cys mutant with MTSCE. 
184 
Investigation into potential CO2 binding sites Phillip Holliday 
a) 
0=0=0 
b) 
-O2C, 
_ 0 S 
HS / 
8 
185 
Investigation into potential CO2 binding sites Phillip Holliday 
Figure 6.5: A) SDS-PAGE gel of Rvl 625c204-443 mutant proteins. 2 |jg of 1) 
K296C and 2) K296C modified with MTSCE was applied to each lane with 
molecular weight standards on the left of each gel and the gel was stained with 
Coomassie Brilliant Blue G. B) MS data for Rv1625c204^3 K296C. C) MS data 
for Rv1625c204-443 K296C modified with MTSCE. 
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Figure 6.6: CO2 dependence assay for Rv1625c204^3 K296C mutant proteins. 
K296C mutant proteins were assayed at 37 °C for CO2 sensitivity at pH 6.5 (50 
mM MES) with 2 mM Mn *^ in the presence of 200 pM ATP and 20 mM 
NaHCOs or NaCI for 40 minutes with a pre-incubation time of 30 minutes. Error 
bars are standard error of the mean (n=6) (*p<0.05) compared to CI" value at 
corresponding pH value. A) 7.2 pM K296C. B) 7.2 pM K296C modified with 
MTSCE. 
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The formation of a stable carbannate at K296, as a chennical mimic for 
CO2 activation of the enzyme, was therefore investigated. 
The formation of a steric analogue of the carbamate at K296 may 
permanently activate Rv1 625C204-M3 and therefore the enzyme will no longer 
be responsive to CO2. K296 was mutated to Cys, which allowed for the 
modification of the thiol group of Cys with MTSCE (see Section 3.2.17) to form 
a carboxylate group that mimics the hypothesised carbamate binding of CO2 to 
K296 (Figure 6.4). Therefore the modified Rv1625c204-443 K296C should be 
CO2 insensitive as the modification mimics the CO2 bound form of Rv1625c204-
443, however, specific activity should be comparable to CO2 activated 
Rv1625C204^3 wt. 
K296C was overexpressed in E. coli and purified by affinity 
chromatography to homogeneity to generate a recombinant protein. The 
protein was analysed for purity by SDS-PAGE and MS. The SDS-PAGE gel of 
K296C (Figure 6.5A1) shows a single protein band at approximately 27 kDa. 
There were no contaminating protein bands. The MS data (Figure 6.5B) for the 
K296C mutant protein confirmed that the actual molecular weight of the 
purified protein matched the theoretical molecular weight of 27665 Da for 
Rv1625c204^3 K296C mutant protein 
500 [JM of the K296C mutant protein was modified with MTSCE to add 
the carboxylate group (Figure 6.4). The modified protein was analysed for 
purity by SDS-PAGE and MS. The SDS-PAGE gel of K296C (Figure 6.5A2) 
shows a single protein band at approximately 27 kDa. There were no 
contaminating protein bands. The MS data (Figure 6.5C) for the modified 
K296C mutant protein confirmed that the actual molecular weight of the 
purified protein matched the theoretical molecular weight of 27771 Da for the 
modified Rv1625c204^3 K296C mutant protein. 
The K296C and modified K296C mutant proteins were analysed for CO2 
dependence by performing a CO2 dependence assay against a CI" control 
curve. A small shift in the pH value of the assay containing CO2 was noticed 
that could be suggested as the cause of the increase in specific activity, so a 
Cr control curve at three different pH values was conducted to differentiate 
between small changes in assay pH and reduced responses to CO2. The 
result of the CO2 dependence assay on K296C (Figure 6.6A) shows that 
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K296C was stimulated by CO2 with a 1.4 fold stimulation. The result of the CO2 
dependence assay on the modified K296C (Figure 6.6B) shows that the 
modified K296C was also stimulated by CO2 with a CO2 fold stimulation of 1.6. 
Noticeably, there is a 1000-fold drop in basal specific activity of the modified 
K296C, most likely due to the modification of the Cys at K296 in the active site, 
which placed a larger carbamate group in the active site, thus making the 
binding of ATP more difficult and decreasing specific activity. A kinetics assay 
would need to be performed to determine this hypothesis precisely. The CI" 
assays demonstrated that the increase in specific activity was due to CO2 
stimulation and not a change in pH. As Rv1625c204^3 K296C mutant protein 
was stimulated by CO2, the substrate defining Lys could not be the sole CO2 
binding site in Rv1625c204^3- As the modified protein is also stimulated, K296 
would appear to not be part of a CO2 binding pocket despite the contrary 
findings in CyaB1 of Anabaena P C C 7120 (Cann et a/., 2003). The 
identification of the substrate defining Lys as being involved in Ci stimulation 
was discovered in the Class 11 lb AC CyaB 1595^59, thus it may be possible that 
Class Ilia ACs and Class 11 lb ACs have different mechanisms of CO2 
stimulation. 
6.4 sAC structure 
During the third year of research on this thesis, the mammalian sAC 
protein was crystallised with HCOa' bound and a diffraction set collected by 
another research group (Saalau-Bethell ef a/., 2007). Analysis of the diffraction 
data of the sAC crystal with HCOa' bound showed that the three residues that 
are required for HCO3" binding are the substrate defining Lys K95, the 
transition state stabilising Arg, R176 and a valine (Val) of unknown activity, 
V167 (Figure 6.7). The diffraction data was entered into Pymol, a program that 
generates protein structures and the HCO3" was identified by the diffraction 
data to sit in a binding pocket. HCO3" binds to the side chains of K95 and R176 
and also binds to the 'backbone' main chain of VI67. sAC is activated by CO2 
and HCO3" but whether the binding site is the same for CO2 and HCOs' or 
whether there are two binding sites is unknown. 
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Figure 6.7: Pymol generated image of HCO3" binding to sAC from 
crystallisation data (Saalau-Bethell et a/., 2007). a) Whole catalytic domain of 
sAC with HCO3" (red molecule) in binding pocket, b) HCOa' (red molecule) 
binding to residues K95 (blue residue on left), V167 (grey residue on right) and 
R176 (blue residue on right). 
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Figure 6.8: Alignment of the catalytic domain of Rv1625c from M. tuberculosis 
and sAC from Homo sapiens. K95, VI67 and R176, the residues of sAC that 
bound Ci (arrows) were aligned with the catalytic domain of Rv1625c to obtain 
the corresponding residues in Rv1625c. 
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J 
Mycobacteria Rvl625c 252 VLFADIVGFTERASST APADLVRFLDRLYSAFDELVDQHGLEKIKVSGDSYM 
Human 3ACI 43 LMFVDISGFTAMTEKFSTAHYMDRGAEQLVEILNYYISAIVEKVLIFGGDILKFAGDALL 
Mycobacteria Rvl625c 304 W SGVPRPRPDHTQALADFALDMTNVAAQLKDPRGN 
Human sACl 103 AL W KVERKQLKNIITVVIKCSLEIHGLFEA 
1 1 
Mycobacteria Rvl625c 340 PVPLRVGLATG. . . PWAGVVGSRRFFYDVW.GDAVN. . . VASRMEST 
Human sACl 133 KEVEEGLDIRVKIGLAAGHITMLVFGDETRNYFLV.IGQAVDD..V..RLAQN 
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Figure 6.9: SDS-PAGE gel of Rv1625c204^3 mutant proteins. 2 pg of 1) V366A 
2) K296A, R376A and 3) K296A, V366A, R376A was applied to each lane with 
molecular weight standards on the left of each gel and the gel was stained with 
Coomassie Brilliant Blue G. 
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6.5 Analysis of double and triple mutant proteins of 
Rv1625C204-443 
As the single K296 mutant protein of Rv1625c204^3 and the twelve 
identified single amine group residue mutant Rv1625c204^3 proteins have all 
been demonstrated not to be the sole CO2 binding site, the possibility that 
there was more than one residue involved in CO2 binding was considered. 
Thus CO2 may be forming a carbamate with the amino side group of a residue, 
but may also be stabilised with other residues in the active site. No ablation of 
CO2 activity was observed in the single mutant proteins as the other residues 
in the binding site were able to 'bind' CO2 and stimulate Rvl 625c204^3. 
A crystal structure of mammalian sAC with bound HCO3' showed that 
the residues K95, VI67 and R176 all bound HCO3". By creating an alignment 
of mammalian sAC and Rv1625c, the corresponding residues in Rv1625c can 
be identified and mutated. As Rv1625c corresponds to half of a mammalian 
AC, it is likely that the same binding pocket will exist in Rv1625c as in 
mammalian sAC (Figure 6.7). A logical experiment would be to create the 
corresponding single, double and triple mutant proteins in Rv1625c204^3 to 
ascertain by AC assay, whether these residues are required for CO2 binding in 
a Class Ilia AC. 
The corresponding three residues that bind HCOa' in sAC, the substrate 
defining Lys, the transition state stabilising Arg and the backbone residue Val, 
were identified in Rv1625c by an alignment of the catalytic domains of sAC 
and Rv1625c (Figure 6.8). The Rv1625c residues are K296, V366 and R376. 
Single mutant proteins of each of these residues were constructed, 
overexpressed and assayed for CO2 dependency as was the double substrate 
defining mutant protein, K296A, R376A and the triple mutant protein, K296A, 
V366A, R376A. As K296A and R376A single mutant proteins have previously 
been overexpressed and purified (See Section 5.2), V366A single mutant 
protein was also overexpressed and purified. The K296A, R376A double 
mutant protein and K296A, V366A, R376A triple mutant protein were formed 
through restriction enzyme digestion and ligation of the appropriate single 
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mutant DNA, double checked through forward and reverse DNA sequencing of 
the DNA and finally expressed and purified. 
The Rv1625c204^3 V366A single mutant protein, K296A, R376A double 
mutant protein and K296A, V366A, R376A triple mutant protein were 
overexpressed in E. coli and purified by affinity chromatography to 
homogeneity to generate three recombinant proteins. The mutant proteins 
were analysed for purity by SDS-PAGE. 
The SDS-PAGE gel of the expressed and purified Rvl 625c204-443 
mutant proteins (Figure 6.9) shows a single protein band at approximately 30 
kDa for the V366A single mutant protein (Figure 6.9(1)). The K296A, R376A 
double mutant protein also shows a band at approximately 30 kDa (Figure 
6.9(2)) and the K296A, V366A, R376A triple mutant protein also shows a band 
at approximately 30 kDa (Figure 6.9(3)). The theoretical weight of Rv1625c204-
443 is 26790 Da and so the expressed Rv1625c204^3 mutant proteins match 
the theoretical weight of the Rv1625c204^3 mutant and the mutant proteins are 
pure as there are no contaminating protein bands seen on the SDS-PAGE gel. 
The three single mutant proteins, K296A, V366A and R376A, the double 
mutant protein, K296A, R376A and the triple mutant protein, K296A, V366A, 
R376A were analysed for CO2 responsiveness by performing CO2 dependence 
assays against CI' control curves. The CI" control curves were included to 
investigate the theory that a small change in pH of the assay due to the 
addition and degassing of CO2 may be the cause of the fold stimulation of 
Rvl625C204-443 and not that Rvl625c204-443 is CO2 sensitive. The pH values of 
the CI" control curves were between pH 6.45 and 6.6 and the pH value of the 
assay containing CO2 was measured and kept within the CI" curve. Figure 
6.1 OA shows the CO2 dependence assay for the K296A single mutant protein. 
K296A is stimulated by CO2 with a 1.5-fold CO2 stimulation. The specific 
activities of the CI" curve and the CO2 stimulated assay correspond with the 
results previously observed with K296A (see Section 5.2). Figure 6.1 OB shows 
that the V366A single mutant protein is stimulated by CO2 with a 1.5-fold CO2 
stimulation. The specific activities of the CI" curve correspond to the basal 
specific activity of Rvl 625c204-443 wt. Figure 6.1 OC shows that the R376A 
single mutant protein is stimulated by CO2 with a 2-fold CO2 stimulation. 
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Figure 6.10: CO2 dependence assay for Rv1625c204^43 K269A, V366A, R376A 
mutant proteins. Mutant proteins were assayed at 37 °C for CO2 sensitivity at 
pH 6.5 (50 mM MES) with 2 mM Mn *^ in the presence of 200 pM ATP and (20 
mM Ci) for 40 minutes with a pre-incubation time of 30 minutes. Error bars are 
standard error of the mean (n=6) (*p<0.05) compared to all CI' values 
observed. A) 7.2 pM K296A, B) 1.2 pM V366A, C) 556 nM R376A, D) 18 pM 
K296A, R376A, E) 70 pM K296A, V366A, R376A. 
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Figure 6.11: A) SDS-PAGE gel of RV1625C212-M3 K296E, F363R, D365C 
mutant protein. 10 pL of 1) Ni-NTA purified, 2) Q-sepharose purified and 3) 
Superdex 200 purified mutant protein was applied to each lane with molecular 
weight standards on the left of each gel and the gel was stained with 
Coomassie Brilliant Blue G. B) CO2 dependence assay for Rv1625c204-443 
K296E, F363R, D365C mutant protein. Mutant protein was assayed at 37 X 
for CO2 sensitivity at pH 6.5 (50 mM MES) with 2 mM Mn^ "" in the presence of 
200 pM ATP and (20 mM Ci) for 40 minutes with a pre-incubation time of 30 
minutes. Error bars are standard error of the mean (n=6) (*p<0.05). 
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The specific activities of the CI' curve and the CO2 stimulated assay 
correspond with the results previously observed with R376A (see Section 5.2). 
Figure 6.10D shows that the double mutant protein, K296A, R376A is 
stimulated by CO2 with a 2-fold CO2 stimulation. 
Figure 6.1 OE shows that the triple mutant protein, K296A, V366A, 
R376A is stimulated by CO2 with a 1.5-fold CO2 stimulation. In all the CI" 
control assays, the specific activity increased with an increase of pH from 6.5 
to 6.6, an expected result as the optimal pH for Rv1625c204^3 is pH 7.5 (Guo 
et a/., 2001). However, this pH-dependent increase in specific activity was less 
than half the increase in specific activity due to CO2 sensitivity. The CO2 
stimulation is not a pH effect as the addition of CO2 to the assay would 
decrease the pH value as CO2 equilibrates to form a small amount of HCO3" 
and H*. Therefore basal enzyme activity does increase with an increase in pH 
towards the optimal pH value, however the fold stimulation caused by the 
addition of CO2 to the assay has a larger effect. 
All the single, double and triple Rv1625c204^3 mutant proteins were 
stimulated by CO2 with CO2 fold stimulations of between 1.5-2. This result 
demonstrates that none of these residues by themselves is the CO2 binding 
site or that CO2 is binding to more than one of these residues to stimulate 
Rv1625c204-M3. This result suggests that CO2 and HCO3" have different binding 
sites on ACs, a logical presumption as the two Cis are different shapes and 
have different ionic charges. As sAC is stimulated by both CO2 and HCO3", 
sAC must have two different binding sites for the two Cis. 
6.6 Crystallographic studies on Rv1625c2i2^3 
As all attempts to identify the CO2 binding site have been unsuccessful, 
X-ray crystallography was employed to directly observe CO2 bound to the 
active site of Rv1625c protein crystals. Rv1625c has previously been 
crystallised (Ketkar et a/., 2004), however due to stabilisation problems with 
the wild type protein, attributed to a mixture of monomeric and dimeric catalytic 
domains, the K296E, F363R, D365C triple mutant protein was the only stable 
mutant protein of Rv1625c that formed crystals as the triple mutant existed 
204 
Investigation into potential CO2 binding sites Phillip Holliday 
predominately as a monomer (Shenoy et a/., 2003). In Rv1625c, K296 and 
D365 are the substrate defining residues and F363 is required for efficient AC 
activity. The triple mutant was initially generated to convert Rv1625c from an 
AC to a GC, however the mutations failed to convert Rv1625c to a G C and 
reduced its AC activity and altered its oligomeric state (Shenoy et a/., 2003). 
Rv1625c2i2^3K296E, F363R, D365C was overexpressed in E. co//and 
purified by affinity chromatography, anion exchange chromatography and gel 
filtration chromatography to generate a recombinant protein. After each 
chromatographic step the protein was analysed for purity by SDS-PAGE. 
The SDS-PAGE gel of the expressed and purified Rv1625c2i2^3 
K296E, F363R, D365C (Figure 6.11 A) shows the protein bands from the three 
chromatographic steps. After the Ni-NTA column, the eluted protein (Figure 
6.11A (1)) gives a large band at approximately 30 kDa of approximately 15 pg 
protein. The theoretical weight of Rv1625c2i2^3 K296E, F363R, D365C is 
26874 Da. The gel also shows that there are contaminating protein bands at 
approximately 20 kDa, 130 kDa and 170 kDa. The eluted protein after the Q-
Sepharose column (Figure 6.11 A (2)) shows a large band at approximately 30 
kDa of approximately 10 pg protein. The gel shows that there are no other 
contaminating protein bands. The eluted protein after the final column, the 
Sephadex 100 column (Figure 6.11 A (3)) shows a large band at approximately 
30 kDa of approximately 8 pg protein. Again the gel shows that there are no 
other contaminating protein bands. Thus the mutant protein is > 99 % pure and 
is pure enough for crystallisation trials. The SDS-PAGE gels (Figure 6.11) also 
show a decrease in the quantity of mutant protein recovered from the different 
chromatographic steps. This loss of protein is due to non-specific interactions 
of the protein to the columns and also incomplete recovery of the eluted 
proteins from the eluant. The SDS-PAGE gels also show that the mutant 
protein was pure after the Q-Sepharose column, however the mutant protein 
was purified on the final column so as to replicate the published conditions and 
to change the protein buffer to 20 mM HEPES-NaOH, a buffer known to aid 
crystallisation of Rv1625c2i2^43 and also to desalt the buffer from the high salt 
concentration used in the anion exchange chromatography (Ketkar et a/., 
2004). 
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Figure 6.12: Crystals of Rv1625c2i2-443 K296E, F363R, D365C mutant protein 
grown by the hanging-drop method. Crystal size is 150 x 30 x 30 A. 
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Figure 6.13: Diffraction pattern of Rv1625c2i2-443 K296E, F363R, D365C 
mutant protein crystal exposed to C O 2 , collected at the Swiss Light Source 
(Paul Scherrer Instltut, Villigen, Switzerland). 
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For the crystallisation of Rv1625c2i2^3 K296E, F363R, D365C in the 
presence of C O 2 the mutant protein was first shown to be activated by C O 2 . If 
the mutant protein was not stimulated by C O 2 , it may have been due to the 
C O 2 binding residue(s) being one of the mutated residues and thus the crystal 
structure would not show C O 2 bound to the protein. A C O 2 dependence assay 
on Rv1625c2i2^3 K296E, F363R, D365C was performed (Figure 6.1 I B ) . 
Figure 6.1 I B shows that Rv1625c2i2^3 K296E, F363R, D365C was 
stimulated by C O 2 with a 2.5 fold stimulation. Therefore the mutant protein 
does bind C O 2 and thus the protein crystals incubated with C O 2 will hopefully 
produce a diffraction data set that when solved will display C O 2 bound to 
residue(s) of Rv1625c2i2-443 K296E, F363R, D365C. 
With the help of Dr K. Betz (Department of Chemistry, Durham 
University), crystallisation trials were set up with Rv1625c2i2^3 K296E, 
F363R, D365C a s described in Section 3.3.5 and crystals with a typical length 
of 20-30 pm grown under the conditions of 7-8 % P E G 8000 and 6 % glycerol 
were selected for C O 2 exposure (Figure 6.12) as the largest crystals grew 
under these conditions. Optimal sized crystals were removed from the 
crystallisation trials, exposed to C O 2 in C O 2 chamber (see Section 3.3.6) and 
cryogenically frozen for transportation to a synchrotron. 
Both cryogenically frozen native Rv1625c2i2^3 K296E, F363R, D365C 
protein crystals and C O 2 exposed protein crystals were subjected to X-ray 
diffraction studies and data sets were collected (Figure 6.13). The Rv1625c2i2-
443 K296E, F363R, D365C protein crystallised in space group P4^, with unit-
cell parameters a = b = 77.3, c = 110.3 A, which are similar parameters to the 
published data (Ketkar et a/., 2004) but with a resolution of 2.8 A, which is 
better than the published data of 3.4 A. However, the structure of the C O 2 
bound protein had a high R-factor, which measures the agreement between 
the crystallographic model and the experimental X-ray diffraction data (Morris 
et a/., 1992), of >35 %, a more acceptable value is <25 %. 
The high R-factor causes the phase error to be high and thus the 
electron density is poor. This result was observed for a second native protein 
crystal so is a real effect caused by the crystals. With a resolution of 2.8 A, 
C O 2 would not be seen in the structure of the C O 2 exposed protein crystals. 
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6.7 Conclusion 
In this chapter numerous experiments were conducted to identify 
whether C O 2 bound to Rv1625c204^3 through a single amino acid, with the 
most likely residue being K296, or via other residues that contain an amine or 
amide sidechain group, such as Lys, His and Arg. However, C O 2 dose 
dependence a s s a y s of the single mutants showed that all the single mutant 
proteins assayed were stimulated by C O 2 and were therefore not the C O 2 
binding site. Thus experiments into multiple amino acids being the potential 
C O 2 binding site were investigated. The multiple residues were identified 
through aligning the HCOs' binding residues of s A C with Rv1625c204^3, 
however, C O 2 dependence a s s a y s on the multiple residue mutant proteins 
showed that they were all stimulated by C O 2 . Finally Rv1625c was 
investigated by growing protein crystals, exposing the crystals to C O 2 and 
collecting a diffraction data set, however, the resolution of the diffracted crystal 
was too low to observe C O 2 in the structure. 
Unfortunately the C O 2 binding site of Rv1625c was not identified, 
however, this work has identified a C lass Ilia A C a s being activated by C O 2 , 
identified that C O 2 binds solely to the apoprotein and has narrowed down the 
potential binding sites of C O 2 to Rv1625c204^3. A range of techniques for 
determining the mode of C O 2 binding to A C s were identified but were not 
effective. It can only be a matter of time before the C O 2 binding site on 
Rv1625c is discovered. 
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7.1 Final discussion 
Rv1625c is an excellent model to use for studying A C biochemistry for a 
number of reasons. 
• the Rv1625c protein consists of six putative transmembrane helices 
and a single C lass Ilia A C catalytic domain (Guo et a/., 2001). This 
corresponds to exactly one half of a mammalian G protein-regulated A C . 
In addition, the six key catalytic residues distributed between the two 
catalytic domains of mammalian A C s are also found in the active site of 
Rv1625c (Guo a/., 2001). Rv1625c is the closest bacterial progenitor of 
mammalian A C s identified to date, therefore, it is likely that Rv1625c 
responds to Ci stimulation in a similar fashion to mammalian A C s . 
• Rv1625c can be expressed using a bacterial expression system in 
vivo as the protein does not require post-translational modification for 
activity. Using a bacterial expression system, compared to a mammalian 
expression system, enables large amounts of protein to be expressed 
and also simplifies subsequent purification steps. A greater, purer yield is 
therefore, obtained with fewer purification steps. With protein expressed 
quickly, experiments can be conducted faster and results obtained in a 
shorter time than if a mammalian A C was used. Expressing mammalian 
A C s using a bacterial expression system does not post-translationally 
modify the protein and yield is lower. Using a mammalian expression 
system to express mammalian A C s would be preferable, however, the 
maintenance of mammalian cells and the subsequent purification of the 
protein is more problematic. 
• The conditions required for an A C assay using Rv1625c are simpler 
than a mammalian A C assay. Rv1625c does not require any activators 
for basal A C activity, whereas mammalian A C s require the plant 
diterpene forskolin and/or the monomeric GsO subunit to detect significant 
basal A C activity (data not shown). Thus, GsO subunits have to be 
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expressed, purified, and activated. A G s O dose dependence curve 
generated, a forskolin dose dependence curve generated and/or a 
synergistic forskolin/GsO dose dependence curve must be generated 
before commencing on mammalian A C a s s a y s . As mammalian A G s are 
heterodimers, for A C activity two subunits are required for the formation 
of a catalytic site, whereas Rv1625c is a homodimer and thus dimerises 
with two single subunits to form two catalytic sites. 
Although Rv1625c is a useful model for G protein-regulated mammalian 
A G s , there is, however, a limitation to studying C O 2 stimulation of Rv1625c 
solely as a model for C O 2 stimulation in mammalian A G s . C O 2 stimulation of 
Rv1625c only suggests that G protein-regulated mammalian A G s are also 
stimulated by C O 2 since Rv1625c is a bacterial A C and mammalian A G s may 
respond differently to C O 2 since there are numerous activators specific to 
mammalian A G s that do not activate Rv1625c. To prove that mammalian A G s 
are G O 2 responsive, a s s a y s using mammalian A G s must be conducted. Work 
done by Townsend et al. has demonstrated that G protein-regulated 
mammalian AGs are stimulated by C O 2 (Townsend et al., 2009), thus, 
supporting the use of Rv1625c as a model for C O 2 stimulation in G protein-
regulated mammalian AGs . 
The in vitro study of C O 2 stimulation of Rv1625c has numerous 
advantages over in vivo experiments. 
• In vitro AG assays allow for closely controlled experimental conditions 
on an isolated catalytic domain of the enzyme. Therefore, any changes in 
A C activity can be attributed to the change in experimental conditions. 
Kinetic parameters of AG stimulation can be calculated to understand the 
mechanism of the stimulation. 
• Expression and purification of recombinant A C protein is 
straightfonward and yield is high, allowing for numerous in vitro A C 
a s s a y s to be conducted. By contrast, M. tuberculosis grows slowly and 
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as its genome contains 15 putative A C domains, thus, it is difficult to 
associate any change in cAMP concentration with Rv1625c. 
The disadvantage of in vitro a s s a y s is that they do not explain how the 
enzyme functions in vivo. A C proteins possess regulatory domains, such as 
the HAMP domain of Rv1319c of M. tuberculosis that decreases specific 
activity by 70 % (Linder 2004), that can modulate the activity of the A C domain 
and must therefore, be considered. There are also other activators and 
inhibitors in the in vivo signalling cascade, such as P D E s that degrade cAMP, 
that also affect A C activity and are unaccounted for with in vitro a s s a y s . In M. 
tuberculosis, there is the added problem of 14 other A C s that may interact and 
affect the response of C O 2 activated Rv1625c. This interaction of other M. 
tuberculosis A C s in the absence of Rv1625c is demonstrated clearly by work 
done to identify Rv1625c in vivo pathogenecity by infecting a mouse with a 
rv1625c knockout. The rv1625c knockout still caused pathogenesis, likely due 
to redundancy of the 14 other A C s (Guo ef a/., 2005). 
There are numerous difficulties with experiments that require C O 2 . 
• C O 2 saturation of water causes the acidification of the water due to 
formation of carbonic acid. Therefore the addition of C O 2 saturated water 
to the A C a s s a y s requires a high concentration of buffer and close 
regulation of the pH of the buffer for the duration of the experiment. 
Control a s s a y s must have an identical pH value because at low pH value, 
a pH change of a s little a s 0.1 could mask an A C stimulation due to A C 
activity increasing as pH increases. At pH values approaching 7.5, 
significant amounts of C O 2 in the assay solution are converted to HCO3' 
(so a s to maintain the Ci equilibrium) and thus, there is an overall lower 
concentration of C O 2 in the assay than in the stock C O 2 saturated water. 
Thus there is a lower concentration of C O 2 in the assay and a diminished 
C O 2 stimulation is observed at pH 7.5. 
• C O 2 degasses readily from a saturated C O 2 solution due to a steep 
concentration gradient between the solution and the atmosphere. 
215 
Discussion Phillip Holliday 
• C O 2 saturated water gives a 30 mM C O 2 solution, which limits the 
addition of C O 2 to the assay . 
A C a s s a y s were an integral part of the investigation into C O 2 stimulation 
of Rv1625c. The use of [a-^^P] A T P as a substrate allowed for the 
measurement, via a scintillation counter, of the amount of [2,8-^H] cAMP 
formed during the assay and taking into account the concentration of enzyme 
used, the A C activity was calculated. There are a few considerations made for 
this A C activity calculation. 
• Individual Dowex and aluminium oxide columns, which separate the 
[2,8-^H] cAMP from [a-^^P] ATP , are used for each replicate sample, thus 
there may be discrepancies between replicates. This discrepancy can be 
reduced by increasing the number of replicates per assay and repeating 
a s s a y s while randomising the columns used. 
• There is a maximum amount of A T P that can be added to the a s s a y s . If 
the concentration of A T P used is higher than 100 mM, the ratio of 
ATP:[a-^^P] ATP is too great and the amount of [2,8-^H] cAMP produced 
decreases as more cAMP is produced, which gives a decrease in the 
sensitivity of the A C assay and erroneously suggests that there is a 
decrease in A C activity. 
• The kinetic calculations of the A C assay assume that all measurements 
of specific activity are of the initial rate of reaction. To maintain this 
assumption, the A C assay conditions must be controlled so that the 
conversion of substrate is kept below 10 %, otherwise there will be a 
significant drop in substrate concentration and specific activity will no 
longer be a measure of the initial rate of reaction. Another reason for 
maintaining the substrate conversion at below 10 % is that high PPi 
concentrations can inhibit A C activity. 
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The 'Investigation into in vitro and in vivo Ci stimulation of Rv1625c204-
443' chapter showed that Rv1625c204^3 was stimulated by C O 2 at pH 6.5 and 
that C O 2 stimulated Rv1625c204^43 through increasing kcat- Rv1625c204^3 was 
also stimulated by C O 2 in vivo. Rv1625c204-443 is the first C l a s s Ilia A C shown 
to be stimulated by C O 2 , although numerous other prokaryotic A C s have been 
previously shown to be C O 2 responsive. The C lass 11 lb A C s Slr1991 from 
Synechocystis P C C 6803 and C y a B I from Anabaena P C C 7120 were both 
proven to be regulated by C O 2 through an increase in kcat (Hammer ef a/., 
2006). As A C s from both C l a s s Ilia and C lass lllb A C s are C O 2 responsive, it 
is possible that all C l a s s III A C s may be responsive to C O 2 . In the literature, 
C lass lllb A C s are defined as being HCO3' responsive (Linder and Schultz, 
2003), however. Hammer et al suggest that the wrong Ci form has been 
previously identified as the activator, as HCO3' is in equilibrium with C O 2 . This 
anomaly is likely due to performing A C s a s s a y s at pH 7.5, where the Ci is 93.9 
% in the form HCO3" and 5.9 % in the form C O 2 . Indeed, experiments 
conducted on the C l a s s lllb A C s mammalian s A C and C y a C from S . platensis 
suggested that HCO3' stimulated these enzymes (Chen et al., 2000), however, 
work done by Townsend et al demonstrated that mammalian s A C is regulated 
not only by HCOs' but by C O 2 as well (Townsend et al., 2009). The C lass Ilia 
G-protein regulated mammalian A C , 7 C 1 . 2 C 2 was also demonstrated to be 
C O 2 activated (Townsend et al., 2009). It is likely that the C O 2 binding 
mechanism is similar to the C O 2 binding mechanism of Rv1625c. Work done 
on the crystallisation of C y a C in the presence of HCO3' did not produce 
crystals and soaking C y a C crystals in HCO3" dissolved the crystals (Steegborn 
et al., 2005). Flash soaking and freezing of the crystal demonstrated a 
conformational change, but as HCO3" was not identified in the structure, the 
conformational change may be induced by C O 2 instead. 
In support of the in vivo C O 2 stimulation of Rv1625c, another C l a s s Ilia 
A C , mammalian 7 C 1 . 2 C 2 has been demonstrated to be regulated in vivo 
(Townsend et al., 2009). 7 C i . 2 C 2 in H E K 293T cells were activated by 5 % 
C O 2 (compared to atmospheric C O 2 ) in the presence of isoproterenol, a P-
adrenergic receptor agonist. 
The 'Elucidation of A C C O 2 binding conditions' chapter showed that 
C O 2 increased the affinity of Rv1625c204.443 for Mn^* and increased the co-
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operativity of the two binding sites for recruiting metal ions. This finding agreed 
with Steegborn et al., who suggested that Ci stimulates A C by recruiting a 
second metal ion to the active site (Steegborn et al., 2005). The authors also 
suggested that Ci stimulation of C y a C causes a marked active site closure, 
however, C D spectroscopy of Rv1625c204^43 (Figure 5.5) did not identify any 
change in secondary structure due to the addition of G O 2 . In the 'Elucidation of 
A C C O 2 binding conditions' chapter, spectroscopic techniques such as FTIR 
spectroscopy and HCO3" dependent luminescence probe spectroscopy were 
explored, but were unable to identify the conditions required for G O 2 binding. 
Binding assays with Rv1625c204^3 using ^''G02 (which had previously been 
used to identify G O 2 binding to Rubisco (Lorimer, 1979)) identified that G O 2 
bound to apoprotein and no other co-factors, such as Mg^ "" or Mn^*, were 
required. A G a s s a y s can not be used to identify whether metal ions are 
required for C O 2 binding as if the metal ions are removed from the assay, no 
catalysis can occur. As G O 2 is not binding directly with the metal ion in the 
active site but aiding metal recruitment, G O 2 is likely bound to a single 
conserved residue or a conserved site in the active site of Rv1625c. A likely 
candidate for a G O 2 binding site is the conserved substrate defining Lys (K296 
in Rv1625c). Gann et al. demonstrated that a point mutation of the substrate 
defining Lys of GyaBI from Anabaena P C C 7120 (K646) ablated Ci activation 
(Cann et al., 2003). The authors suggest that Ci stimulation (in the form of 
HGO3 ) occurs through the formation of a hydrogen bond with K646. However, 
further work from the same lab has identified C O 2 and not HCOs' a s the 
activator of GyaBI (Hammer et al., 2006) and thus the mechanism of 
activation is likely to be C O 2 forming a carbamate with the amino group of the 
substrate defining Lys , a s observed with Rubisco (Lorimer et al., 1976). 
The 'Investigation into potential G O 2 binding sites' chapter showed that 
G O 2 was not binding solely to the substrate defining Lys in Rv1625c, K296, nor 
was it solely binding to 12 other amino group containing residues in the active 
site. The formation of a carbamate is the most likely interaction that G O 2 would 
make to an amino acid, as observed with Rubisco (Lorimer et al., 1976). 
However, G O 2 may be forming a carbamate with a single residue but also 
require stabilisation via other residues in a binding pocket. This would explain 
why no ablation of G O 2 activity was seen in the C O 2 dose dependence assays 
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of single mutant proteins, as other C O 2 binding residues in the binding pocket 
are able to 'bind' C O 2 and cause an activation. With the difficulty in measuring 
E.C.50 values of the mutant proteins, changes in the affinity of C O 2 to the 
mutant proteins can not be calculated. 
s A C can bind both HCO3" and C O 2 , however, it is unknown whether the 
Ci species bind at the same binding site or whether there are two distinct sites. 
Creating the corresponding multiple residue binding sites in Rv1625c of the 
HCOa' binding residues of mammalian s A C , which were identified from the 
crystal structure of s A C and HCO3" (Saalau-Bethell ef a/., 2007), did not ablate 
C O 2 sensitivity and so are unlikely to be the C O 2 binding site. This could be 
due to two main reasons. First, the identified coordinates of HCOa' from the 
s A C crystal structure may not fit into the binding pocket of s A C correctly. This 
was demonstrated by the need to rotate the coordination of the sidechain of 
R176 in the s A C crystal structure to represent its normal orientation and create 
a binding pocket in the structure. If the coordinates of the binding residues 
from the s A C crystal structure were incorrect, the corresponding residues in 
Rv1625c would also be incorrect and the C O 2 binding site would not be 
identified. Second, as s A C can bind both HCOa" and C O 2 , perhaps there are 
two different binding sites for the two Ci species for s A C and as Rv1625c does 
not bind HCO3', mutation of the residues that correspond to the HCOa' site 
would have no affect on C O 2 stimulation of Rv1625c. 
Crystals of Rv1625c were grown and exposed to C O 2 . The diffraction 
data that were collected gave a higher resolution model than previously 
published, but had a high R-factor, which increased the phase error and made 
the electron model density poor. However, even if the Rv1625c structure was 
solved the C O 2 binding site would not be identified since C O 2 would not be 
visible in the structure. This is because C O 2 , with an approximate length of 234 
pm (2.34 A), is smaller than the resolution obtained from the Rv1625c crystal 
(2.8 A) and therefore would not be resolved. As expressing, purifying and 
growing Rv1625c crystals took over 1 month and the diffraction data could only 
be collected at a synchrotron, there was only time for one attempt at solving 
the crystal structure of Rv1625c with C O 2 bound. 
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7.2 Future Work 
The initial future work is to answer the question, what are the C O 2 
binding residues of Rv1625c? The crystal structure of Rv1625c exposed to 
C O 2 is required and so expression, purification and growth of more 
Rv1625c2i2^3 K296E, F363R, D365C mutant protein are required. The 
exposure of the Rv1625c crystal to C O 2 should be repeated and another data 
set collected at a synchrotron facility. To improve the resolution of the 
diffraction data collected, larger crystals are required. The concentration of 
protein solution added to the crystallisation screens may be decreased, as the 
concentrations used (30 mg/mL) formed numerous small crystals, whereas a 
lower concentration of protein solution (e.g. 15 mg/mL) may form fewer 
crystals, but, incubated for a longer time period, the crystals may be larger. An 
ideal time period to initially test is 2 months of growing. The exposure of C O 2 
can also be modified to find the optimal time period for exposure, too short a 
time and C O 2 would not be able to bind, too long a time and the crystal would 
dry out and not diffract correctly. Protein crystals of other C O 2 activated A C 
proteins should also be grown, such as Slr1991 from Synechocystis P C C 6803 
and C y a B I from Anabaena P C C 7120 to confirm that the C O 2 binding site is 
conserved between A C s . As the growing conditions of the new A C s are not 
known, it may take time to identify the correct conditions for optimal crystal 
growth. Mutant proteins may also need to be considered as they were with 
Rv1625c, because native A C protein may dimerise and inhibit crystallisation. If 
mutant proteins are required due to problems with crystallisation of the wt 
proteins, the Slr1991 and C y a B I corresponding triple mutants of Rv1625c2i2-
443 K296E, F363R, D365C would be obvious initial tests, however, other 
mutations may need to be investigated in order to inhibit dimerisation. s A C 
would also be an interesting protein to crystallise and expose to C O 2 , since the 
HC03' binding site has been previously identified by crystallisation (Saalau-
Bethell et a/., 2007), it would be interesting to observe the C O 2 binding site. 
To back up the theory that all C l a s s III A C s are C O 2 responsive, C l a s s 
lllc and C l a s s llld A C s should be assayed for C O 2 responsiveness. Rv1264 
(Under et a/., 2002) and Rv1900c (Sinha et a/., 2005) are both C l a s s lllc A C s 
from M. tuberculosis that have previously been expressed as recombinant 
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proteins and assayed for A C activity. The A C from Candida albicans is a C l a s s 
llld A C that has previously been expressed as a recombinant protein and 
assayed for A C activity (Klengel et a/., 2005). The protein constructs can be 
obtained and the A C proteins expressed and purified. Conducting C O 2 dose 
dependence a s s a y s on the A C s will determine whether they are responsive or 
non-responsive to C O 2 . 
Once all the subdivisions of C l a s s III A C s have been tested for C O 2 
responsive, the next step would be to examine the C O 2 responsiveness of the 
other A C c lasses . Are all A C c lasses C O 2 responsive? A s the other c lasses of 
A C s were formed by convergent evolution, they all have unique catalytic 
domains and it is therefore, unlikely that C O 2 responsiveness is conserved 
within the other c lasses of A C s . The C l a s s I A C Cya from E . coli (Linder, 
2008), the C l a s s II A C E F from 8. anthracis (Guo ef a/., 2004) and the C l a s s IV 
A C A C 2 from A. hydrophilia (Sismeiro ef a/., 1998) have previously been 
expressed as a recombinant proteins, purified and assayed for A C activity. The 
C lass V A C from P. ruminicola (Cotta ef a/., 1998) and the C lass VI A C from R. 
ef// (Tel lez-Sosa ef a/., 2002) have not been expressed as recombinant 
proteins and thus molecular cloning to insert the catalytic domains of the A C 
genes into plasmids would be required before assaying for C O 2 
responsiveness. 
With Rv1625c responsiveness to C O 2 characterised in vitro, another 
area of future work would be to study in vivo C O 2 responsiveness of M. 
tuberculosis and any potential links with virulence via the halting of 
phagosomal acidification (Lowrie ef a/., 1979), and Rv1625c. Is Rv1625c the 
C O 2 sensor for M. tuberculosis? As the M. tuberculosis genome encodes for 
15 putative A C genes, it may be difficult to assign any change in cAMP 
production to Rv1625c and thus, prove that Rv1625c is the C O 2 sensor. A 
rv1625c knockout infected in mice was still pathogenic (Guo ef a/., 2005) and 
the result is likely due to the redundancy provided by the other 14 A C s . M. 
tuberculosis could be grown both in ambient and high C O 2 levels and the 
concentration of cAMP formed measured by E L I S A . It would be hypothesised 
that as long a s high C O 2 levels do not inhibit M. tuberculosis growth, cAMP 
levels will be higher in the presence of high C O 2 than compared to ambient 
C O 2 levels. This result could be compared to a rv1625c knockout strain grown 
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both in ambient and high C O 2 levels. However there may be an identical 
increase in cAMP due to C O 2 stimulation of the other ACs. Therefore, as C O 2 
may play an important role in pathogenesis, the C O 2 sensor in M. tuberculosis 
may not be a single AC, but may be a combination of all ACs. 
In summary, a Class Ilia AC from M. tuberculosis, Rv1625c, has been 
demonstrated to be stimulated by C O 2 both in vitro and in vivo. The conditions 
for C O 2 binding to Rv1625c were investigated using numerous techniques and 
it was identified that C O 2 bound solely to the Rv1625c apoprotein, without the 
requirement of any cofactors or metal ions. The identification of the C O 2 
binding site of Rv1625c was attempted using numerous techniques, however 
the binding site was not elucidated. Further work is required to identify the C O 2 
binding site. 
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